Washington University in St. Louis

Washington University Open Scholarship
Arts & Sciences Electronic Theses and
Dissertations

Arts & Sciences

Winter 12-15-2021

Deconvolving Genomic Regulatory Heterogeneity with SelfReporting Transposons
Arnav Moudgil
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Genetics Commons

Recommended Citation
Moudgil, Arnav, "Deconvolving Genomic Regulatory Heterogeneity with Self-Reporting Transposons"
(2021). Arts & Sciences Electronic Theses and Dissertations. 2617.
https://openscholarship.wustl.edu/art_sci_etds/2617

This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an
authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Division of Biology and Biomedical Sciences
Computational and Systems Biology

Dissertation Examination Committee:
Robi D. Mitra, Chair
Donald F. Conrad
Joseph D. Dougherty
Benjamin D. Humphreys
Samantha A. Morris

Deconvolving Genomic Regulatory Heterogeneity with Self-Reporting Transposons
by
Arnav Moudgil

A dissertation presented to
The Graduate School
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

May 2022
St. Louis, Missouri

© 2022, Arnav Moudgil

Table of Contents
List of Figures .............................................................................................................................. viii
List of Tables ................................................................................................................................. xi
Acknowledgments......................................................................................................................... xii
Abstract ...................................................................................................................................... xviii
Chapter 1: Introduction ................................................................................................................... 1
1.1

Background, Significance, and Scope ............................................................................ 1

1.2

References ..................................................................................................................... 14

Chapter 2: Self-reporting transposons enable simultaneous readout of gene expression and
transcription factor binding in single cells .................................................................................... 35
2.1

Abstract ......................................................................................................................... 35

2.2

Introduction ................................................................................................................... 35

2.3

Results ........................................................................................................................... 39

2.3.1

SRTs can be mapped from mRNA instead of genomic DNA ............................................... 39

2.3.2

SP1 fused to piggyBac directs SRT insertions to SP1 binding sites ..................................... 45

2.3.3

Clustering of undirected piggyBac insertions identifies BRD4-bound super-enhancers ...... 48

2.3.4

scCC simultaneously identifies cell type and cell type-specific BRD4 binding sites ........... 58

2.3.5

scCC identifies binding sites across a spectrum of TFs and in a variety of cell types .......... 63

2.3.6

scCC reveals bromodomain-dependent cell state dynamics in K562 cells ........................... 67

2.3.7

scCC deconvolves cell type-specific BRD4 binding sites in the mouse cortex .................... 75

2.4

Discussion ..................................................................................................................... 82

2.5

Methods......................................................................................................................... 87

2.5.1

Materials and data availability............................................................................................... 89

2.5.2

Experimental model and subject details ................................................................................ 94

2.5.3

DNA- vs RNA-based recovery.............................................................................................. 95

2.5.4

In vitro bulk calling card experiments ................................................................................... 96

2.5.5

Isolation and RT of bulk RNA .............................................................................................. 97

2.5.6

Amplifying self-reporting transcripts from RNA .................................................................. 97

2.5.7

Generation of bulk RNA calling card libraries...................................................................... 98

2.5.8

In vitro single cell calling card experiments.......................................................................... 99

2.5.9

Single cell RNA-seq library preparation ............................................................................. 100

2.5.10

Single cell calling cards library preparation .................................................................. 101

2.5.11

Staining protocols for K562 cells................................................................................... 103

2.5.12

JQ1 treatment of K562 cells........................................................................................... 104

ii

2.5.13

BRD4 CRISPRi of K562 cells ....................................................................................... 104

2.5.14

Imatinib treatments of K562 cells .................................................................................. 106

2.5.15

Cell cycle perturbation of K562 cells ............................................................................ 106

2.5.16

SRT-tdTomato fluorescence validation ......................................................................... 107

2.5.17

In vivo scCC experiments .............................................................................................. 107

2.5.18

Quantification and statistical analysis ............................................................................ 109

2.5.19

Sequencing and analysis: bulk DNA CC libraries ......................................................... 109

2.5.20

Sequencing and analysis: bulk RNA CC libraries ......................................................... 110

2.5.21

Sequencing and analysis: scRNA-seq libraries .............................................................. 111

2.5.22

Sequencing and analysis: scCC libraries ....................................................................... 111

2.5.23

Peak calling on calling card data.................................................................................... 112

2.5.24

TF binding analysis ........................................................................................................ 115

2.5.25

BRD4 sensitivity, specificity, and precision .................................................................. 115

2.5.26

Downsampling and replication analysis ........................................................................ 116

2.5.27

Analysis of external datasets .......................................................................................... 116

2.5.28

Cell state analyses of K562: scRNA-seq and scCC ....................................................... 118

2.5.29

Analysis of K562 experiments ....................................................................................... 118

2.5.30

In vivo scCC analysis and validation ............................................................................. 119

2.5.31

Additional resources ...................................................................................................... 120

2.6

References ................................................................................................................... 120

Chapter 3: The qBED track: a novel genome browser visualization for point processes........... 144
3.1

Abstract ....................................................................................................................... 144

3.1.1

Summary ............................................................................................................................. 144

3.1.2

Availability and Implementation ......................................................................................... 144

3.2

Introduction ................................................................................................................. 144

3.3

Implementation ........................................................................................................... 146

3.4

Applications ................................................................................................................ 149

3.5

Conclusion .................................................................................................................. 152

3.6

References ................................................................................................................... 153

Chapter 4: Fast and optimal genome segmentation with Bayesian blocks ................................. 158
4.1

Abstract ....................................................................................................................... 158

4.2

Introduction ................................................................................................................. 158

4.3

Results ......................................................................................................................... 161

4.3.1

Review of Bayesian blocks ................................................................................................. 161

4.3.2

Calling peaks using Bayesian blocks .................................................................................. 166

iii

4.3.2

Identifying CpG islands using Bayesian blocks .................................................................. 171

4.4

Discussion ................................................................................................................... 174

4.5

Methods....................................................................................................................... 177

4.6

Proofs .......................................................................................................................... 178

4.6.1

Properties of Poisson point processes ................................................................................. 178

4.6.2

Derivation of the Bayesian blocks likelihood function ....................................................... 179

4.6.3

Adapting Bayesian blocks to PELT .................................................................................... 181

4.7

References ................................................................................................................... 182

Chapter 5: Self-reporting transposons reveal chromosomal compartmentalization ................... 190
5.1

Introduction ................................................................................................................. 190

5.2

Results ......................................................................................................................... 191

5.2.1

Sleeping Beauty SRTs are not uniformly distributed across the genome............................ 191

5.2.2

Densities of Sleeping Beauty SRTs reveal chromosomal compartments ............................ 194

5.2.3

Inferring compartmentalization from sparse Sleeping Beauty data ..................................... 199

5.3

Discussion ................................................................................................................... 200

5.4

Methods....................................................................................................................... 202

5.5

References ................................................................................................................... 203

Chapter 6: Future directions........................................................................................................ 212
6.1

Future directions for piggyBac transposon calling cards ............................................ 212

6.2

Future directions for Sleeping Beauty transposon calling cards ................................. 218

6.3

Industrial applications for SRTs ................................................................................. 219

6.4

Tagmentation-free SRTs ............................................................................................. 220

6.5

Expanding the palette of self-reporting transposons ................................................... 223

6.5.1

Mos1 .................................................................................................................................... 223

6.5.2

Tol2 ..................................................................................................................................... 224

6.5.3

LINE-1................................................................................................................................. 225

6.5.4

Helraiser .............................................................................................................................. 227

6.5.5

Final thoughts ...................................................................................................................... 229

6.6

The ecology of chromatin ........................................................................................... 229

6.7

References ................................................................................................................... 230

Appendix 1: Mammalian Calling Cards Quick Start Guide ....................................................... 241
A1.1

Abstract ....................................................................................................................... 241

A1.2

Guidelines ................................................................................................................... 241

A1.3

Materials ..................................................................................................................... 241

A1.4

Steps ............................................................................................................................ 243
iv

A.1.4.1

Cloning and Sequence Validation of YFTF-HyPBase Fusions ...................................... 243

A1.4.2

Functional Validation of YFTF-HyPBase Fusions ......................................................... 243

A1.4.3

Calling Card Library Preparation .................................................................................... 245

A1.4.4

Sequencing, Analyzing, and Visualizing Calling Card Data .......................................... 245

A1.4.5

Next Steps ....................................................................................................................... 246

Appendix 2: Bulk Calling Cards Library Preparation ................................................................ 247
A2.1

Abstract ....................................................................................................................... 247

A2.2

Guidelines ................................................................................................................... 247

A2.3

Materials ..................................................................................................................... 248

A2.4

Steps ............................................................................................................................ 250

A2.4.1

RNA Extraction with QIAGEN's RNEasy Plus Mini Kit ............................................... 250

A2.4.2

cDNA Synthesis .............................................................................................................. 252

A2.4.3

Amplification of Self-Reporting Transcripts .................................................................. 253

A2.4.4

Purification of PCR Products .......................................................................................... 255

A2.4.5

Generation of Bulk Calling Card Libraries ..................................................................... 256

A2.4.6

Final Quantitation and Sequencing ................................................................................. 258

Appendix 3: Single Cell Calling Cards Library Preparation ...................................................... 260
A3.1

Abstract ....................................................................................................................... 260

A3.2

Guidelines ................................................................................................................... 260

A3.3

Materials ..................................................................................................................... 261

A3.4

Steps ............................................................................................................................ 264

A3.4.1

Single Cell Barcoding and Reverse Transcription .......................................................... 264

A3.4.2

Single Cell RNA-seq Library Preparation and Sequencing ............................................ 265

A3.4.3

Amplification of Self-Reporting Transcripts .................................................................. 266

A3.4.4

Purification of PCR Products .......................................................................................... 268

A3.4.5

Single Cell Calling Cards – Circularization .................................................................... 269

A3.4.6

Single Cell Calling Cards – Exonuclease and Setup....................................................... 270

A3.4.7

Single Cell Calling Cards – Shearing and Capture ......................................................... 273

A3.4.8

Single Cell Calling Cards – End Repair, A-Tailing, and Adapter Ligation.................... 274

A3.4.9

Single Cell Calling Cards – Final PCR and Purification ................................................ 277

A3.4.10

Single Cell Calling Cards – Sequencing ......................................................................... 280

Appendix 4: Processing Bulk Calling Card Sequencing Data .................................................... 282
A4.1

Abstract ....................................................................................................................... 282

A4.2

Guidelines ................................................................................................................... 282

A4.3

Materials ..................................................................................................................... 283
v

A4.4

Steps ............................................................................................................................ 284

A4.4.1

Preamble.......................................................................................................................... 284

A4.4.2

Adapter Trimming........................................................................................................... 286

A4.4.3

Alignment........................................................................................................................ 288

A4.4.4

Annotation ....................................................................................................................... 289

A4.4.5

Finishing Up .................................................................................................................... 290

A4.4.6

Notes ............................................................................................................................... 291

Appendix 5: Processing Single Cell Calling Card Sequencing Data .......................................... 294
A5.1

Abstract ....................................................................................................................... 294

A5.2

Guidelines ................................................................................................................... 294

A5.3

Materials ..................................................................................................................... 295

A5.4

Steps ............................................................................................................................ 296

A5.4.1

Preamble.......................................................................................................................... 296

A5.4.2

Adapter Trimming........................................................................................................... 300

A5.4.3

Alignment........................................................................................................................ 302

A5.4.4

Annotation ....................................................................................................................... 304

A5.4.5

Demultiplexing................................................................................................................ 306

A5.4.6

Notes ............................................................................................................................... 311

Appendix 6: Calling Peaks on piggyBac Calling Card Data ...................................................... 313
A6.1

Abstract ....................................................................................................................... 313

A6.2

Guidelines ................................................................................................................... 313

A6.3

Materials ..................................................................................................................... 314

A6.4

Steps ............................................................................................................................ 315

A6.4.1

Preprocessing .................................................................................................................. 315

A6.4.2

Bayesian Blocks .............................................................................................................. 317

A6.4.3

Calling BRD4 Peaks ....................................................................................................... 318

A6.4.4

Calling TF Peaks ............................................................................................................. 323

A6.4.5

Final Thoughts ................................................................................................................ 329

Appendix 7: Visualizing Calling Card Data on the WashU Epigenome Browser ..................... 331
A7.1

Abstract ....................................................................................................................... 331

A7.2

Guidelines ................................................................................................................... 331

A7.3

Materials ..................................................................................................................... 331

A7.4

Steps ............................................................................................................................ 331

A7.4.1

Introduction ..................................................................................................................... 331

A7.4.2

Uploading Data from an External Server ........................................................................ 333

vi

A7.4.3

Uploading Local Data Files ............................................................................................ 342

A7.4.4

Interacting with the Calling Card Track ......................................................................... 344

Appendix 8: Online Resources ................................................................................................... 347
A8.1

Links to Online Resources .......................................................................................... 347

vii

List of Figures
Figure 1.1:
Figure 2.1:
Figure 2.2:
Figure 2.3:
Figure 2.4:
Figure 2.5:
Figure 2.6:
Figure 2.7:
Figure 2.8:
Figure 2.9:
Figure 2.10:
Figure 2.11:
Figure 2.12:
Figure 2.13:
Figure 2.14:
Figure 2.15:
Figure 2.16:
Figure 2.17:
Figure 2.18:
Figure 2.19:
Figure 2.20:
Figure 2.21:
Figure 2.22:
Figure 2.23:
Figure 2.24:

The landscape of multimodal scRNA-seq technologies ..........................................7
Self-reporting transposons (SRTs) are mapped more efficiently from
RNA compared to DNA.........................................................................................40
Properties of self-reporting transposons (SRTs) ....................................................42
piggyBac, SP1-piggyBac fusions, and Sleeping Beauty display different
local transposition rates depending on chromatin state .........................................44
SP1 fused to piggyBac (SP1-PBase) redirects SRTs to SP1 binding sites ............47
SP1 fused to hyperactive piggyBac (SP1-HyPBase) also redirects SRTs to
SP1 binding sites ....................................................................................................48
Undirected piggyBac (PBase) SRTs mark BRD4-bound
super-enhancers (SEs) ............................................................................................50
Undirected hyperactive piggyBac (HyPBase) SRTs also mark BRD4-bound
super-enhancers (SEs) ............................................................................................51
Downsampling undirected and directed piggyBac insertions simulates
assay performance ..................................................................................................53
Redirectability of SP1-piggyBac fusion constructs ...............................................54
Examples of BRD4-bound super-enhancers identified by bulk PBase
and HyPBase calling cards in HCT-116 cells ........................................................55
piggyBac is more tolerant of transcription factor fusions than Sleeping Beauty ...56
BRD4 calling cards with undirected piggyBac is not equivalent to ATAC-seq ....58
Single cell calling cards (scCC) maps BRD4 binding in single cells ....................59
Filtering single cell SRTs reduces intermolecular artifacts ...................................61
Validation and performance of undirected in vitro
single cell calling cards (scCC)..............................................................................63
Single cell calling cards (scCC) works with a variety of
transcription factors (TFs) and cell lines ...............................................................64
Validation and performance of TF-directed in vitro
single cell calling cards (scCC)..............................................................................65
Clustering of K562 cells into stem-like and differentiated states ..........................68
Single cell calling cards uncovers bromodomain-dependent cell state dynamics
in K562 cells ..........................................................................................................69
Validation of bromodomain-dependent K562 cell states.......................................71
Single cell calling cards (scCC) deconvolves BRD4-bound loci in the
mouse cortex ..........................................................................................................76
Clustering of SRT-treated cortical cells and associated marker genes ..................78
Validation of in vivo BRD4 binding in astrocytes and neurons.............................80
Single cell calling cards (scCC) deconvolves BRD4 binding in
viii

Figure 3.1:
Figure 3.2:
Figure 4.1:
Figure 4.2:
Figure 4.3:
Figure 4.4:
Figure 4.5:
Figure 4.6:
Figure 4.7:
Figure 4.8:
Figure 5.1:
Figure 5.2:
Figure 5.3:
Figure 5.4:
Figure 5.5:
Figure 5.6:
Figure 6.1:
Figure 6.2:
Figure 6.3:
Figure 6.4:
Figure 6.5:
Figure A2.1:
Figure A2.2:
Figure A3.1:
Figure A3.2:
Figure A5.1:
Figure A5.2:
Figure A6.1:
Figure A6.2:
Figure A7.1:
Figure A7.2:
Figure A7.3:
Figure A7.4:
Figure A7.5:
Figure A7.6:
Figure A7.7:
Figure A7.8:

cortical excitatory neurons and identifies known layer markers ...........................82
Overview of the qBED format and qBED tracks.................................................148
Application of the qBED specification to other genomic datasets ......................150
Example calling cards tracks ...............................................................................160
Overview of Bayesian blocks ..............................................................................162
Effect of varying p0 on segmentation ..................................................................165
Calling peaks on calling cards data with Bayesian blocks ..................................166
Additional benchmarking of peak calling ............................................................168
TF-directed block sizes are a function of relative enrichment .............................170
Detecting CpG islands with Bayesian blocks ......................................................171
Length distributions of CpG islands ....................................................................174
SB insertion densities are correlated with chromosomal compartment ...............193
Comparison of SB insertion densities by compartment .......................................195
Functional validation of SB compartments..........................................................197
SB compartment analysis of a nucleolus organizing region (NOR) ....................198
Downsampling analysis of SB compartments .....................................................200
Model of transposase activity as function of sub-nuclear localization ................201
Predicted disorder for the hyperactive piggyBac transposase..............................215
Alignment of MMLV's BET interaction motif against piggyBac........................218
Alternative SRT library strategies without tagmentation ....................................221
Proposed workflow for mapping L1 SRTs ..........................................................226
Lineage tracing with self-reporting transposons ..................................................229
Representative products of SRT amplification ....................................................255
Representative TapeStation trace of bulk calling card libraries ..........................259
Representative TapeStation trace of SRT amplification from 10x 3'
scRNA-seq library ...............................................................................................269
Representative TapeStation trace of scCC libraries.............................................280
Example of a 10x Chromium chip loaded for a
single cell calling cards experiment .....................................................................298
Demultiplexing scCC libraries .............................................................................307
Example of a BRD4-directed calling cards peak .................................................323
Example of an SP1-directed calling cards peak ...................................................329
WashU Epigenome Browser splash page ............................................................339
Custom tracks pane ..............................................................................................340
Load custom data hub ..........................................................................................340
Successfully uploaded data hub ...........................................................................341
Default view after uploading data hub .................................................................341
Text track pane .....................................................................................................342
Uploading a calling cards text file .......................................................................343
Default view after uploading text file ..................................................................343
ix

Figure A7.9: Hovering over a calling cards insertion ...............................................................344
Figure A7.10: Calling cards customization pane ........................................................................345
Figure A7.11: Various customizations applied to calling card tracks .........................................346

x

List of Tables
Table 2.1:
Table 2.2:
Table 2.3:
Table 2.4:
Table 2.5:
Table 2.6:

Summary of bulk calling cards experiments ..............................................................45
Summary of single cell calling cards experiments .....................................................61
Breakdown of cortical cell types and scCC HyPBase insertions per cluster .............79
Oligonucleotides referenced in this work ...................................................................87
Key Resources Table ..................................................................................................89
ChromHMM chromatin state annotations in HCT-116 cells ...................................117

xi

Acknowledgments
A PhD may have a clear start and end on a calendar, but it is one part of a larger trajectory of
growth and learning. To properly acknowledge everyone who has helped me on this journey, I
look both before and after in time.
My parents recognized, at an early age, my innate curiosity. I am told, for I have no
recollection of these events, that I asked a lot of questions as a child about how things work and
why the world is the way it is. I am ever grateful that they fostered this personality trait,
encouraging my love for mathematics and science as well as supporting me in my pursuit of a
PhD. Likewise, I am thankful for my siblings, Pranav and Divya, who inspire me to stay
grounded and who are, perhaps, even more excited than I am about finishing this degree.
As an undergraduate, I had a superlative mentor in Jill Helms. She recognized my
potential for a career in science years before I did. Whereas I went through periods of doubt, her
convictions were steadfast. I can only hope to inspire the next generation of scientists to the same
extent that she inspired me.
During these years, I was fortunate to have had the opportunity to work in two
complementary laboratories. Marcus Feldman and Michael Palmer gave me my first shot at
“real” research as a late blooming senior. During these years I first solidified my computational
skills and pursued very theory-driven work. This experience has turned out to be more formative
than I realized at the time, and I am grateful they took me under their wings.
Shortly after graduating, Peter Parham offered me a position in his laboratory. Those two
years I spent as a research technician were invaluable for establishing my current research
trajectory. Coming from a computational background, I picked up a solid foundation of wet lab
xii

skills that would pay dividends during my PhD. It was this experience that illustrated the value
of being equally adept at molecular and informatic methods. While there was a lot of hard work,
there was also a lot of joy. For this, I can only credit my amazing colleagues. In particular, Libby
Guethlein and Paul Norman were fantastic mentors and I was as eager to learn from them as (I
hope) they were eager to teach me. Hugo Hilton, Amir Horowitz, Ana Goyos, Emily
Wroblewski, and Jeroen Blokhuis were all postdocs at the time and created a welcoming,
positive, and playful environment for a young scientist like me. To all of them I say, simply,
thank you.
My support network during this time was a crew of close friends from college,
collectively referred to as Kipling because that was the street on which they were renting a
house. Douglas Stanford, Allison Dedrick, Adam Hepworth, Paul Schaffert, and JD Porter were
Heather’s and my closest friends during this time. At a time when we could have been obsessed
with our careers, worried about whether we were “doing the right thing,” they helped us
celebrate the simple joy of good friendship. Thank you for being there for us.
I would also include Anish Mitra in this group, who bridges the pre- and post-MD/PhD
arcs. Anish and I have been friends since college, and I owe him three key votes of thanks. He
was the first person to encourage me to pursue MD/PhD training. What’s more, he helped sell us
on coming to St. Louis for this opportunity. And finally, he has been consistently supportive and
encouraging throughout this journey. Even though he and his fiancée Rachel have moved away
for residency, we still find time to play board games together over the Internet. Thank you for
having been there for me all this time.
I have learned much from my cohort of fellow MD/PhD students, who find ways to
continually surprise, inspire, and rejuvenate me. It has been an honor to have organized our
xiii

weekly journal clubs, which were cut short not by attrition but by a global pandemic. So, to
Moises Arriaga, Willie Zhang, Gregg Fox, Olga Neyman, Jared Goodman, Kayla Berry, Jerry
Fong, Lindsey Steinberg, Wilbur Song, Deng Pan, Matthew Matlock, Jennifer Stevens, Bernie
Mulvey, Umber Dube, and Drew Sinha: thank you for the past seven years. Heather and I have
grown especially close to Umber, his wife Amanda, Drew, and his wife Marilyn. Here’s to more
nights spent making pizza and playing Overcooked!
To the (as of this writing) 635 people following me on Twitter, as well as the countless
people I have met at conferences, who have listened to me give a talk or stopped by my poster:
thank you! A PhD is difficult, not necessarily due to physical labor, but because it taxes you
mentally and emotionally. There have been difficult moments over the past few years and it has
felt isolating at times. I am grateful for all your kind words, encouragement, and excitement. You
inspire me to pay the warmth forward.
The chapters presented in this thesis give the illusion of a solo body of work. In reality,
modern science is a team effort. While my coauthors are credited in print and online, I would
like to thank them for here as well. Chapter 2 would not have been possible without help from
Michael Wilkinson, Xuhua Chen, June He, Alexander Cammack, Michael Vasek, Tomás
Lagunas, Jr., Zongtai Qi, Matthew Lalli, Chuner Guo, Samantha Morris, and Joseph Dougherty.
Chapter 3 came together thanks to the concerted efforts Daofeng Li, Silas Hsu, Deepak
Purushotham, and Ting Wang. Chapter 4 would not exist but for the generous help provided by
Jeffrey Scargle and Rebecca Killick. Finally, I am indebted to Zoltán Ivics, Ivana Grabundzija,
Fred Dyda, and Alex Holehouse for their contributions to Chapter 6. My thesis committee, which
includes Sam and Joe as well as Don Conrad and Ben Humphreys, has been consistently

xiv

supportive. They all wrote me letters of reference for my NIH fellowship application and helped
sharpen my writing. Thank you for guiding me along the path.
It takes a lab to raise a graduate student, and while the Mitra Lab has experienced
turnover during my five years, one constant has been their collective push for rigor. One of my
aims in graduate school was to build a solid foundation in scientific reasoning and methodology,
and if I have succeeded it is thanks to my fellow lab members. Zongtai Qi taught me to be a
better bench scientist. Justin Melendez taught me to think laterally about molecular biology.
Christian Shively taught me to think deeply about my biological system. Jiayue Liu taught me to
blend biology with computation. Xuhua Chen taught me to be consistent. Matthew Lalli taught
me to carefully dissect biological arguments. Michael Wilkinson taught me to think big. Alex
Cammack, an honorary lab member, taught me to relax. To all the rotation students I mentored,
you have taught me to be a better teacher and leader. To all the new members who have joined
recently, you have taught me to be optimistic for the future.
I am extremely fortunate and grateful to have had Rob Mitra as my mentor for graduate
school. One reason why this partnership has been particularly successful is that Rob and I
naturally think along similar lines. Thus, we have been on similar wavelengths for much of this
journey. Beyond that, Rob is generous. For the vast majority of my PhD, we have had a standing,
hour-long meeting every Thursday morning. What started as a way for him to make sure I was
making progress gradually evolved into a more spontaneous conversation where I could take the
lead. These meetings were effective precisely because Rob is open to talking about anything. In
addition to the usual project-specific discussions, we have had freewheeling conversations
ranging from the philosophical nature of science, the career challenges facing academics,
fundamental problems in biology and mathematics, and practical advice for leadership. This last
xv

point cannot be stressed enough: one of the main ways I have grown during my PhD is as a
project manager, which Rob has enthusiastically supported. Finally, Rob is an eternal optimist
and great motivator. I can come into his office prepared to wallow about something and I
inevitably leave feeling better than when I walked in. This kind of buoyancy is key part of Rob’s
mentorship style. Rob, thank you for a transformative five years. I am excited to see what the
next five have in store for both of us.
To close, I look to the new family that has nucleated around me in the past few years. My
in-laws, Larry and Pita Benz, and their extended families, have been very positive during my
PhD. I know they are incredibly proud and excited for me, and I am thrilled to have their
support. Heather and I have been together for almost ten years now, married for almost three.
When we first started dating, she had unwavering confidence in my decision to pursue MD/PhD
training. To this day, her belief in me has not faltered. She reminds me to keep things in
perspective, to take breaks as needed, and to have more fun outside. Neither of us expected to
spend the past few months in self-imposed house arrest during a global pandemic while the
world literally, and figuratively, burns to the ground. But I would not choose to spend them with
anyone else.
During this time, we brought our daughter Ruby into the world. She is a shining light of
unbridled potential and a reminder of what is most important in life. Ruby, you do not realize it
yet, but your charming little smile is an instant cure for a stressful day. It is a privilege and joy to
see you grow. Thank you.
Arnav Moudgil
Washington University in St. Louis
May 2022
xvi

Dedicated to Ruby, whose toothless smile sparks joy

xvii

ABSTRACT OF THE DISSERTATION
Deconvolving Genomic Regulatory Heterogeneity with Self-Reporting Transposons
by
Arnav Moudgil
Doctor of Philosophy in Biology and Biomedical Sciences
Computational and Systems Biology
Washington University in St. Louis, 2022
Professor Robi David Mitra, Chair
A cell’s identity is a function of the genes expressed in that cell, which are in turn
regulated by transcription factors. Over the last decade, single-cell RNA sequencing (RNA-seq)
has emerged as a powerful class of techniques to characterize cellular diversity in heterogeneous
tissues. These methods barcode transcripts by their cell-of-origin and assign them to specific
genes. The resulting high-dimensional data are further processed to reveal clusters of cells
sharing transcriptional states. Annotating these clusters, based on either known or discovered
marker genes, offers a glimpse into the dynamic composition of an organ or biological process.
While single-cell RNA-seq excels at describing cell states, it alone does not inform us
about the mechanisms maintaining a particular state. In recent years, multi-modal single cell
technologies have flourished, combining single cell RNA-seq with at least one other genomic
modality. As a result, joint assays now exist for assaying gene expression simultaneously with
genotype, with methylation, with chromatin accessibility, or with lineage. Collectively, these
methods aim to connect gene expression to regulatory processes in the genome, thereby gaining
insight into the molecular foundations underpinning cellular identity.
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Transcription factors are key protein regulators of gene expression. Master transcription
factors organize gene regulatory networks to promote differentiation or homeostasis and are
often used as markers of cell type. Unfortunately, no methods exist to measure single-cell RNAseq and map transcription factor binding in those same cells. Such a technique would be uniquely
poised to identify both the identity of a cell and candidate regulatory elements contributing to
that identity. The Mitra Lab has developed transposon calling cards as an alternative assay to
map transcription factor binding, using transcription factor-transposase fusions to mark binding
sites with deposited transposon sequences. Here, I present a single cell extension of this
technique using a novel construct, the self-reporting transposon, whose genomic location can be
mapped from single-cell RNA-seq libraries. Thus, in one workflow, single cell calling cards
identifies cell types in complex systems and deconvolves cell-type-specific regulatory elements
bound by a transcription factor in those cell types.
The remainder of this dissertation is organized as follows. Chapter 1 reviews the
biological and technological context for this work, with particular focus on single-cell RNA-seq
techniques and methods to assay transcription factor binding sites. Chapter 2 presents the central
advancement of this dissertation, the self-reporting transposon and its use in single cell calling
cards to map cell-type-specific transcription factor binding sites in complex systems. Chapter 3
discusses the qBED track, a medium for visualizing calling cards data, and its accompanying
data format for storing results. Chapter 4 examines the Bayesian blocks algorithm, a method
adopted from the astrophysics community, and employs it to call peaks in calling cards data.
Chapter 5 explores a new use for self-reporting transposons as surveyors of chromosomal
compartmentalization. Chapter 6 concludes this dissertation, offering suggestions for future work
and positing a broader role for self-reporting transposons in genomics.
xix

Chapter 1: Introduction
1.1 Background, Significance, and Scope
Multicellular life is characterized by heterogenous populations of cells woven together to form
tissues and complex organs. How such diversity arises is a fundamental and cross-disciplinary
question in biology (Trapnell, 2015). Cataloging the diversity of cell types in an organism has
inspired several cellular atlas projects (Han et al., 2018b, 2018b; Karaiskos et al., 2017; Regev et
al., 2017) but these efforts are complicated by variability in cell state. For example, individual
skeletal muscle cells may appear uniform under a microscope but can have diverse expression
patterns of myosin isoforms (Biressi et al., 2007). Cell types traditionally thought to be relatively
homogeneous, such as neutrophils (Silvestre-Roig et al., 2016) and tissue-specific stem cells
(Goodell et al., 2015; Krieger and Simons, 2015), are proving to be much more functionally
diverse than previously appreciated. Such heterogeneity is not simply restricted to normal
development. Cellular diversity is also a hallmark of pathologies like cancer (Almendro et al.,
2013). A tumor cell population can have widely varying morphologies, gene expression profiles,
and chemotherapeutic resistance potentials (Brooks et al., 2015; Knoechel et al., 2014;
Litzenburger et al., 2017; Michor and Polyak, 2010). This can present practical challenges for
diagnostics, therapy, and prognosis. Characterizing cell type diversity, while a necessary first
step, is not sufficient to mechanistically understand how cell identity is generated during
development, maintained during homeostasis, and ultimately dysregulated during disease.
Single-cell RNA sequencing (scRNA-seq) is revealing cellular heterogeneity at
unprecedented resolution. Investigators have used these methods to discover new subpopulations
of cells in the immune compartment (Jaitin et al., 2014; Shalek et al., 2014), brain (Zeisel et al.,
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2015), lungs (Plasschaert et al., 2018; Treutlein et al., 2014), intestine (Grün et al., 2015), and
retina (Macosko et al., 2015); to profile rare circulating tumor cells in cancer patients (Cann et
al., 2012; Miyamoto et al., 2015; Ramsköld et al., 2012); and uncover patterns of transcription
during embryogenesis (Xue et al., 2013) as well as facilitate preimplantation diagnosis (Yan et
al., 2013). In one particularly memorable example, researchers discovered a previously
uncharacterized subset of planarian neoblast that, when transplanted into a carcass, completely
regenerated an entire worm (Zeng et al., 2018). A major strength of scRNA-seq is that it allows
researchers to sample tissues in an unbiased fashion and detect new cell types for which there is
no known marker or culture method (Jaitin et al., 2014; Shapiro et al., 2013; Wen and Tang,
2016). This kind of discovery, in one sense a eukaryotic equivalent to bacterial metagenomics
(Lasken, 2012), represents the power and promise of scRNA-seq.
Single-cell transcriptomic technologies are rapidly evolving. Following the first
demonstration of single-cell RNA sequencing (Tang et al., 2009), researchers have developed
STRT-seq (single-cell tagged reverse transcription) (Islam et al., 2011, 2012), Smart-seq/Smartseq2 (Picelli et al., 2013; Ramsköld et al., 2012), CEL-seq/CEL-seq2 (cell expression by linear
amplification) (Hashimshony et al., 2012, 2016), Quartz-seq (Sasagawa et al., 2013), MARS-seq
(massively parallel single-cell RNA-sequencing) (Jaitin et al., 2014), MALBAC-RNA (multiple
annealing and looping-based amplification cycles) (Chapman et al., 2015), Drop-seq (Macosko
et al., 2015), inDrops (Klein et al., 2015), 10x Genomics (Zheng et al., 2017), sci-RNA-seq (Cao
et al., 2017), and SPLiT-seq (Rosenberg et al., 2018), to name a few. (Many of these techniques
are concisely reviewed in (Wen and Tang, 2016).)
Broadly speaking, scRNA-seq methods rely on isolating single cells into either individual
wells of a culture plate or within microliter-sized droplets (Wen and Tang, 2016). The cells are
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lysed, messenger RNA (mRNA) is reverse transcribed, and a complementary DNA (cDNA)
library is created. The use of barcoded adapters and template-switching oligonucleotides
uniquely labels molecules from each cell, which are then pooled and sequenced. The resulting
reads are mapped to a reference genome to identify which genes are expressed and the barcode is
used to link gene expression values to individual cells. A gene expression matrix can then be
constructed with cell barcodes along one axis and gene expression values along the other.
Clustering algorithms reduce the high-dimensional transcriptional profiles of individual cells into
groups of cell types with shared transcriptomic profiles (Becht et al., 2019; Grün et al., 2015;
Satija et al., 2015; Xu and Su, 2015; Zeisel et al., 2015). The pattern of gene expression within
each cluster can then be used to assign cell type. Recently, researchers have been able to overlay
directional information on top of clusters by comparing the relative ratios of intronic to exonic
read counts (La Manno et al., 2018; Svensson and Pachter, 2018).
The assorted scRNA-seq methods have their strengths and weaknesses. STRT-seq only
captures the 5’ ends of transcripts while CEL-seq captures the 3’ ends. Although this may be
suitable for measuring gene expression, they cannot be used to detect alternative splicing or
isoform switching. Smart-seq creates a shotgun library out of the entire transcript, which avoids
biasing data towards either end, but is incompatible with the use of unique molecular indexes
(UMIs) (Ziegenhain et al., 2017). Individual cells contain such little mRNA (Macaulay and Voet,
2014) that amplification bias, drop-out, and other PCR artifacts can skew the interpretability of
the final dataset. UMIs enable digital counting of transcripts, which is a more noise-tolerant way
of measuring transcript abundance than relative comparisons of mRNA content (Islam et al.,
2013).
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Methods relying on manual processing of individual cells in wells can sequence, at most,
a few hundred cells per run (Wen and Tang, 2016). The Fluidigm C1 microfluidic platform has
been another popular option for scRNA-seq (Achim et al., 2015; Bacher and Kendziorski, 2016;
Xin et al., 2016) because of its ability to automatically sort cells into 96-well plate, perform
reverse transcription, and generate sequencing libraries in a hands-off manner (Hebenstreit,
2012). Although it can be used to sequence several hundreds of cells in a single experiment
(Wen and Tang, 2016), it is the most expensive platform for scRNA-seq due to its use of
proprietary equipment and consumables (Ziegenhain et al., 2017). More self-reliant platforms,
like Drop-seq (Macosko et al., 2015) and inDrops (Klein et al., 2015), provide microfluidic
scRNA-seq at an affordable price point. 10x Genomics’ Chromium platform has further
increased adoption of scRNA-seq by offering easy-to-use kits and competitive cell recovery rates
(Zheng et al., 2017). Recently, microwells (Han et al., 2018b) and combinatorial barcoding
strategies (Cao et al., 2017; Datlinger et al., 2021; Rosenberg et al., 2018) have pushed scRNAseq to ever larger library sizes, breaking the million-cell barrier (Cao et al., 2019).
Drop-seq provides a representative example of how microfluidic scRNA-seq techniques
work. This method uses microparticle beads which are tagged polythymidine oligonucleotides.
Each oligonucleotide on a bead has a constant sequence (SMART), a 12-bp barcode shared
across each of probes (the cell barcode), and an 8-bp UMI which is unique to each
oligonucleotide. The beads are sent through a microfluidic device in a lysis buffer where they
intersect a parallel stream of single cells in suspension. Immediately afterwards, an oil stream
splits the aqueous stream into distinct microfluidic droplets. These droplets now contain a single
cell and as the cell lyses, polyadenylated mRNA molecules are captured by the polythymidine
sequences on the bead. Library preparation occurs in bulk after droplets have been disrupted.
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However, single-cell resolution is retained due to the incorporation of the cell barcode and UMI
into the cDNA. Amplification of the cDNA followed by tagmentation results in a library of 3’
transcript ends tagged with information connecting them to cell-of-origin (cell barcode) and
transcript-of-origin (UMI).
This library is sequenced and the reads are mapped to a reference. To classify cell types
from this data, a digital gene expression (DGE) matrix is generated. This table lists cell barcodes
along one axis and genes along the other. The values in the matrix are integer counts of the
number of UMIs observed for a given gene for a specified cell barcode. Each UMI can only have
originated from a single transcript, but PCR jackpotting (Cha and Thilly, 1993) may lead to the
preferential and disproportionate amplification of a few molecules (Lou et al., 2013). Restricting
the values of the matrix to the UMI counts helps correct for these kinds of biases (Stegle et al.,
2015).
A number of informatic strategies can be used to identify transcriptionally distinct groups
of cells (Butler et al., 2018; Hsu and Culhane, 2020; Satija et al., 2015; Stuart et al., 2019; Wolf
et al., 2018). Typically this process begins by identifying a subset of highly variable genes across
the dataset, then performing a combination of principal components analysis (PCA) of these
genes followed by either t-distributed stochastic neighbor embedding (t-SNE) (van der Maaten
and Hinton, 2008) or uniform manifold approximation and projection (UMAP) (McInnes and
Healy, 2018). PCA clusters cells according to vectors which are linear combination of genes;
these vectors reflect genes that strongly covary with each other (Heimberg et al., 2016). This
high-dimensional representation is then transformed into a two-dimensional projection (using tSNE or UMAP) such that points that were close to each other in high-dimensional space remain
close to each other in low-dimensional space. Clusters are identified within this representation
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using either a density-based approach (Ester et al., 1996) or community detection algorithms
(Blondel et al., 2008; Traag et al., 2019) Finally, the clusters are organized hierarchically and
gene expression profiles within each cluster are used for cell type assignment. The original Dropseq paper used this method to discover rare subpopulations of retinal amacrine cells that had not
been previously described and proposed new marker genes for their identification (Macosko et
al., 2015).
Limitations of Drop-seq, and droplet microfluidic methods more generally, include a low
cell capture efficiency: the ratio of beads to cells is chosen to minimize the number of droplets
containing two cells (Macosko et al., 2015). As a result, only about 5% of beads will be
encapsulated with a cell, while the rest of the droplets will be empty (i.e. a bead without a cell)
(Ziegenhain et al., 2017). Thus, relatively large number of cells are required as input into the
microfluidic device, posing a challenge for rare cell type detection. Close packing of hydrogel
beads containing barcoded reverse transcription primers improves cell recovery rates (Klein et
al., 2015; Zheng et al., 2017). There are also limits to the amount of mRNA captured by the
microparticles; estimates suggest that only 10-20% of all mRNA in a droplet is actually
represented in the final library (Macosko et al., 2015), which could result in data biased towards
abundantly transcribed genes. Despite this low-coverage libraries can still be used for cell type
classification due to strong covariances within gene expression networks (Heimberg et al., 2016).
Multi-modal scRNA-seq techniques have emerged to mechanistically understand the
factors governing a particular transcriptional state (Figure 1). We now have methods to
simultaneously measure single cell transcripts and: genotype (Dey et al., 2015; Han et al., 2018a;
Li et al., 2015; Macaulay et al., 2015); methylated cytosines (Angermueller et al., 2016; Hu et
al., 2016); chromatin accessibility (Cao et al., 2018; Ma et al., 2020); protein levels
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(Katzenelenbogen et al., 2020; Peterson et al., 2017; Stoeckius et al., 2017); genetic perturbation
(Datlinger et al., 2017; Dixit et al., 2016; Jaitin et al., 2016); and lineage (Alemany et al., 2018;
Biddy et al., 2018; Raj et al., 2018; Spanjaard et al., 2018; Wagner et al., 2018). However, one
major class of studies that, until very recently, was absent from this suite of techniques were
transcription factor binding assays.

Figure 1.1: The landscape of multimodal scRNA-seq technologies. Methods in grey are theoretically compatible
with scRNA-seq but have not demonstrated this in practice.

Transcription factors (TFs) encompass DNA-binding and chromatin-associated proteins
that regulate gene expression. It is well-established that TFs are responsible for determining cell
fate and maintaining cell identity (Baumgardt et al., 2007; Hevner, 2006; Holmberg and
Perlmann, 2012; Iwafuchi-Doi and Zaret, 2016; Kuo and Grabtree, 1992; Orkin and Zon, 2002;
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Roeder and Radtke, 2009; Wilson et al., 2003). TFs can directly bind promoters as well as more
distant elements termed enhancers. A subset of enhancers known as super-enhancers are thought
to regulate cell identity genes and are characterized by high densities of cell-type-specific TFs,
permissive epigenetic marks, and transcriptional coactivators like BRD4 and MED1 (Di Micco
et al., 2014; Hnisz et al., 2013; Niederriter et al., 2015; Whyte et al., 2013). Overexpression of
TFs can force the transdifferentiation of one cell type into another (Holmberg and Perlmann,
2012; Liu et al., 2008; Megeney et al., 1996; Takahashi and Yamanaka, 2006; Tapscott, 2005),
while removal of binding sites can profoundly alter morphology (Gonen et al., 2018; Kvon et al.,
2016).
TF binding is commonly assayed using chromatin immunoprecipitation followed by
sequencing (ChIP-seq) in which cellular proteins and DNA are chemically crosslinked with
formaldehyde (Johnson et al., 2007; Park, 2009; Shlyueva et al., 2014). The DNA is then
sonicated to an average of 200-600 bp fragments; optionally, fragmentation with an exonuclease
(ChIP-exo), micrococcal nuclease (ChEC-seq), or the transposase Tn5 can be used to increase
resolution (Furey, 2012; Schmid et al., 2004; Schmidl et al., 2015; Skene and Henikoff, 2017;
Zentner et al., 2015). An antibody isolates fragments of genomic DNA bound by the TF of
interest. The TF-DNA crosslinks are reversed and the freed DNA is used to construct a
sequencing library whose reads should map back to regions bound by the TF. Another approach
to identifying binding sites, DamID, relies on fusing TFs to Escherichia coli DNA adenine
methyltransferase (dam) (Greil et al., 2006; Vogel et al., 2007). When the fusion protein binds
DNA, the dam domain methylates adenines at nearby GATC sites. This modification does not
occur naturally in mammalian cells and so is specific to the TF fusion. A methylation-specific
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PCR amplifies bases bound by the TF and sequencing these reads should correspond to TF
binding sites.
DNase-seq (Song and Crawford, 2010) and assay for transposase-accessible chromatin
using sequencing (ATAC-seq) (Buenrostro et al., 2013) are two methods for identifying open
chromatin. They work by either lightly digesting or tagmenting (Adey et al., 2010) the genome,
which fragments unbound DNA. Sequencing these regions can lend insight into which genes
may be actively transcribed; meanwhile, regions that were not found by sequencing may be
silenced. By themselves, however, these methods cannot inform us as to which TFs may be
regulating the activity of particular genes. Instead, they describe regions where certain binding
motifs may be accessible or not (Stergachis et al., 2013), but this is correlative evidence at best,
not causal. Different TFs can share very similar motifs, making it even more difficult to identify
which protein was actually bound (Shively et al., 2019). In combination with TF-specific ChIPseq, ATAC-seq data has been used to infer TF binding (Buenrostro et al., 2013), but this
necessitates having good ChIP-seq data for a particular cell type.
No technologies exist to jointly assay gene expression and TF binding in single cells.
Such a technique would be uniquely poised to make mechanistic connections between TF
activity and cell identity. Several antibody-based single cell techniques have recently been
developed to measure DNA-protein contacts (Ai et al., 2019; Carter et al., 2019; Grosselin et al.,
2019; Hainer et al., 2019; Harada et al., 2019; Kaya-Okur et al., 2019; Rotem et al., 2015; Wang
et al., 2019) but they are unable to also recover mRNA. As such, their use is restricted to predefined cell types and, in general, for highly abundant proteins like histones and master TFs.
Single cell DamID has been reported (Kind et al., 2013, 2015) and has recently been combined
with scRNA-seq (Rooijers et al., 2019) but has only been used for studying interactions between
9

the genome and the nuclear lamina. Thus, to measure TF binding in single cells, a new method is
needed.
Our lab has previously developed transposon calling cards as a unique method of
recording interactions between DNA-binding proteins and the genome (Wang et al., 2007, 2011,
2012). It relies on two components: a transposable donor element (the “calling card”), which
becomes permanently integrated into the genome; and a helper, which is a TF fused to either a
protein that directs a transposase–as in yeast; (Shively et al., 2019; Wang et al., 2007, 2011)–or a
transposase itself–as in mammalian cells; (Cammack et al., 2020; Wang et al., 2012; Yen et al.,
2018). The TF-transposase complex directs insertion of the donor element to genomic loci
visited by the TF. After a period of time, genomic DNA is harvested, transposon insertions are
recovered, sequenced, and analyzed.
For mammalian cells we use the piggyBac (PB) transposase (PBase), originally isolated
from the moth Trichoplusia ni (Yusa, 2015), and its hyperactive version (HyPBase) (Yusa et al.,
2011) as helpers. These proteins show robust activity in a variety of animal cell types (Di Matteo
et al., 2014; Galvan et al., 2009; Wu et al., 2006; Yusa, 2013) and are amenable to N-terminal TF
fusions (Wu et al., 2006). The donor element is a screenable or selectable marker gene (e.g.
tdTomato, puromycin N-acetyltransferase) flanked by PB terminal repeat sequences. Between
the marker gene and the downstream terminal repeat, we have added a bank of restriction sites, a
barcode sequence (to uniquely identify a particular donor), and a next-generation sequencing
site. In a typical calling cards experiment, a plasmid encoding the TF-PBase is transfected along
with several barcoded donor plasmids. The TF-PBase directs insertion of the donor transposons
near TF binding sites. The timing of transposase activity is critical for recording. One way to
manage this is to simply transfect the helper plasmid when we want to record TF binding. We
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can also fuse TF-PBase to the estrogen receptor ERT2 (Cadiñanos and Bradley, 2007) or a
destabilization domain (Banaszynski et al., 2006) to create an inducible transposase (Higdon III,
2015; Mayhew, 2014; Qi et al., 2017). These constructs are inactive until treatment with
tamoxifen, an estrogen analog, or the small molecule Shld1, respectively. When induced, the TFPBase directs insertion of the donor into the genome; upon removal of these agents, TF-PBase
activity stops (Qi et al., 2017).
At a later point, we harvest cells, isolate genomic DNA, and digest it. The fragmented
libraries are then diluted and incubated overnight to promote self-circularization. Next, an
inverse PCR is performed to specifically amplify transposon insertions that have successfully
circularized. The products of this step are sent for high-throughput sequencing. One read will
start within the terminal repeat, read through the PB insertion site motif (“TTAA”) and into
genomic sequence. The other read will pick up the barcode labeling that donor sequence. The
first read is trimmed and mapped back to the genome, which informs us to loci visited by the TF.
To increase confidence that a given mapped read represents a true TF-genome interaction, we
require multiple barcoded insertions at the same locus.
Integration of the donor sequence provides a permanent record of TF-genome
interactions. These marks are stably passed on during mitosis, so interactions recorded in
progenitor or stem cells are preserved in terminally differentiated cell types. The differentiated
cells may also be more numerous than the progenitor cells, so in a sense the TF binding signal
becomes naturally amplified. We have successfully used transposon calling cards to map TF
binding in progenitor motor neurons in mouse embryoid bodies (Mayhew, 2014) and in zebrafish
embryos (Higdon III, 2015).
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One understandable criticism of transposon calling cards is the potential for mutagenesis
caused by the TF-PBase fusion integrating donors into the genome. Off-target effects in a stem
cell population may lead to aberrant development and thus may not represent normal
transcriptional regulation. Moreover, gene trap constructs delivered with piggyBac has been used
to discover cancer driver genes (Cadiñanos and Bradley, 2007). Our experience suggests that in
vivo mutagenic effects are not a significant concern. Transfection of zebrafish embryos with
calling cards plasmids revealed successful transposition in nearly every cell without a visible
phenotypic effect (Higdon III, 2015). Typically, we expect 50-100 insertions per cell, a small
number of relative to the size of vertebrate genomes. Our model organisms are also diploid, so in
the event that one promoter or enhancer is disrupted, the other copy may still be haplosufficient.
TF-PBase constructs tend to insert donors 100-300 bases away from the TF binding site (Wang
et al., 2012), so the ability of the TF to bind and exert its function is likely preserved. Finally, in
diploid yeast–which has much smaller intergenic regions than mammalian genomes–we recover
essential genes at comparable frequencies to non-essential genes (Wang et al., 2011), suggesting
at most a tolerable amount of mutagenesis.
Other limitations are related to sequence constraints. The piggyBac transposase almost
always inserts into TTAA tetranucleotide motifs (Wang et al., 2012). In relatively GC-rich
regions, there may be no suitable insertion site and so a potentially meaningful TF interaction
may not be recorded. Furthermore, genomic sequence downstream of the insertion must contain
one of the restriction sites found in the donor sequence. If no site is sufficiently close, the inverse
PCR product will be too long to sequence on the Illumina platform (Wang et al., 2012). One
potential way to overcome this is to use capture probes designed against the piggyBac terminal
repeat, thereby isolating all the insertions in the genome (Mann et al., 2016).
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Applying transposon calling cards to heterogeneous tissues is not straightforward. Bulk
calling card data would have the same interpretability problem that faces ChIP-seq: we would
observe an amalgam of binding sites without a clear link to any particular cell type. While
scRNA-seq can successfully identify unique cell types, it is an RNA-based technique while
transposon calling cards is a DNA-based assay. Dual-assay techniques that combine genome
sequencing with scRNA-seq have recently been described (Macaulay et al., 2015) but amplifying
genomic DNA from single cells is susceptible to allelic dropout and amplification bias (Gawad et
al., 2016). Given the relatively small number (50-100) of insertions per cell we expect, relying
on single-cell genome sequencing may result in noisy data that would not adequately reflect a
TF’s binding portfolio.
Our solution, as described over the remainder of this dissertation, is the “self-reporting”
transposon. This is a novel calling card donor that can be isolated from RNA instead of DNA.
This is one of our standard piggyBac donor plasmids with a puromycin resistance marker driven
by the constitutively active promoter elongation factor 1-alpha (EF-1ɑ). Unlike prior donors,
however, this construct lacks a polyadenylation signal. Thus, as RNA polymerase II transcribes
the resistance gene, it continues through the downstream PB terminal repeat and into the flanking
genomic sequence. Hence, it “self-reports” its genomic coordinates via mRNA.
Our new method, single cell calling cards, enables single cell recovery of SRTs. This
protocol starts from scRNA-seq libraries, allowing us to characterize the transcriptomes our cell
population and assign cell barcodes to distinct clusters. Transcripts from SRTs are captured and
tagged with cell barcodes and UMIs alongside cellular mRNA. We can specifically amplify the
SRT transcripts and create a library where both the junction of the genome-SRT junction and the
cell barcode and UMI are on the same piece of DNA. High-throughput sequencing allows us to
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map each insertion to a specific cell barcode. By aggregating insertion sites found across all
barcodes within a cluster, we characterize the TF binding profiles of each cell type. Thus, with
one single cell calling cards experiment we can assay TF binding across multiple cell types, free
from the constraints of in vitro cultures.
Finally, while SRTs clearly enable single cell calling cards, the idea of SRTs may have
broader utility than TF binding. Any genomic assay extracting location information could, in
theory, be combined with scRNA-seq via SRTs. Deploying SRTs across the genome, particularly
in an unbiased fashion, could be used to discover underappreciated regulatory mechanisms such
as cryptic polyadenylation or splicing. More abstractly, the location of the SRT itself can be
conceptualized as a positional barcode. Since transpositions are vertically transmitted, their
distribution across a population of cells may reflect patterns of clonality and be used to infer
lineage relationships. Finally, conditionally expressed SRTs may be useful as molecular sentinels
of a kind, activating in response to upstream triggering events. Whether these constructs are
widely adopted by the genomics community remains to be seen. In the interim, we might
surprise and delight ourselves by thinking creatively and open-mindedly about SRTs and their
application.
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Chapter 2: Self-reporting transposons enable
simultaneous readout of gene expression and
transcription factor binding in single cells
(A version of this chapter was published in Cell 182, pp. 992-1008)

2.1 Abstract
Cellular heterogeneity confounds in situ assays of transcription factor (TF) binding. Single cell
RNA-seq (scRNA-seq) deconvolves cell types from gene expression, but no technology links
cell identity to TF binding sites (TFBS) in those cell types. We present self-reporting transposons
(SRTs) and use them in single cell calling cards (scCC), a novel assay for simultaneously
measuring gene expression and mapping TFBS in single cells. The genomic locations of SRTs
are recovered from mRNA, and SRTs deposited by exogenous, TF-transposase fusions can be
used to map TFBS. We then present scCC, which maps SRTs from scRNA-seq libraries,
simultaneously identifying cell types and TFBS in those same cells. We benchmark multiple TFs
with this technique. Next, we use scCC to discover BRD4-mediated cell state transitions in K562
cells. Finally, we map BRD4 binding sites in the mouse cortex at single cell resolution,
establishing a new method for studying TF biology in situ.

2.2 Introduction
Transcription factors (TFs) regulate gene expression during the most critical junctures in the
specification of cell fate (Gurdon, 2016; Hafler et al., 2012; Mizuguchi et al., 2001; Zhu et al.,
2012). They are central to the maintenance of stem cell pluripotency (Liu et al., 2008; Takahashi
and Yamanaka, 2006) and are required for normal organogenesis during development (Fogarty et
al., 2017). Overexpression of certain TFs can transdifferentiate one cell type into another (Davis
et al., 1987), while abolishing TF binding sites can result in striking global phenotypes (Gonen et
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al., 2018; Kvon et al., 2016). Furthermore, the pattern of TF binding is often dysregulated in
disease states (Lee and Young, 2013). A better understanding of TF binding during tissue
development and homeostasis would provide insights into how cellular diversity arises and is
maintained under normal and abnormal biological conditions.
In the past few years, single cell RNA-seq (scRNA-seq) has emerged as the de facto
paradigm for characterizing cellular diversity in complex tissues and organisms (Campbell et al.,
2017; Cao et al., 2017; Fincher et al., 2018; Han et al., 2018; Karaiskos et al., 2017; Zeisel et al.,
2015). More recently, multi-modal scRNA-seq technologies have been developed (Angermueller
et al., 2016; Cao et al., 2018; Clark et al., 2018; Dey et al., 2015; Macaulay et al., 2015; Peterson
et al., 2017; Stoeckius et al., 2017) that link transcriptional information to other genomic assays.
These methods are motivated by the realization that while scRNA-seq can describe the current
state of a biological system, it alone cannot explain how that state arose. Thus, for a given
population of cells, one can now simultaneously measure transcriptome and genome (Dey et al.,
2015; Macaulay et al., 2015), or methylome (Angermueller et al., 2016; Clark et al., 2018), or
chromatin accessibility (Cao et al., 2018; Clark et al., 2018), or cell surface markers (Peterson et
al., 2017; Stoeckius et al., 2017). These techniques enable greater insight into the regulatory
processes driving individual transcriptional programs.
A notable lacuna in the single cell repertoire is a method for simultaneously assaying
transcriptome and TF binding. Such a method would allow for the genome-wide identification of
TF binding sites across multiple cell types in complex tissues. ChIP-seq is the most popular
technique for studying TF binding (Johnson et al., 2007), relying on antibodies specific to the
factor of interest to pull down bound DNA. While a number of antibody-based single cell
epigenomic methods have been reported (Ai et al., 2019; Carter et al., 2019; Grosselin et al.,
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2019; Hainer et al., 2019; Harada et al., 2019; Kaya-Okur et al., 2019; Rotem et al., 2015; Wang
et al., 2019), these technique have generally mapped highly abundant proteins, such as modified
histones and CTCF. DamID can recover TF binding sites by identifying nearby exogenously
methylated adenines (Greil et al., 2006; Vogel et al., 2007), but in single cells it has only been
used to study lamina-associated domains (Kind et al., 2013, 2015; Rooijers et al., 2019).
Moreover, while combined single cell DamID and transcriptome (scDamID&T) has been
described (Rooijers et al., 2019), it is a plate-based assay which limits throughput. None of the
other single cell epigenomic techniques simultaneously capture mRNA (Ai et al., 2019; Carter et
al., 2019; Grosselin et al., 2019; Hainer et al., 2019; Harada et al., 2019; Kaya-Okur et al., 2019;
Rotem et al., 2015; Wang et al., 2019), restricting their use to predetermined cell types. In
contrast, single cell assays for transposase-accessible chromatin (Buenrostro et al., 2015; Cao et
al., 2018) can be used to identify nucleosome-free regions that may be bound by TFs across large
numbers of mixed cells. However, they can only suggest the identity of potential DNA binding
proteins by motif inference. These assays do not directly measure TF occupancy; moreover, they
cannot be used to study transcriptional regulators that bind DNA indirectly or non-specifically,
such as chromatin remodelers.
Our lab has previously developed transposon calling cards as an alternative assay of TF
binding (Wang et al., 2007, 2011, 2012a). This system relies on two exogenous components: a
fusion between a TF and a transposase, and a transposon carrying a reporter gene. The fusion
transposase deposits transposons near TF binding sites, which are subsequently amplified from
genomic DNA and subjected to high-throughput sequencing. Thus, the redirected transposase
leaves “calling cards” at the genomic locations it has visited, which can be identified later in
time. The result is a genome-wide assay of all binding sites for that particular TF. In mammalian
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cells, we have heterologously expressed the piggyBac transposase (Ding et al., 2005) fused to the
TF SP1 and shown that the resulting pattern of insertions reflects SP1’s DNA binding
preferences (Wang et al., 2012a). However, this method was only feasible in bulk preparations of
thousands to millions of cells.
Here we present single cell calling cards (scCC), an extension of transposon calling cards
that simultaneously profiles mRNA content and TF binding at single cell resolution. The key
component of our work is a novel construct called the self-reporting transposon (SRT). The
genomic coordinates of inserted SRTs can be mapped from either mRNA or DNA, but the use of
mRNA leads to both higher efficiency and compatibility with single-cell transcriptomics. We
first establish that TF-directed SRTs, in bulk samples, retain the ability to accurately identify TF
binding sites. Next, we demonstrate that the unfused piggyBac transposase, through its native
affinity for the bromodomain TF BRD4, can be used to identify BRD4-bound super-enhancers
(SEs). We then present the scCC method, which allows cell-specific mapping of SRTs from
scRNA-seq libraries. This enables, in one experiment, concomitant assignment of cell types and
identification of TF binding sites within those cells. We highlight the range of this technology by
mapping the binding of multiple TFs in a variety of cell lines. We then use scCC to discover
bromodomain-dependent cell state dynamics in K562 cells. We conclude by identifying cell type
specific BRD4 binding sites in vivo in the postnatal mouse cortex. These results demonstrate that
scCC could be a broadly applicable tool for the study of specific TF binding interactions across
multiple cell types within heterogeneous systems.
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2.3 Results
2.3.1 SRTs can be mapped from mRNA instead of genomic DNA
To combine scRNA-seq with calling cards, we first developed a transposon whose genomic
location could be determined from mRNA. We created a piggyBac self-reporting transposon
(SRT) by removing the polyadenylation signal from our standard DNA-based calling card vector
(Figure 2.1A). This enables RNA polymerase II (Pol II) to transcribe the reporter gene contained
in the transposon and continue through the terminal repeat (TR) into the flanking genomic
sequence. Thus, SRTs “self-report” their locations through the unique genomic sequence found
within the 3’ untranslated regions (UTRs) of the reporter gene transcripts. Although previously
published gene- or enhancer-trap transposons (Cadiñanos and Bradley, 2007) could, in principle,
also capture local positional information via RNA, they are resolution-limited to the nearest gene
or enhancer, respectively. In contrast, the 3’ UTRs of SRT-derived transcripts contain the
transposon-genome junction in the mRNA sequence, so we can map insertions with base-pair
precision.
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Figure 2.1: Self-reporting transposons (SRTs) are mapped more efficiently from RNA compared to DNA. (A)
Schematics of a self-reporting piggyBac transposon with puromycin reporter gene (PB-SRT-Puro) and undirected
(PBase) and SP1-directed (SP1-PBase) piggyBac transposases. (B) Molecular workflow for mapping SRTs from
bulk RNA libraries. (C) Overlap of SRTs recovered by DNA- or RNA-based protocols in HCT-116 cells. (D)
Distribution of insertions with respect to genetic annotation between SRT libraries prepared from either DNA or
RNA. TR: terminal repeat; Puro: puromycin; PAS: polyadenylation signal.

SRTs are mapped following reverse transcription (RT) and PCR amplification of selfreporting transcripts. These transcripts contain stretches of adenines that are derived from either
cryptic polyadenylation signals (PAS) or polyadenine tracts encoded in genomic DNA
downstream of the SRT insertion point (Figure 2.1B). A poly(T) RT primer hybridizes with these
transcripts and introduces a universal priming site at one end of the transcripts. We then perform
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a pair of nested PCRs with an intermediate tagmentation step (Picelli et al., 2014) to recover the
transposon-genome junction. After adapter trimming and alignment, the 5’ coordinates of these
reads identify the genomic locations of insertions in the library. Libraries generated without
transposase yield very few reads that map to the genome, but the protocol is highly efficient
when transposase is added (Figure 2.2A).
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Figure 2.2: Properties of self-reporting transposons (SRTs). (A) Efficiencies of bulk RNA calling card libraries
prepared from HEK293T cells transfected with PB-SRT-tdTomato with or without HyPBase transposase. (B)
Overlap of SRTs recovered by two technical replicates of bulk RNA calling cards in HCT-116 cells transfected with
PB-SRT-Puro and SP1-PBase. (C) Distribution of insertions with respect to chromatin state between SRT libraries
prepared from either DNA or RNA. (D) Breakdown of sequencing reads mapping to the genome or plasmid from
SRT libraries prepared from either DNA or RNA.
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To compare transposon recovery between the new RNA-based protocol and our standard
DNA-based inverse PCR protocol (Wang et al., 2012a), we transfected HCT-116 cells with a
plasmid carrying a piggyBac SRT (PB-SRT-Puro) and a plasmid encoding a fusion of the TF
SP1 and piggyBac transposase (SP1-PBase; Figure 2.1A). After two weeks of selection, we
obtained approximately 2,300 puromycin-resistant clones. We split these cells into two
populations: one half underwent inverse PCR while the other half were processed with our new
RNA-based method. With inverse PCR, we obtained 31,001 insertions, while the RNA-based
protocol recovered 62,500 insertions (mean coverage: 709 and 240 reads per insertion,
respectively; Table 2.1). About 80% of the insertions recovered by DNA calling cards were also
recovered in the RNA-based library (25,060 insertions; Figure 2.1C), an overlap comparable to
that between technical replicates of the RNA workflow (Figure 2.2B). However, the RNA
protocol recovered a further 37,440 insertions that were not found in the DNA-based library. To
determine if these extra insertions were genuine, we analyzed the distribution of insertions by
genetic annotation (Figure 2.1D) or chromatin state (Figure 2.2C). Transposons mapped from
either the DNA or the RNA libraries showed comparable distributions with respect to genic
annotation or chromatin states. This indicates that RNA-based recovery of transposons appears
to be unbiased with respect to our established, DNA-based protocol.
Since SRT recovery relies on transcription, we wondered if SRTs deposited in
euchromatic regions were recovered more efficiently than SRTs in less permissive chromatin
states, which might lead to biases when mapping TF binding. Since piggyBac is known to
preferentially insert near active chromatin (Yoshida et al., 2017), this question cannot be easily
answered using this transposon. Prior studies have shown that the Sleeping Beauty transposase
(Ivics et al., 1997; Mátés et al., 2009) has very little preference for chromatin state (Yoshida et
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al., 2017). Therefore, we created a self-reporting Sleeping Beauty transposon and compared its
genome-wide distribution to that of SRTs deposited by wild-type piggyBac (Table 2.1; Figure
2.3A-B). Undirected piggyBac transposases appeared to modestly prefer transposing into
promoter and enhancers, which is consistent with previous reports (Gogol-Döring et al., 2016;
Yoshida et al., 2017). By contrast, Sleeping Beauty showed largely uniform rates of insertions
across all chromatin states, including repressed and inactive chromatin (Figure 2.3B). These
results affirm that while RNA-based recovery is more efficient, it still preserves the underlying
genomic distributions of insertions. Furthermore, because SRTs can be recovered from virtually
any chromatin state, RNA-based calling card recovery can be employed to analyze a variety of
TFs with broad chromatin-binding preferences.

Figure 2.3: piggyBac, SP1-piggyBac fusions, and Sleeping Beauty display different local transposition rates
depending on chromatin state. (A) Chromatin state analysis on the local rates of transposition of undirected
piggyBac, SP1-piggyBac fusions, and Sleeping Beauty transposases in HCT-116 cells. (B) Same data as (A) but with
different x-axes for each graph. IPKM: insertions per kilobase per million mapped insertions.
Table 2.1: Summary of bulk calling cards experiments
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Sample
Construct
Modality Replicatesa Insertions
Reads
Mean coverage
HCT-116 SP1-PBase
DNAb
1
31,001
21,975,948
708.9
HCT-116 SP1-PBase
RNAb
1
62,500
14,993,901
239.9
HCT-116 PBase
RNA
10
1,521,048
58,316,389
38.3
HCT-116 SP1-PBase
RNA
10
410,588
35,526,586
86.5
HCT-116 HyPBase
RNA
12
5,771,207
47,572,324
8.2
HCT-116 SP1-HyPBase
RNA
11
2,029,931
40,214,827
19.8
HCT-116 SB100X
RNA
12
26,515,072 67,650,985
2.6
OCM-1A HyPBase
RNA
10
5,951,669
261,476,361 43.9
OCM-1A BAP1-HyPBase RNA
10
5,740,754
293,332,813 51.1
a
Biological replicates. b These experiments were used to assess DNA- vs. RNA-based recovery (Figure 2.1C).

A common artifact observed in DNA-based transposon recovery is a large fraction of
reads aligning to the donor transposon plasmid instead of the genome. Although this can be
mitigated by long selection times or by digestion with the methyladenine-sensitive enzyme DpnI
(Wang et al., 2012a), these methods do not completely eliminate background and are not
compatible with all experimental paradigms (e.g. viral transduction). To reduce this artifact, we
included a hammerhead ribozyme (Yen et al., 2004) in the SRT plasmid downstream of the 5’
TR. Before transposition, the ribozyme will cleave the nascent transcript originating from the
marker gene, thus preventing RT. Transposition allows the SRT to escape the downstream
ribozyme, leading to recovery of the self-reporting transcript. In our comparison of DNA- and
RNA-based recovery, about 15% of reads from the SP1-PBase DNA library aligned to the
plasmid, compared to fewer than 1% of reads from the RNA library (Figure 2.2D). Thus, the
addition of a self-cleaving ribozyme virtually eliminated recovery of un-excised transposons.

2.3.2 SP1 fused to piggyBac directs SRT insertions to SP1 binding sites
Since the SRT is a new reagent, we sought to confirm that bulk RNA calling cards can, like
DNA calling cards (Wang et al., 2012a), be used to identify TF binding sites. We transfected 1012 replicates of HCT-116 cells with plasmids containing the PB-SRT-Puro donor transposon and
SP1 fused to either piggyBac (SP1-PBase) or a hyperactive variant of piggyBac (Yusa et al.,
2011) (SP1-HyPBase). As controls, we also transfected a similar number of replicates with
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undirected PBase or HyPBase, respectively. We obtained 410,588 insertions from SP1-PBase
and 1,521,048 insertions from PBase; similarly, we obtained 2,029,931 SP1-HyPBase insertions
and 5,771,207 insertions from HyPBase (Table 2.1).
Just as we had observed previously with DNA calling cards (Wang et al., 2012a), RNA
calling cards were also redirected by SP1-PBase and SP1-HyPBase to SP1-bound regions of the
genome (Figure 2.4A and Figure 2.5A). Each circle in the insertions track is an independent
transposition event whose genomic coordinate is along the x-axis. The y-axis is the number of
reads supporting each insertion on a log10 scale. To better compare transposition across libraries
with different numbers of insertions, we plotted the normalized local insertion rate as a density
track. All three of the loci shown in Figure 2.4A and Figure 2.5A show a specific enrichment of
calling card insertions in the SP1 fusion experiments that is not observed in the undirected
control libraries. Next, we called peaks at all genomic regions enriched for SP1-directed
transposition. The number of insertions observed at significant peaks for both SP1-PBase and
SP1-HyPBase was highly reproducible between biological replicates (R2 = 0.87 and 0.96,
respectively; Figure 2.4B and Figure 2.5B). Furthermore, calling card peaks were highly
enriched for SP1 ChIP-seq signal at their centers, both on average (Figure 2.4C and Figure 2.5C)
and in aggregate (Figure 2.4D and Figure 2.5D). SP1 is known to preferentially bind near TSSs
and is also thought to play a role in demethylating CpG islands (Brandeis et al., 1994; Macleod
et al., 1994; Philipsen and Suske, 1999). We confirmed that the SP1-directed transposases
preferentially inserted SRT calling cards near TSSs, CpG islands, and unmethylated CpG islands
at statistically significant frequencies (p < 10-9 in each instance, G test of independence; Figure
2.4E and Figure 2.5E). Moreover, compared to undirected piggyBac, SP1-directed piggyBac
showed a striking preference for depositing insertions into promoters (Figure 2.3A-B). Lastly,
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regions targeted by SP1-PBase and SP1-HyPBase were enriched for the core SP1 DNA binding
motif (p < 10-70 in each instance; Figure 2.4F and Figure 2.5F). Taken together, these results
indicate that the genome-wide binding of SP1 can be accurately mapped using piggyBac SRTs.

Figure 2.4: SP1 fused to piggyBac (SP1-PBase) redirects SRTs to SP1 binding sites. (A) Browser view of bulk
SP1-PBase calling cards in HCT-116 cells. (B) Reproducibility of normalized insertions at bulk SP1-PBase peaks.
(C) Mean SP1 ChIP-seq signal at bulk SP1-PBase peaks. (D) Heatmap of SP1 ChIP-seq signal at bulk SP1-PBase
peaks. (E) Enrichment of SP1-PBase-directed insertions to TSSs, CGIs, and unmethylated CGIs (G test of
independence p < 10-9). (F) SP1 core motif elicited from bulk SP1-PBase peaks. IPM: insertions per million mapped
insertions; FC: fold change; TSS: transcription start sites; CGI: CpG island.
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Figure 2.5: SP1 fused to hyperactive piggyBac (SP1-HyPBase) also redirects SRTs to SP1 binding sites. (A)
Browser view of bulk SP1-HyPBase calling cards in HCT-116 cells. (B) Reproducibility of normalized insertions at
bulk SP1-HyPBase peaks. (C) Mean SP1 ChIP-seq signal at bulk SP1-HyPBase peaks. (D) Heatmap of SP1 ChIPseq signal at bulk SP1-HyPBase peaks. (E) Enrichment of SP1-HyPBase-directed insertions to TSSs, CGIs, and
unmethylated CGIs (G test of independence p < 10-9). (F) SP1 core motif elicited from bulk SP1-HyPBase peaks.
IPM: insertions per million mapped insertions; FC: fold change; TSS: transcription start sites; CGI: CpG island.

2.3.3 Clustering of undirected piggyBac insertions identifies BRD4-bound
super-enhancers
Previous studies have shown that undirected PBase preferentially inserts transposons near superenhancers (SEs) (Yoshida et al., 2017), a unique regulatory element that is thought to play a
critical role in regulating cell identity (Hnisz et al., 2013). SEs are often enriched for the histone
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modification H3K27ac as well as RNA polymerase II and transcriptional coactivators like the
mediator element MED1 and the bromodomain protein BRD4 (Hnisz et al., 2013; Lovén et al.,
2013; Whyte et al., 2013). Moreover, PBase has a strong biophysical affinity for BRD4, as these
proteins can be co-immunoprecipitated (Gogol-Döring et al., 2016). We hypothesized that, given
the millions of insertions we assayed from the undirected PBase and HyPBase controls in the
SP1-directed experiments (Figure 2.4A, Figure 2.5A), we would be able to identify BRD4-bound
SEs simply from the localization of undirected piggyBac transpositions.
Both undirected PBase and HyPBase showed non-uniform densities of insertions at
BRD4-bound loci (Figure 2.6A and Figure 2.7A). At statistically significant peaks of piggyBac
calling cards, PBase and HyPBase showed high reproducibility of normalized insertions between
biological replicates (R2 > 0.99 in each instance; Figure 2.6B and Figure 2.7B). We calculated
the mean BRD4 enrichment, as assayed by ChIP-seq (McCleland et al., 2016), over all piggyBac
peaks, which showed significantly increased BRD4 signal compared to a permuted control set (p
< 10-9 in both instances, Kolmogorov-Smirnov test; Figure 2.6C and Figure 2.7C). Maximum
BRD4 ChIP-seq signal was observed at calling card peak centers and decreased symmetrically in
both directions. Furthermore, piggyBac peaks showed striking overlap with ChIP-seq profiles for
several histone modifications (Sloan et al., 2016; The ENCODE Project Consortium, 2012), in
particular an enrichment for H3K27 acetylation (Figure 2.6D, Figure 2.7D). Since
bromodomains bind acetylated histones, this observation further supports the hypothesis that
undirected piggyBac insertions can be used to map BRD4 binding. Peaks were also enriched in
H3K4me1, another canonical enhancer mark, and depleted for H3K9me3 and H3K27me3,
modifications associated with heterochromatin (Lawrence et al., 2016). Taken together, these
results demonstrate that piggyBac insertion density is highly correlated with BRD4 binding
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throughout the genome and that regions enriched for undirected piggyBac insertions share
features common to enhancers.

Figure 2.6: Undirected piggyBac (PBase) SRTs mark BRD4-bound super-enhancers (SEs). (A) Browser view
of an undirected PBase insertions in HCT-116 cells at a SE alongside BRD4 and H3K27ac ChIP-seq data. (B)
Reproducibility of normalized insertions at PBase peaks. (C) Mean BRD4 ChIP-seq signal at PBase peaks compared
to permuted control set. (D) Heatmap of H3K27ac, H3K4me1, H3K9me3, and H3K27me3 ChIP-seq signal at PBase
peaks. (E) Receiver-operator characteristic curve for SE detection using PBase peaks. (F) Precision-recall curve for
SE detection using PBase peaks. See also Figure S1. SE: super-enhancer; IPM: insertions per million mapped
insertions; AUROC: area under receiver-operator curve; AUPRC: area under precision-recall curve; FC: fold
change.
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Figure 2.7: Undirected hyperactive piggyBac (HyPBase) SRTs also mark BRD4-bound super-enhancers
(SEs). (A) Browser view of undirected HyPBase insertions at a SE alongside BRD4 and H3K27ac ChIP-seq data in
HCT-116 cells. (B) Reproducibility of normalized insertions at HyPBase peaks. (C) Mean BRD4 ChIP-seq signal at
HyPBase peaks compared to permuted control set. (D) Heatmap of H3K27ac, H3K4me1, H3K9me3, and
H3K27me3 ChIP-seq signal at HyPBase peaks. (E) Receiver-operator characteristic curve for SE detection using
HyPBase peaks. (F) Precision-recall curve for SE detection using HyPBase peaks. SE: super-enhancer; IPM:
insertions per million mapped insertions; AUROC: area under receiver-operator curve; AUPRC: area under
precision-recall curve; FC: fold change.

We next assessed whether undirected piggyBac peaks can be used to identify BRD4bound SEs. We used BRD4 ChIP-seq data from HCT-116 cells (McCleland et al., 2016) to
create a reference list of BRD-bound SEs (Pott and Lieb, 2014; Whyte et al., 2013) (Figure 2.6A,
Figure 2.7A). We then constructed receiver-operator characteristic curves based on our ability to
detect SEs from PBase- and HyPBase-derived peaks (Figure 2.6E and Figure 2.7E). The high
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areas under the curves (0.98 in each instance) indicate that we can robustly identify BRD4-bound
SEs from piggyBac transpositions. Across a range of sensitivities, calling card peaks are highly
specific and have high positive predictive value (AUPRC = 0.92 in each instance; Figure 2.6F
and Figure 2.7F). Thus, undirected piggyBac transpositions are an accurate assay of BRD4bound SEs.
To project how calling cards would scale to single cell experiments, where molecular
techniques show broadly reduced sensitivity compared their bulk counterparts, we simulated
assay performance under increasingly sparse conditions. We quantified the relationship between
SE sensitivity and the number of insertions recovered in undirected calling cards experiments by
downsampling the data from the PBase and HyPBase experiments in half-log increments and
calculating sensitivity (Figure 2.8A-B). These heatmaps show that sensitivity increases with the
total number of insertions recovered. Since we cannot predict how many, or few, insertions will
be recovered in future experiments, we also performed linear interpolation on the downsampled
data. The resulting contour plots (Figure 2.8C-D) indicate the approximate sensitivity of BRD4bound SE detection in HCT-116 cells. Our analysis suggests that even with as few as 10,000
insertions, we can still obtain sensitivities around 50%. Similarly, we investigated the
reproducibility of SP1-directed peaks at a various downsampled numbers of insertions, using the
peaks obtained from our bulk SP1-HyPBase experiment as our reference set (Figure 2.8E-F). We
found that peak detection is directly proportional to the number of SP1-directed insertions
recovered. At a lower limit of 10,000 insertions in both the experimental and control datasets,
there was 40% overlap with peaks called from our bulk dataset. Together, these analyses provide
a guide for how well calling cards will perform in the limit of insertion recovery.
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Figure 2.8: Downsampling undirected and directed piggyBac insertions simulates assay performance. (A)
Downsampling analysis of BRD4-bound SE detection by PBase insertions (in HCT-116 cells) at various p-value
thresholds. (B) Downsampling analysis in (A) applied to HyPBase insertions. (C) Linear interpolation applied to (A)
to predict SE sensitivity across a range of insertions. (D) Linear interpolation applied to (B). (E) Reproducibility of
bulk SP1 calling card peaks at various numbers of HyPBase and SP1-HyPBase insertions, relative to the full dataset
(top right corner). (F) Linear interpolation applied to (E) to predict peak reproducibility across a arange of
experimental and control insertions.

piggyBac’s baseline preference for BRD4 raises questions about how efficiently TFpiggyBac fusions can redirect insertions near TF binding sites. We further analyzed the bulk SP1
directed experiments and found that SP1-piggyBac increased insertion density at SP1-bound,
BRD4-depleted regions by five- to seven-fold, on average (Figure 2.9A, C). We also saw a
decrease in insertion density at non-SP1-bound BRD4 peaks on the order of 30 to 50 percent
(Figure 2.9B, D). This suggests that, while the reduction of signal at BRD4-bound loci may be
modest, the redirection to TF binding sites can be quite stark, explaining how TF binding sites
can be accurately identified (Wang et al., 2012a). In contrast to piggyBac, Sleeping Beauty has a
more uniform background distribution of insertions (Figure 2.10), which suggests that the latter
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transposon system might be even more redirectable and allow us to perform TF-directed calling
cards without the need for an undirected transposase control. Unfortunately, direct fusions of TFs
to Sleeping Beauty almost completely abolish transposase activity (Wu et al., 2006). We
confirmed this in a colony formation assay with SP1 fused to either piggyBac or Sleeping
Beauty. The SP1-Sleeping Beauty fusion had virtually undetectable levels of transposition,
whereas the SP1-piggyBac construct was still enzymatically functional (Figure 2.11). Currently,
piggyBac remains the practical choice for mammalian calling cards, while the prospect of a
background-free calling card strategy should motivate future research.

Figure 2.9: Redirectability of SP1-piggyBac fusion constructs. (A) Left: distribution of insertion densities at SP1PBase peaks that either overlap, or do not overlap, BRD4-directed PBase peaks (BRD4+ and BRD4–, respectively)
in HCT-116 cells. Right: mean and SD of distributions. (B) Left: distribution of insertion densities at BRD4directed, PBase peaks that either overlap, or do not overlap, SP1-Pbase peaks (SP1+ and SP1–, respectively). Right:
mean and SD of distributions. (C-D) Similar analysis as (A-B) applied to the SP1-HyPBase and HyPBase datasets,
respectively. SD: standard deviation.
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Figure 2.10: Examples of BRD4-bound super-enhancers identified by bulk PBase and HyPBase calling cards
in HCT-116 cells. Three different loci exhibiting non-uniform densitites of piggyBac insertions correlated with
BRD4 and H3K27ac ChIP-seq data. Sleeping Beauty insertions at those same loci are more uniformly distributed.
Density tracks are shown before and after smoothing.
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Figure 2.11: piggyBac is more tolerant of transcription factor fusions than Sleeping Beauty. Colony formation
assays of HCT-116 cells transfected with the specified construct(s), selected with puromycin, and stained with
crystal violet. Numbers indicate biological replicates. (A) PB-SRT-Puro (B) Untransfected (no DNA). (C) PB-SRTPuro and hyperactive piggyBac transposase (HyPBase). (D) PB-SRT-Puro and SP1 fused to hyperactive piggyBac
(SP1-HyPBase). (E) SB-SRT-Puro and hyperactive Sleeping Beauty (SB100X). (F) SB-SRT-Puro and SP1 fused to
hyperactive Sleeping Beauty (SP1-SB100X).

56

Lastly, we investigated how similar undirected piggyBac transposition is to that of Tn5,
the transposase at the heart of ATAC-seq (Buenrostro et al., 2013, 2015), which preferentially
inserts into open chromatin. Since BRD4 and H3K27ac tend to accumulate at accessible
chromatin, it may be that undirected calling cards and ATAC-seq provide redundant information.
If that were the case, we should be able to identify BRD4-bound SE’s with high sensitivity from
ATAC-seq data alone, much as we have shown for piggyBac. We took publicly available ATACseq data from HCT-116 cells (Ponnaluri et al., 2017) and called “super-enhancers” in the same
manner that we did for BRD4 ChIP-seq. We found almost no overlap between BRD4-bound SEs
and these so-called SEs from ATAC-seq data–of the 162 SEs in our gold standard set, only 1 was
identified through our ATAC-seq analysis (Figure 2.12A). Moreover, there are a small number
(4.3%) of piggyBac peaks that are not found in accessible chromatin (Figure 2.12B), suggesting
that there are regulatory elements in closed chromatin that calling cards is better able to detect.
Globally, we find that over 20% of Tn5 insertions are directed to accessible sites, as defined by
DNase-seq, while undirected piggyBac, hyperactive piggyBac, and Sleeping Beauty show starkly
decreased affinities for such loci (Figure 2.12C). Interestingly, fusing SP1 to piggyBac appears to
rescue this behavior, highlighting the efficacy of transposase redirection to TF binding sites
which tend to fall in accessible chromatin. Finally, we examined BRD4 ChIP-seq signal at
DNase-seq peaks, ATAC-seq peaks, and undirected piggyBac peaks (Figure 2.12D). We find
that piggyBac peaks are an order-of-magnitude larger than either DNase- or ATAC-seq peaks
and capture more BRD4 binding than either of the other two assays. We conclude that, as
expected, unfused piggyBac reflects BRD4’s binding preferences, whereas Tn5 reports on all
accessible chromatin; as a result, undirected calling cards is not equivalent to ATAC-seq.
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Figure 2.12: BRD4 calling cards with undirected piggyBac is not equivalent to ATAC-seq. (A) Overlap of
BRD4 super-enhancers, as inferred from BRD4 ChIP-seq, and “super-enhancers” inferred from open chromatin
ATAC-seq peaks in HCT-116 cells. (B) Browser view of a BRD4 calling card peak that is not detected by ATACseq nor DNase-seq. (C) Comparison of transposase predilections for accessible chromatin. (D) Comparison of peak
sizes and BRD4 ChIP-seq enrichment as called by DNase-seq, ATAC-seq, and undirected piggyBac calling cards,
resepectively. Peaks are scaled to the median peak width (denoted by the start and end ticks) and are flanked by 3 kb
in either direction. SE: super-enhancer; DHS: DNaseI hypersensitivity site; FC: fold change; kb: kilobase.

2.3.4 scCC simultaneously identifies cell type and cell type-specific BRD4
binding sites
We next sought to recover SRTs from scRNA-seq libraries. This would let us identify cell types
from transcriptomic clustering and, using the same source material, profile TF binding in those
cell types. We adopted the 10x Chromium platform due to its high efficiency of cell and
transcript capture as well as its ease of use (Zheng et al., 2017). Like many microfluidic scRNAseq approaches (Klein et al., 2015; Macosko et al., 2015), the cell barcode and unique molecular
index (UMI) are attached to the 3’ ends of transcripts. This poses a molecular challenge for SRTs
since the junction between the transposon and the genome may be many kilobases away,
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precluding the use of high-throughput short read sequencing. To overcome this barrier, we
developed a circularization strategy to physically bring the cell barcode in apposition to the
insertion site (Figure 2.13A).

Figure 2.13: Single cell calling cards (scCC) maps BRD4 binding in single cells. (A) Schematic of the scCC
library preparation strategy from scRNA-seq libraries. (B) Barnyard plot of scCC on a mixture of human HCT-116
and mouse N2a cells. (C) UMAP of scRNA-seq of a mixture of human HCT-116 and K562 cells. (D) Browser view
of BRD4 peaks specific to HCT-116 and K562 cells deconvolved using scCC. See also Figures S2 and S3. TR:
terminal repeat; BC: barcode; pA: poly(A) sequence; UMI: unique molecular index.

We used a modified version of the bulk SRT amplification protocol where we amplified
with primers that bound to the universal priming sequence next to the cell barcode and the
terminal sequence of the piggyBac TR. These primers were biotinylated and carried a 5’
phosphate group. The PCR products of this amplification were diluted and allowed to self-ligate
overnight. They were then sheared and captured with streptavidin-coated magnetic beads. The
rest of the library was prepared on-bead and involved end repair, A-tailing, and adapter ligation.
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A final PCR step added the required Illumina sequences for high-throughput sequencing. The
standard Illumina read 1 primer sequenced the cell barcode and UMI, while a custom read 2
primer, annealing to the end of the piggyBac 5’ TR, sequenced into the genome. Thus, we
collected both the location of a piggyBac insertion as well as its cell of origin. We call this
method single cell calling cards (scCC).
We validated the method by performing a species-mixing experiment with human HCT116 cells and mouse N2a cells transfected with HyPBase and PB-SRT-Puro. Cells were cultured
independently and mixed prior to droplet generation. The resulting emulsion was processed
through first strand synthesis using the standard 10x Chromium 3’ protocol. We then took half of
the RT and finished preparing scRNA-seq libraries from it. The resulting analysis revealed
strong species separation with an estimated multiplet rate of 3.2% (Figure 2.14A). The remainder
of the first strand synthesis product was used for the scCC protocol. We restricted our calling
card analysis to those insertions whose cell barcodes were observed in the scRNA-seq library
(Table 2.2). The distribution of insertions across these cells reflected a continuum from pure
mouse to pure human (Figure 2.14B-C). Since intramolecular ligation and subsequent PCR may
introduce unwanted artifacts, such as the mis-assignment of a barcode from an N2a cell to an
insertion site in an HCT-116 cell, we required that a given insertion in a given cell must have at
least two different UMIs associated with it. Imposing this filter improved the number of pure
mouse and human cells (Figure 2.14D), yielding clear species separation with an estimated
multiplet rate of 7.9% (Figure 2.13B). This establishes that our method can accurately map
calling card insertions in single cells.
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Figure 2.14: Filtering single cell SRTs reduces intermolecular artifacts. (A) Barnyard plot from scRNA-seq of
human HCT-116 and mouse N2a cells. (B) Barnyard plot from scCC of HCT-116 and N2a cells without filtering
(estimated multiplet rate of 25.1%). (C) Distribution of cell barcode purity from unfiltered scCC data. The x-axis is
the proportion of transcripts mapping to the human or mouse genomes. (D) Distribution of species purity after
filtering scCC data. UMI: unique molecular indexes.
Table 2.2: Summary of single cell calling cards experiments
Sample

Construct

Libraries

Cells

Insertions

Reads

Mean
coverage

Mean
IPC

Median
IPC

HCT-116
& N2a
HCT-116
K562
HCT-116

HyPBase

1a

6,068

33,223

1,710,525

51.5

5.4

4

% cells
with ≥ 1
insertion
91.8

HyPBase
HyPBase
SP1HyPBase
SP1HyPBase
HyPBase
FOXA2HyPBase
HyPBase
BAP1-

4b
4b
4

12,891
11,912
30,411

37,774
107,385
77,210

4,768,230
10,404,042
9,874,157

126.2
96.9
127.9

3.0
9.5
2.6

2
6
2

93.4
96.9
83.8

4

21,554

327,465

44,851,070

137.0

15.3

9

95.8

3
3

17,195
16,623

144,176
105,000

20,035,606
15,677,152

139.0
149.3

8.4
6.3

6
4

96.1
96.0

3
3

23,978
19,572

150,707
215,330

19,794,848
27,666,808

131.3
128.5

6.3
11.0

4
7

96.2
97.6

K562
HepG2
HepG2
OCM-1A
OCM-1A
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Mouse
cortex

HyPBase
HyPBase

9c

35,950

111,382

12,204,369

109.6

3.1

3

73.7

a

This library was from a species-mixing experiment (Figures 2.13B and 2.14). b These libraries were demultiplexed
from a cell line-mixing experiment (Figures 2.13C-D and 2.15). c This experiment is further stratified by cell type in
Table 2.3. IPC: insertions per cell.

We then asked whether scCC could discern cell type specific BRD4 binding. We
transfected two human cell lines, HCT-116 and K562, with HyPBase and PB-SRT-Puro and
mixed them together. The resulting scRNA-seq libraries clearly identified the two major cell
populations (Figure 2.13C; Figure 2.15A). We prepared scCC libraries from these cells and used
the cell barcodes from the HCT-116 and K562 clusters to assign insertions to the two different
cell types. We obtained 37,774 insertions from 12,891 HCT-116 cells and 107,385 insertions
from 11,912 K562 cells (Table 2.2). The distribution of insertions per cell varied by cell type
(Figure 2.15D) and does not appear to be correlated with differences in total RNA content
(Figure 2.15B-C). Over 93% and 96% of HCT-116 and K562 cells, respectively, had at least one
insertion event (Table 2.2). Using scCC insertion data alone, we called peaks and successfully
identified BRD4-bound loci that were specific to HCT-116 cells, shared between HCT-116 and
K562, and specific to K562 cells, respectively (Figure 2.13D). Both HCT-116 and K562 peaks
showed statistically significant enrichment for BRD4 ChIP-seq signal over randomly permuted
peaks (p < 10-9 in both instances, Kolmogorov-Smirnov test; Figure 2.15E-F). Furthermore, 57%
of HCT-116 peaks and 81% of K562 peaks were specifically bound in their respective cell type.
From our earlier downsampling analysis, we estimated that with a p-value cutoff of 10-9, our
sensitivity for detecting BRD4-bound SEs would be approximately 60% (Figure 2.8D). The
actual sensitivity at this level of recovery was 67%, validating that downsampling analysis can
reasonably estimate the performance of scCC. To conclude, we investigated the reproducibility
of the scCC method. Single cell HyPBase insertions showed high concordance between
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biological replicates at statistically significant peaks in both HCT-116 and K562 cells (R2 = 0.91
and 0.94, respectively; Figure 2.15G-H). In all, these experiments demonstrate that scCC can be
used to deconvolve cell type specific BRD4 binding.

Figure 2.15: Validation and performance of undirected in vitro single cell calling cards (scCC). (A) Single cell
expression levels of three marker genes in a mixed scRNA-seq library of human HCT-116 and K562 cells. (B)
Distributions of genes per cell by cell type. (C) Distributions of transcripts per cell by cell type. (D) Distributions of
HyPBase insertions recovered per cell in HCT-116 and K562 cells. (E-F) Mean BRD4 ChIP-seq signal at HyPBase
peaks in HCT-116 and K562 cells, respectively, compared to randomly permuted peaks (KS test p < 10-9 in each
case). (G-H) Reproducibility of normalized insertions deposited by HyPBase and recovered by scCC at BRD4
binding sites in HCT-116 and K562 cells, respectively. KS: Kolmogorov-Smirnov.

2.3.5 scCC identifies binding sites across a spectrum of TFs and in a variety
of cell types
Our success mapping BRD4 binding in single cells gave us confidence that we would also be
able to map TF binding with scCC. We tested the SP1-HyPBase construct in both HCT-116 and
K562 cells. We recovered 77,210 insertions from 30,682 HCT-116 cells and 327,465 insertions
from 21,554 K562 cells (Table 2.2). We used the data generated when we mapped BRD4
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binding in these cells as control datasets. As was observed in bulk (Figure 2.5A), SP1-HyPBasedirected insertions recovered from single cells localized to SP1 binding sites in both HCT-116
and K562 cells (Figure 2.16A and 2.16E). In both cell lines, we observed significant enrichment
of SP1 ChIP-seq signal at peaks (Figure 2.16B-C and Figure 2.16F-G) and motif analysis
identified the SP1 DNA binding motif (Figure 2.16D and Figure 2.16H) (p < 10-30 in each
instance). Finally, as with bulk SP1 calling cards (Figure 2.16D and Figure 2.5E), scCC SP1
calling cards showed significant enrichments for insertions near TSSs, CpG islands, and
unmethylated CpG islands (G test of independence p < 10-9 in each instance; Figure 2.17A-B).

Figure 2.16: Single cell calling cards (scCC) works with a variety of transcription factors (TFs) and cell lines.
(A-D) scCC with SP1-HyPBase in HCT-116 cells reveals SP1 binding sites. (A) Browser view of a peak from SP1
scCC. (B) Mean SP1 ChIP-seq signal at scCC SP1 peaks. (C) Heatmap of SP1 ChIP-seq signal across all scCC SP1
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peaks. (D) Core SP1 motif elicited from SP1 scCC peaks. (E-H) Same as (A-D) but in K562 cells. (I-L) scCC with
FOXA2-HyPBase in HepG2 cells reveals FOXA2 binding sites. (I) Browser view of a peak from FOXA2 scCC. (J)
Mean FOXA2 ChIP-seq signal at scCC FOXA2 peaks. (K) Heatmap of FOXA2 ChIP-seq signal across all scCC
FOXA2 peaks. (L) Core FOXA2 motif elicited from FOXA2 scCC peaks. (M-P) scCC with BAP1-HyPB in OCM1A cells reveals BAP1 binding sites. (M) Browser view of a peak from BAP1 scCC. (N) Mean bulk BAP1 calling
cards signal at scCC BAP1 peaks. (O) Heatmap of bulk BAP1 calling cards signal across all scCC BAP1 peaks. (P)
YY1 motif elicited from BAP1 scCC peaks. See also Figure S4. FC: fold change

Figure 2.17: Validation and performance of TF-directed in vitro single cell calling cards (scCC). (A-B)
Enrichment of SP1-HyPBase-directed insertions to TSSs, CGIs, and unmethylated CGIs in single HCT-116 and
K562 cells, respectively (G test of independence p < 10-9). (C) Enrichment of BAP1-HyPBase-directed insertions
TSSs in single OCM-1A cells (G test of independence p < 10-9) . (D) Percent of BAP1 targets that increase
expression upon BAP1 KD stratified by binding site (Fisher’s exact test p < 10-9). The dashed gray line represents
the overall fraction of genes that increased expression upon KD. (E-H) Reproducibility of normalized insertions
deposited by either HyPBase or TF-HyPBase fusions and recovered by scCC at TF binding sites, for the respective
TF-cell line pair. (I-L) The distribution of recovered insertions per cell by construct (HyPBase vs TF-HyPBase) and
cell type. TF: transcription factor; TSS: transcription start site; CGI: CpG island; KD: knockdown; IPM: insertions
per million mapped insertions; n.s.: not significant.

We next performed scCC in HepG2 cells with the pioneer factor FOXA2 , which has
been shown to be required for normal liver development and drives core transcriptional networks
in cancer cells (Fournier et al., 2016; Lee et al., 2005). We mapped 144,176 undirected HyPBase
insertions in 17,195 HepG2 cells, and from a further 16,623 cells we recovered 105,000 FOXA2HyPBase insertions (Table 2.2). As with SP1, we observed a specific enrichment of insertions at
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FOXA2 binding sites (Figure 2.16I). Peaks called from scCC FOXA2 data were enriched in
FOXA2 ChIP-seq signal (Figure 2.16J-K), and motif analysis was able to infer the core FOXA2
DNA binding motif (Figure 2.16L).
Lastly, we mapped the binding of BAP1 in the uveal melanoma cell line OCM-1A (Yen
et al., 2018) using scCC. Unlike SP1 and FOXA2, BAP1 does not bind DNA directly; instead, it
is drawn to chromatin in a complex by cofactors (Carbone et al., 2013; Yu et al., 2010) where it
acts as a histone deubiquitinase. We retrieved 150,707 undirected HyPBase insertions from
23,978 OCM-1A cells and 215,330 BAP1-HyPBase insertions from another 19,572 cells (Table
2.2). Despite the fact that this protein associates with chromatin indirectly, we were able to
resolve sharp BAP1-directed peaks (Figure 2.16M). These peaks showed high concordance with
bulk RNA calling card data that we also generated in this system (Figure 2.16N-O; Table 2.1).
Sequence analysis elicited the motif of YY1 (Figure 2.16P), a DNA binding TF and known
member of the BAP1 complex (Yu et al., 2010). BAP1 is known to preferentially bind promoters
(Dey et al., 2012); accordingly, we observed a significant enrichment for BAP1-directed
insertions near TSS (G test of independence p < 10-9; Figure 2.17C). While BAP1 is a member of
the Polycomb repressive complex, there are conflicting reports as to whether it activates or
represses gene expression (Campagne et al., 2019; Matatall et al., 2013; Yu et al., 2010). We
cross-referenced our single cell BAP1 peaks against published RNA-seq data obtained in
unperturbed and BAP1 knockdown OCM-1A cells (Yen et al., 2018). Genes where BAP1 is
bound at the promoter, as opposed to in the gene body or at a nearby intergenic locus, are
significantly more likely to have increased expression upon BAP1 knockdown (Fisher’s exact
test p < 10-9; Figure 2.17D). This suggests that, in OCM-1A cells, promoter-bound BAP1
primarily acts as a repressor of gene expression.
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Collectively, these results indicate that single cell calling cards can successfully map
DNA-protein interactions for a range of TFs and in a variety of cell types. Furthermore, scCC
showed high reproducibility in all four tested conditions (R2 between 0.71 and 0.95; Figure
2.17E-H). While TF-piggyBac fusions have been reported to decrease transposase activity (Wu
et al., 2006), our findings were more equivocal: BAP1 and SP1 fusions in K562 cells showed
greater activity than undirected HyPBase; FOXA2 showed decreased activity; and SP1 in HCT116 cells showed roughly the same activity (Figure 2.17I-L). This suggests that there may be
some variability in the number of recovered insertions depending on the TF and cell type of
interest but, overall, the method is robust.

2.3.6 scCC reveals bromodomain-dependent cell state dynamics in K562 cells
K562 is a chronic myelogenous leukemia (CML) cell line first isolated in 1970 (Lozzio and
Lozzio, 1975) and has been a workhorse of molecular biology ever since (Zhou et al., 2019).
Recently, K562 cultures have been shown to be mixtures of a stem-like state characterized by
high levels of the surface marker CD24, and a more differentiated, erythroleukemic state marked
by low CD24 expression, with individual cells dynamically oscillating between these two
extremes (Litzenburger et al., 2017). Since we profiled BRD4 binding in K562 cells with scCC,
we wondered whether we could see evidence of these two states in the scRNA-seq data.
Principal components analysis (PCA) of single cell gene expression (Figure 2.18A) revealed
CD24 as one of the top genes in PC1, while PC2 was enriched in hemoglobin genes, particularly
the fetal-specific markers HBE1 and HBZ. Furthermore, the expression of top PC1 and PC2
genes appear to be anticorrelated: cells that strongly expressed CD24 are not likely to express
HBZ, and vice-versa (Figure 2.18B), suggesting mutually exclusive states. Scoring single cells
on a subset of top PC genes revealed a gradient of cell states along a stem-like-to-differentiated
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axis (Figure 2.19A). We then clustered cells on the basis of this state score to define stem-like
and differentiated populations (Figure 2.18C-D), which faithfully recapitulate the expression
differences detected by PCA (Figure 2.18E).

Figure 2.18: Clustering of K562 cells into stem-like and differentiated states. (A) Principal component analysis
of K562 scRNA-seq data. (B) Relative expression levels of highest-ranking genes in PC1 (top) and PC2 (bottom).
(C) Gaussian mixture modeling of a cell-state score to define stem-like and differentiated K562 clusters. (D)
Visualization of assigned cell clusters in the UMAP projection. (E) Specific expression of CD24 and HBZ in the
stem-like and differentiated clusters, respectively. (F) Genome browser view of scCC in the stem-like and
differentiated clusters alongside bulk BRD4 and H3K27ac ChIP-seq as well as RNA Pol II ChIA-PET. (G)
Expression of VMP1 and PVT1 in the stem-like and differentiated clusters. PC: principal component.
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Figure 2.19: Single cell calling cards uncovers bromodomain-dependent cell state dynamics in K562 cells. (A)
Gradient of cell states from scRNA-seq analysis of K562 cells. (B) Differential BRD4 binding analysis of undirected
HyPBase peaks in K562 cells. (C) Representative distributions of CD24high and CD24low cells after either 96 hours of
DMSO (top) or JQ1 (bottom) treatment. (D) Proportion of CD24high cells over a seven-day time course of JQ1
treatment (three-way ANOVA p < 0.01). (E) Proportion of CD24high cells after BRD4 CRISPRi (Welch’s t-test p <
0.01). (F) Representative plots of annexin V and PI staining in K562 cells pretreated with either DMSO or JQ1 (250
nM) and subsequently treated for 48 hours with either DMSO or imatinib (1 µM). (G) Quantification of (F) (twoway ANOVA p < 0.01). Bars represent means; error bars denote standard deviations. Experiments were performed
in triplicate. See also Figures S5 and S6. DMSO: dimethyl sulfoxide; SSC: side scatter; CRISPRi: CRISPR
interference; NT: non-targeting; gRNA: guide RNA; IMA: imatinib; PI: propidium iodide.

69

Super-enhancers and BRD4 are thought to mark genes important for specifying cell
identity, and while the strongest evidence for this comes from comparisons between organ
systems and sharply delineated disease states (Hnisz et al., 2013; Whyte et al., 2013), recent
studies have shown that even closely related subpopulations of the same cell type can show
subtle changes in BRD4 enrichment and enhancer utilization (Knoechel et al., 2014; Rathert et
al., 2015). Therefore, we asked whether we could detect any differences in BRD4 binding
between CD24high and CD24low cells. We first stratified scCC insertions by cell state, assigning
41,707 to the stem-like state and 38,482 to the differentiated cluster (Figure 2.20F). We then
analyzed the peaks generated across all K562 cells and quantified differential binding between
the two clusters. Indeed, we found multiple peaks that showed significant differential binding at
a false-discovery rate threshold of 10% (Figure 2.19B). We corroborated these hits by comparing
our peak calls to bulk BRD4 and H3K27ac ChIP-seq data, as well as to RNA pol II ChIA-PET
data, which connects putative enhancers to actively transcribed genes (Fullwood et al., 2009).
We highlight two genes that showed both differential binding and expression: VMP1, bound
more in the CD24high stem-like cells; and PVT1, bound more in the differentiated, CD24low cells
(Figure 2.18F-G). VMP1 overexpression is sufficient to induce autophagy (Ropolo et al., 2007),
which is important for hematopoietic stem cell function (Folkerts et al., 2019; Ho et al., 2017)
and may be one pathway recruited during these dynamic state transitions. PVT1 can act as both a
tumor-suppressor and oncogene, in both instances acting on the MYC locus (Cho et al., 2018).
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Figure 2.20: Validation of bromodomain-dependent K562 cell states. (A) Annexin V staining in CD24high (red)
or CD24low (blue) K562 cells treated with DMSO (dashed line) or JQ1 (solid line) over a seven-day time course. (B)
Genome browser view of the CD24 locus. (C) qRT-PCR for MYC and CD24 expression levels in bulk K562 cells
treated with JQ1 relative to DMSO-treated controls. (D) Expression changes in BRD2, BRD3, and BRD4 in K562
cells transduced with dCas9-KRAB and BRD4 CRISPRi gRNA (Welch’s t-test p < 0.05). (E) Annexin V and PI costaining in cells subjected to either non-targeting (top) or BRD4 (bottom) CRISPRi followed by either DMSO (left)
or imatinib (right) treatment. (F) Average percent of annexin V/PI double positive cells in either the non-targeted or
BRD4 CRISPRi replicates, stratified by either DMSO or imatinib exposure (two-way ANOVA p < 0.01). (G)
Percent of K562 cells in either G1 (left) or G2 (right) phase after 36 hours of drug treatment (one-way ANOVA with
Dunnett’s test * p < 0.05, ** p < 0.01). (H) Percent of K562 cells in the CD24high state (left) after 5 days, and the
percent of annexin V/PI double positive cells (right) at the same time point (p < 0.01 in each instance, one-way
ANOVA with Dunnett’s test). Bars/points represent means; error bars denote standard deviations. Experiments were
performed in triplicate. DMSO: dimethyl sulfoxide; n.s.: not significant; FC: fold change; SSC: side scatter;
CRISPRi: CRISPR interference; NT: non-targeting; gRNA: guide RNA; IMA: imatinib; PI: propidium iodide.

We next investigated whether the observed differences in BRD4 binding might be
causally responsible for establishing these two cell states. Since modulation of this epigenetic
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reader has been previously shown to influence cell identity across a range of tissues (Di Micco et
al., 2014; Kfoury et al., 2017; Najafova et al., 2017), we hypothesized that perturbing BRD4
would change the distribution of cells in the stem-like and differentiated states. Moreover, due to
the asymmetric nature of significant hits in Figure 2.19B, there is a subset of peaks specific to
the CD24high state that are not shared by the CD24low state, suggesting that there may be a gene
regulatory network that is recruited as cells transit from the differentiated to stem-like state and
lost as they return. Thus, we predicted that not only should the distribution of CD24high/CD24low
cells change upon BRD4 perturbation, but also that the stem-like CD24high population should be
more susceptible to such a perturbation.
To test this hypothesis, we treated cells with the small molecule bromodomain inhibitor
JQ1, commonly used to disrupt BRD4 binding and alter target gene expression (Delmore et al.,
2011; Garcia-Carpizo et al., 2018; Lovén et al., 2013; Sdelci et al., 2019). We observed that JQ1
exposure was sufficient to shift the population from one containing equal proportions of
CD24high/CD24low cells to one comprised of almost exclusively CD24low cells (> 95% CD24low
cells, Figure 2.19C). A time course analysis showed that this conversion takes place rapidly over
the first two days, plateaus at day four, and remains stable one week after treatment; in contrast
the control cells remain evenly split between the two states at this timepoint (Figure 2.19D; twoway ANOVA p < 0.01). We ruled out the possibility that JQ1 is selectively cytotoxic to CD24high
cells as there were no significant differences in levels of the early apoptotic marker annexin V
between CD24high and CD24low cells, regardless of whether they had been exposed to JQ1 or
DMSO (Figure 2.20A; three-way ANOVA p = 0.84). We also investigated whether CD24 is a
direct target of BRD4, which would imply that the loss of CD24high cells does not reflect a true
change in cell state but is, instead, a trivial transcriptional consequence of downregulating BRD4
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by JQ1. To do so, we examined genomic signals at the CD24 locus and did not find any
prominent BRD4 binding sites, either by ChIP-seq or calling cards, or elevated levels of H3K27
acetylation in the vicinity of CD24 (Figure 2.20B). We also compared the relative changes in
mRNA levels of MYC, a known BRD4 target (Knoechel et al., 2014; Lovén et al., 2013; Rathert
et al., 2015; Zuber et al., 2011), to that of CD24 during the first 24 hours of JQ1 exposure.
Whereas MYC levels fell within the first 3 hours of exposure, transcript levels of CD24
decreased most precipitously somewhere between 3 and 9 hours after JQ1 induction (Figure
2.20C). This delayed response suggests that CD24 is not a direct target of BRD4, but instead its
expression changes as the result of downstream regulatory factors. These results argue that JQ1
treatment does not simply downregulate a cell surface marker, but rather perturbs transcriptional
networks that ultimately include CD24.
While JQ1 shows greatest affinity for BRD4, it does have some promiscuity toward other
bromodomains, such as those of the related bromodomain and extraterminal domain (BET)
proteins BRD2 and BRD3 (Filippakopoulos et al., 2010). Thus, it was possible that the observed
state shift may be arising through off-target effects and not through BRD4 itself. To address this,
we specifically downregulated BRD4 expression with CRISPRi using a dCas9-KRAB (Fulco et
al., 2016; Xie et al., 2017) fusion directed to the BRD4 locus. We confirmed, with qRT-PCR,
that our BRD4 guide RNA (gRNA) resulted in knockdown of BRD4 and not BRD2 nor BRD3
(Figure 2.20D; Welch’s t-test p < 0.05). As with JQ1, we observed a significant decrease in the
proportion of CD24high cells with the BRD4 gRNA compared to the non-targeting (NT) gRNA
(Figure 2.19E; Welch’s t-test p < 0.01), though not to the same levels as JQ1. This result
suggests that BRD4 is necessary for the observed cell state dynamics between CD24high and
CD24low K562 cells, though it is likely that other bromodomains also play a role.
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We next sought to obtain further evidence that bromodomain inhibition shifts K562 cell
state by performing a direct functional assay. The CD24high/CD24low K562 cell states have been
previously shown to have different chemosensitivities, with the latter population showing more
apoptosis when exposed to imatinib (Litzenburger et al., 2017). We wondered whether
bromodomain perturbation similarly increased imatinib sensitivity, or if its effect was restricted
to modulating CD24. We tested this by first pre-treating K562 cells with either DMSO or JQ1
for five days. In the DMSO-treated group, the fraction of CD24high cells rose to 54% on average,
while the mean for JQ1-treated cells was 17% (Figure 2.19F). We then challenged each
pretreatment group with either DMSO or imatinib and measured apoptosis by staining for
annexin V and propidium iodide (PI). We observed a significant increase in annexin V/PI double
positive cells in imatinib-treated cells over those pre-treated with DMSO (Figure 2.19F-G; twoway ANOVA p < 0.01), indicating that JQ1 sensitizes K562 cells to imatinib. We also found that
BRD4 CRISPRi partially phenocopied this sensitization, though again not to the same effect size
as JQ1 (Figure 2.20E-F; Tukey’s honestly significant difference p = 0.68). This phenomenon is
likely dosage dependent: in our experiments, CRISPRi reduced BRD4 mRNA levels by less than
50% (Figure 2.20D), whereas JQ1, at this concentration, is expected to almost completely
abolish BRD4 activity (Filippakopoulos et al., 2010). Thus, while a mild knockdown can reduce
CD24 levels, a higher level of inhibition may be necessary to induce imatinib sensitivity.
Nevertheless, these results establish that bromodomain inhibition functionally, in addition to
phenotypically, shifts the underlying cell state of K562 cells.
Finally, we asked whether the JQ1-induced K562 cell state shift could be a non-specific
response to generic drug treatment. To test this, we treated K562 cultures with cell cycle
inhibitors, another class of commonly used antineoplastic agents. We used lovastatin and
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nocodazole, two drugs classically used to synchronize cells in culture (Jackman and O’Connor,
1998), as well as the cyclin-dependent kinase inhibitors CVT-313 (Brooks et al., 1997) and RO3306 (Vassilev et al., 2006). We first confirmed that all drugs perturbed cell cycle by altering the
proportions of cells in either G1 or G2/M phase (Figure 2.20G). CVT-313 caused a significant
increase in G1 arrest cells (one-way ANOVA p < 0.05) and both nocodazole and RO-3306
caused significant G2 arrest (one-way ANOVA p < 0.01). While lovastatin has been reported to
arrest cells in G1, in our hands it caused a significant decrease in G1 phase K562 cells (one-way
ANOVA p < 0.01). Cultures remained under drug treatment until five days had elapsed, at which
point we measured CD24 levels and stained for apoptotic activity (Figure 2.20H). JQ1 caused the
greatest reduction in CD24high cells (one-way ANOVA p < 0.01) and induced significantly less
apoptosis than its closest competitor, lovastatin (one-way ANOVA p < 0.01). While all cell cycle
inhibitors caused cell death, the mitotic inhibitors nocodazole and RO-3306 had very few
surviving cells after five days of treatment. Thus, JQ1’s effect on cell state appears to be
mediated by a unique mechanism of action that is not readily replicated by cell cycle
perturbation.

2.3.7 scCC deconvolves cell type-specific BRD4 binding sites in the mouse
cortex
To establish broad utility for scCC, we sought to record TF binding in vivo. Since in vivo models
preclude puromycin selection, we designed an SRT carrying the fluorescent reporter tdTomato
(Figure 2.21A) and tested this reagent in cell culture. When this construct was transfected
without transposase, merely 3.4% of cells registered as tdTomato-positive, likely due to the
action of the self-cleaving ribozyme downstream of the transposon. However, when the construct
was co-transfected with PBase or HyPBase, this figure rose to 33% and 48%, respectively,
corresponding to 11- and 16-fold increases in signal (Figure 2.21B). In addition, cells transfected
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with only the fluorescent SRT produced very few reads that mapped to the genome, while the
overwhelming majority of reads from cells co-transfected with transposase mapped to genomic
insertions (Figure 2.2A). Thus, this new construct, PB-SRT-tdTomato, allows us to collect cells
carrying calling card insertions by fluorescence activated cell sorting (FACS).

Figure 2.21: Single cell calling cards (scCC) deconvolves BRD4-bound loci in the mouse cortex. (A) Schematic
of PB-SRT-tdTomato. (B) Distribution of fluorescence intensity in K562 cells transfected with PB-SRT-tdTomato
with and without piggyBac transposase. (C) Neuron and astrocyte clusters from scRNA-seq analysis of mouse
cortex libraries transduced with AAV-HyPBase and AAV-PB-SRT-tdTomato. (D) Browser view of scCC HyPBase
peaks in astrocytes and neurons alongside whole cortex H3K27ac ChIP-seq. (E) Expression specificity distributions
of genes overlapping astrocyte or neuron peaks; horizontal lines indicate medians of the distributions. See also
Figure S7. TR: terminal repeat; Rz: ribozyme.

We chose the mouse cortex for our in vivo proof-of-concept because it is a heterogeneous
tissue that has been the focus of several recent single cell studies (Rosenberg et al., 2018;
Saunders et al., 2018; Tasic et al., 2018; Zeisel et al., 2015, 2018). We separately packaged the
PB-SRT-tdTomato and HyPBase constructs in AAV9 viral particles (Cammack et al., 2020) and
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delivered mixtures of both viruses to the developing mouse cortex via intracranial injections at
P1. After 2-4 weeks, we dissected the cortex, dissociated it to a single cell suspension, performed
FACS to isolate tdTomato-positive cells, and analyzed these cells by scRNA-seq and scCC using
the 10x Chromium platform. We collected nine libraries in total, encompassing 35,950 cells and
111,382 insertions (Table 2.2). We clustered cells by their mRNA profiles and used established
marker genes to classify different cell types (Figure 2.22A-B) (Saunders et al., 2018; Tasic et al.,
2018; Zeisel et al., 2018). Neurons and astrocytes were the two major cell populations we
recovered (Figure 2.21C, Table 2.3), which is consistent with the known tropism of AAV9
(Cammack et al., 2020; Schuster et al., 2014) . We also identified a spectrum of differentiating
oligodendrocytes and trace amounts of microglial, vascular, and ependymal cells. We then used
the cell barcodes shared between the scRNA-seq and scCC libraries to assign insertions to
specific cell types.
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Figure 2.22: Clustering of SRT-treated cortical cells and associated marker genes. (A) Schematic of PB-SRTtdTomato. (B) Distribution of fluorescence intensity in K562 cells transfected with PB-SRT-tdTomato with and
without piggyBac transposase. (C) Neuron and astrocyte clusters from scRNA-seq analysis of mouse cortex libraries
transduced with AAV-HyPBase and AAV-PB-SRT-tdTomato. (D) Browser view of scCC HyPBase peaks in
astrocytes and neurons alongside whole cortex H3K27ac ChIP-seq. (E) Expression specificity distributions of genes
overlapping astrocyte or neuron peaks; horizontal lines indicate medians of the distributions. See also Figure S7.
TR: terminal repeat; Rz: ribozyme.
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Table 2.3: Breakdown of cortical cell types and scCC HyPBase insertions per cluster
Cluster
Cells
Insertions
Mean IPC
Astrocyte
4,727
16,791
3.6
Astro_Neuron_Doublet
394
1,653
4.2
Ependymal
107
153
1.4
Microglia
569
238
0.4
Neuroblast_SVZ
369
1,084
2.9
Neuron_Cajal-Retzius
552
4,363
7.9
Neuron_Excit_AON
1,939
8,190
4.2
Neuron_Excit_Indeterminate
3,660
6,377
1.7
Neuron_Excit_L2-4
9,083
29,465
3.2
Neuron_Excit_L5
5,544
26,437
4.8
Neuron_Excit_L6
1,436
5,169
3.6
Neuron_Granule_DG
535
1,674
3.1
Neuron_Inhibitory
2,409
6,564
2.7
Oligo_Mature
2,740
1,729
0.6
Oligo_NewlyForming
959
674
0.7
Oligo_Progenitor
504
477
0.9
Vascular_endothelial
196
69
0.4
Vascular_meningeal
227
275
1.2
IPC: insertions per cell.

To determine whether scCC could recover biological differences between cell types in
vivo, we analyzed HyPBase insertions in neurons and astrocytes, excluding neuroblasts and
astrocyte-neuron doublets. We collected 88,239 insertions from 25,158 neurons and 16,791
insertions across 4,727 astrocytes (Table 2.3). We then called peaks on the insertions within each
cluster and identified astrocyte-specific, neuron-specific, and shared BRD4 binding sites (Figure
2.21D). Since BRD4 ChIP-seq has not yet been reported for the mouse brain, we compared our
peak calls to a recent cortical H3K27ac ChIP-seq dataset (Stroud et al., 2017). Although this
ChIP-seq dataset was agglomerated over all cell types in the brain, we nevertheless found that
scCC peaks in both astrocytes and neurons showed statistically significant enrichment of
H3K27ac signal (Figure 2.23A, C; Kolmogorov-Smirnov p < 10-9 in each case). BRD4 is also
thought to mark cell type-specific genes, so we identified genes that overlapped or that were near
astrocyte or neuron peaks and evaluated the specificity of expression of these genes. After
accounting for differences in library size, we identified 383 genes near astrocyte peaks and 184
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genes near neuron peaks, with 46 genes found in both datasets. We used bulk RNA-seq data
from purified populations of cells (Zhang et al., 2014) to assign gene expression values for each
gene and plotted the distribution of these values along a continuum from purely astrocytic
expression to purely neuronal expression. Genes near astrocyte peaks were more likely to be
specifically expressed in astrocytes, and vice-versa for genes near neuron peaks (Figure 2.16E).
Gene Ontology enrichment analysis (Mi et al., 2017) on the astrocyte gene list included terms
like “gliogenesis,” and “glial cell differentiation,” as well as copper metabolism (Figure 2.23B),
a known function of astrocytes (Scheiber and Dringen, 2013); while the neuronal gene list was
enriched for terms related to synapse assembly, axonal guidance, and neuron development
(Figure 2.23D). Overall, we conclude that scCC can accurately identify cell type specific BRD4
binding sites in vivo.

Figure 2.23: Validation of in vivo BRD4 binding in astrocytes and neurons. (A) Mean H3K27ac ChIP-seq signal
at HyPBase peaks in astrocytes compared to randomly permuted peaks (KS test p < 10-9) (B) GO term enrichment
analysis of genes near astrocytic BRD4 binding sites. (C) Mean H3K27ac ChIP-seq signal at HyPBase peaks in
neurons compared to randomly permuted peaks (KS test p < 10-9). (D) GO term enrichment analysis of genes near
neuronal BRD4 binding sites. (B and D) The white line indicates the Bonferroni-adjusted p-value threshold at α =
0.05. GO: Gene Ontology; KS: Kolmogorov-Smirnov; FC: fold change.
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Finally, we wondered if scCC in vivo could discriminate BRD4 binding between closely
related cell types, much as we had shown in vitro with K562 cells. From our scRNA-seq data
(Figure 2.22A-B; Figure 2.24B), we identified upper and lower layer cortical excitatory neurons
and compared HyPBase scCC data between them to identify shared and specific BRD4-bound
loci (Figure 2.24A). From 9,083 upper cortical neurons we obtained 29,465 insertions, which
was on par with the 31,606 insertions collected from 6,980 lower cortical neurons (Table 2.3).
As a positive control, we identified a shared BRD4 binding site at the Pou3f3 (Brn-1) locus
(Figure 2.24A, p < 10-9). Pou3f3 was broadly expressed in both populations (Figure 2.24C) and
has been used to label layers 2-5 of the postnatal cortex (Molyneaux et al., 2007; Pucilowska et
al., 2012). We then identified differentially bound regions in each cluster using insertions from
the other cluster as a control. Upper cortical neurons showed specific BRD4 binding at Pou3f2
(Brn-2), which is more restricted to layers 2-4 than Pou3f3 (Fan et al., 2008; Molyneaux et al.,
2007), while lower cortical neurons showed BRD4 binding at Bcl11b (Ctip2) and Foxp2,
common markers of layer 5 and layer 6 neurons, respectively (Figure 2.24A; p < 10-9 in each
instance) (Molyneaux et al., 2007; Rašin et al., 2007). The expression patterns of these genes
mirrored BRD4’s binding specificity, with Pou3f2’s expression mostly retained to the layer 2-4
cluster and the expression of Bcl11b and Foxp2 restricted to the layer 5-6 neuron population
(Figure 2.24C). Thus, scCC can successfully identify differentially bound loci between very
similar cell types in vivo.
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Figure 2.24: Single cell calling cards (scCC) deconvolves BRD4 binding in cortical excitatory neurons and
identifies known layer markers. (A) Browser view of scCC HyPBase peaks in upper (layer 2-4) or lower (layer 56) cortical excitatory neurons alongside whole cortex H3K27ac ChIP-seq. (B) Layer 2-4 and layer 5-6 cortical
excitatory neurons highlighted among the scRNA-seq clusters. (C) Single cell gene expression patterns of the four
genes from (A).

2.4 Discussion
Mapping TF binding in heterogeneous tissues is a challenging problem because traditional
methods combine signals from multiple cell types into a single, agglomerated profile. This
difficulty is further compounded if individual cell types are difficult to identify, isolate, or are
rare. Single cell RNA-seq is the dominant paradigm for handling such heterogeneity; here, we
have combined it with transposon calling cards and developed a novel method to simultaneously
discover cell types and TF binding sites within specific subpopulations. Moreover, we have
shown that single cell calling cards (scCC) is robust and flexible: it can map multiple kinds of
DNA binding proteins–from sequence-specific TFs like SP1 and FOXA2, to histone-associated
factors like BRD4 and BAP1 that bind DNA indirectly–in a variety of in vitro systems and in
vivo in the mouse cortex. Furthermore, our finding that cell state transitions in K562 cells are
mediated by bromodomain proteins including BRD4 demonstrates how scCC can lead to new
hypotheses about transcriptional regulation in dynamic, heterogeneous systems. scCC is an
important addition to the single cell repertoire, fills a recognized void in the field (Shapiro et al.,
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2013; Shema et al., 2018), and, unlike scDamID&T (Rooijers et al., 2019), is compatible with
high-throughput droplet microfluidic platforms such as the 10x Chromium. We anticipate this
technique will empower researchers to study TF binding in a variety of challenging ex vivo and
in situ models.
A concern with any transposon-based technique is the potential for deleterious
interruption of target genes leading to cell death and, consequently, false negatives. Previous
experiments in diploid yeast found that calling cards are deposited into promoters of essential
and non-essential genes at comparable frequencies (Wang et al., 2011). Since mammalian
genomes have much larger intergenic regions than yeast, human and mice genomes are likely
also able to tolerate calling card transpositions. Long term follow-up of mice transduced
intracranially with AAV calling cards showed no significant tissue pathology, behavioral
deficits, developmental defects, or metabolic dysregulation (Cammack et al., 2020). This
suggests calling cards imposes, at most, a small mutagenic burden, though more studies are
needed to verify this.
The relatively few insertions recovered on a per-cell basis is one of the limitations of this
technique, inflating the number of cells that must be analyzed to achieve good sensitivity. Based
on our experiments, we recommend processing enough cells to obtain at least 15,000 insertions
to analyze BRD4-bound super-enhancers with undirected piggyBac; and at least 30,000
insertions for both constructs in TF-directed experiments. These minimum recommendations
should achieve moderate sensitivities (~50%) that can be increased by collecting additional
insertions (Figure 2.8). The limited amount of data recovered on a per-cell level likely stems
from a combination of limited transposase activity—up to 15-30 insertions per cell for PBase
(Kettlun et al., 2011; Saridey et al., 2009; Wang et al., 2008; Wilson et al., 2007), and likely
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higher for HyPBase (Kalhor et al., 2018; Yusa et al., 2011)—and the low capture rate of mRNA
transcripts in droplet scRNA-seq (Hwang et al., 2018). This sparsity precludes certain kinds of
analyses, such as multimodal data integration, and leads to broader peaks with lower spatial
resolution. We overcame the latter constraint by focusing on peak centers and, particularly for
motif analysis, on relatively narrow peaks (e.g., less than 5,000 bp in length). Nevertheless, peak
width is inversely correlated with the number of insertions analyzed; as such, improving the percell recovery of insertions should be prioritized. The inclusion of cis-regulatory features known
to enhance mRNA maturation and stability, such as the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) may increase representation of SRTs in scRNA-seq
libraries. Furthermore, as the transcript capture rates of scRNA-seq technologies improve, we
expect the sensitivity of our method will increase. Sensitivity can also be improved by simply
analyzing larger numbers of cells, such as with Cell Hashing (Stoeckius et al., 2018) or
combinatorial barcoding (Rosenberg et al., 2018). Since the per-cell costs for scRNA-seq are
falling exponentially (Svensson et al., 2018), we expect that scCC could be used to analyze TF
binding in even very rare cell types in the near future.
Another potential limitation of this technique is the exogenous expression of a TF at
supraphysiological levels. One possibility is that overexpression of the TF-piggyBac construct
will lead to ectopic binding and, consequently, false positives. However, we note that over 90%
of our peaks from scCC of SP1 in HCT-116 cells and FOXA2 in HepG2 cells were within 1,000
bp of a ChIP-seq peak from the respective TF. This suggests that calling card peaks reflect
endogenous binding activity, though this behavior may vary by factor. Overexpression might
also alter the transcriptome of transfected cells. Comparing gene expression levels between cells
treated with TF-piggyBac and undirected piggyBac can determine whether there is
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transcriptional perturbation and to what extent. Both concerns can be alleviated by tagging the
endogenous TF locus with piggyBac, which would ensure native expression levels but may be
more time-consuming than transfection or transduction. Although we exclusively used Nterminal fusions in his study, calling cards can also work with C-terminal fusions (Yen et al.,
2018). For viral constructs where space is limited, we have also had success fusing a TF’s
binding domain to piggyBac (Cammack et al., 2020). In general, multiple fusion strategies
should be tested to empirically determine the optimal construct, particularly if the binding
domain lies near one of the termini. Finally, some TFs may not bind when fused to piggyBac and
thus would not work with calling cards, though in our experience this is uncommon (less than
25% of the time or so).
Our scCC experiments employed the piggyBac transposase, but for some applications,
other transposases may prove advantageous. piggyBac inserts almost exclusively into TTAA
tetranucleotides. For TFs that bind GC-rich regions or have high GC-content motifs, piggyBac
fusions may have a difficult time finding nearby insertion sites. Sleeping Beauty, which inserts
into TA dinucleotides, or Tol2, which does not have a strict insertion site preference (Yoshida et
al., 2017), could be used to overcome these limitations. This direction would also improve peak
resolution by increasing the number of potential transposition sites. Neither of these transposases
tolerate TF fusions, however, which would be the first obstacle to address (Meir et al., 2011; Wu
et al., 2006). Meanwhile, the natural affinity of piggyBac for BRD4 makes it ideal for studying
BRD4-bound SEs, which play important regulatory roles in development and disease (Hnisz et
al., 2013; Lovén et al., 2013; Whyte et al., 2013). It is unclear why piggyBac has this
predilection. BRD4 has an intrinsically disordered region and cooperative interactions between
BRD4 and coactivators like MED1 may mediate the formation of intranuclear condensates
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(Sabari et al., 2018) at SEs. One hypothesis is that piggyBac has a similarly disordered domain
that allows it to preferentially enter condensates and enrich SEs with insertions. If such a domain
exists, mutating it may make unfused piggyBac more uniform in its insertion profile, improving
its utility for TF-directed calling cards.
The defining feature of the scCC method is the self-reporting transposon (SRT). While
here we have reported the piggyBac and Sleeping Beauty SRTs, the self-reporting paradigm
should be generalizable to any transposon lacking a polyadenylation signal (PAS) in at least one
terminal repeat. Expanding the palette of SRTs will illuminate the genome-wide behaviors of
transposases and may yield further insight into chromatin dynamics (Yoshida et al., 2017).
Simultaneous expression of many TFs, each tagged to a different transposase, may also enable
multiplexed studies of TF binding in the same cells. Mapping SRTs using cellular RNA appears
to be substantially more efficient than the DNA-based inverse PCR method, but the reasons for
this are unclear. Some efficiency is likely gained by eliminating self-ligation, as well as having
multiple mRNA copies of each insertion to buffer against PCR artifacts. It is also unknown what
fraction of self-reporting transcripts are actually polyadenylated as opposed to merely containing
A-rich genomic tracts. Non-genic PASs prevent anti-sense transcription (Chiu et al., 2018),
which suggests that PASs may be more common in the genome than previously appreciated.
Targeted 3’-end sequencing (Chen et al., 2017; Zheng et al., 2016) of SRT libraries should help
resolve this question, while long-read sequencing of self-reporting transcripts may identify noncanonical PASs. Finally, SRTs could lead to new single cell transposon-based assays. For
example, just as CRISPR/Cas9 has been combined with scRNA-seq to assess the transcriptional
effects of many single gene perturbations in parallel (Datlinger et al., 2017; Dixit et al., 2016),

86

SRTs could enable massively multiplexed transposon mutagenesis screens to be read out by
scRNA-seq.
Finally, calling card insertions, being integrated into the genome and preserved through
mitosis, could serve as a molecular memory for recording TF binding events. For example, the
use of an inducible transposase (Qi et al., 2017) would enable the recording and identification of
temporally-restricted TF binding sites. This would help uncover the stepwise order of events
underlying the regulation of specific genes and inform cell fate decision making. More generally,
transposon insertions could serve as barcodes of developmental lineage. Single transposition
events have been used to delineate relationships during hematopoiesis (Rodriguez-Fraticelli et
al., 2018; Sun et al., 2014). Multiplexing several SRTs across every cell in an organism could
code lineage in a cumulative and combinatorially diverse fashion, generating high-resolution
cellular phylogenies.

2.5 Methods
Table 2.4: Oligonucleotides referenced in this work
Name
SMART_dT18VN

Purification
Standard desalt

SMART

Sequence
AAGCAGTGGTATCAACGCAGAGTACGTTTTTTTTTT
TTTTTTTTTTTTTTTTTTTTTVN
AAGCAGTGGTATCAACGCAGAGT

SRT_PAC_F1
SRT_tdTomato_F1
Raff_ACTB_F

CAACCTCCCCTTCTACGAGC
TCCTGTACGGCATGGACGAG
CCTCGCCTTTGCCGATCCG

Standard desalt
Standard desalt
Standard desalt

Raff_ACTB_R

GGATCTTCATGAGGTAGTCAGTCAGGTCC

Standard desalt

OM-PB-ACG

AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTACGTTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTCTATTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTGATTTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTTGCTTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTTAGTTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTATCTTTACGCAGAC
TATCTTTCTAG

Standard desalt

Notes
RT primer for bulk RNA calling
card recovery
PCR primer for bulk RNA
calling card amplification
Puromycin marker in SRT
tdTomato marker in SRT
Human ACTB primer (for RT
control)
Human ACTB primer (for RT
control)
For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

OM-PB-CTA
OM-PB-GAT
OM-PB-TGC
OM-PB-TAG
OM-PB-ATC
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Standard desalt

OM-PB-CGT

AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTCGTTTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCTGCATTTACGCAGAC
TATCTTTCTAG
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTACGTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTCTATAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTGATTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTTGCTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTTAGTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTATCTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTCGTTAAGTGTATGTAAACT
TCCGACTTCAA
AATGATACGGCGACCACCGAACACTCTTTCCCTACA
CGACGCTCTTCCGATCTGCATAAGTGTATGTAAACT
TCCGACTTCAA
CAAGCAGAAGACGGCATACGAGAT[index]GTCTC
GTGGGCTCGG

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with piggyBac SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

For use with Sleeping Beauty
SRTs

Standard desalt

10x_TSO

AAGCAGTGGTATCAACGCAGAGTACATrGrGrG

Standard desalt

Bio_Illumina_Seq1_scCC_
10X_3xPT

/5Phos/ACACTCTTTCCC/iBiodT/ACACGACGC
TCTTCCGA*T*C*T

HPLC

Bio_Long_PB_LTR_3xPT

/5Phos/GCGTCAATTTTACGCAGAC/iBiodT/AT
CTTTC*T*A*G
AATGATACGGCGACCACCGAGATCTTCACTCATTCC
ACACGACTCCTTGCCAGTCTC*T

HPLC

scCC_P7_adapter

/5Phos/GAGACTGGCAAGTACACGTCGCACTCACC
ATGA[index]ATCTCGTATGCCGTCTTCTGCTTG

Standard desalt

scCC_P5_primer
scCC_P7_primer
scCC_PB_CustomRead2

AATGATACGGCGACCACCGAGATC
CAAGCAGAAGACGGCATACGAGAT
CGTGTAGGGAAAGAGTGTGCGTCAATTTTACGCAGA
CTATCTTTCTAG

Standard desalt
Standard desalt
PAGE

scCC_CustomIndex1

GAGACTGGCAAGTACACGTCGCACTCACCATGA

PAGE

ACTB_PrimerBank_F
ACTB_PrimerBank_R
CD24_PrimerBank_F
CD24_PrimerBank_F
MYC_PrimerBank_F
MYC_PrimerBank_R
BRD2_PrimerBank_F
BRD2_PrimerBank_R
BRD3_PrimerBank_F
BRD3_PrimerBank_R
BRD4_PrimerBank_F
BRD4_PrimerBank_R
BRD4 CRISPRi gRNA

CATGTACGTTGCTATCCAGGC
CTCCTTAATGTCACGCACGAT
CTCCTACCCACGCAGATTTATTC
AGAGTGAGACCACGAAGAGAC
GTCAAGAGGCGAACACACAAC
TTGGACGGACAGGATGTATGC
AATGGCACAAACGCTGGAAAA
CACTGGTAACACTGCCCTG
TGCAAGCGAATGTATGCAGGA
CATCTGGGCCACTTTTTGTAGAA
GAGCTACCCACAGAAGAAACC
GAGTCGATGCTTGAGTTGTGTT
GCGGCTGCCGGCGGTGCCCG

Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
Standard desalt
N/A

Uniquely identifies each bulk
RNA calling card library in
conjunction with barcoded
transposon primer
For continuing 10x scRNA-seq
prep after splitting first RT
product in half
Single cell calling card primer
for use with 10x Chromium 3' v2
kit
Single cell calling card primer
for use with piggyBac SRTs
Adapter for scCC (needs to be
pre-annealed with
scCC_P7_adapter)
Adapter for scCC (needs to be
pre-annealed with
scCC_P5_adapter)
For final scCC library PCR
For final scCC library PCR
For custom sequencing of
piggyBac scCC libraries; read 2
should begin with GGTTAA
For custom sequencing of scCC
libraries
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For qRT-PCR
For knockdown of BRD4 with
CRISPRi

OM-PB-GCA
OM-SB-ACG
OM-SB-CTA
OM-SB-GAT
OM-SB-TGC
OM-SB-TAG
OM-SB-ATC
OM-SB-CGT
OM-SB-GCA
N7 indexed primer

scCC_P5_adapter
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Standard desalt

NT CRISPRi gRNA

N/A

GGAGGCGAGGTAAGACGCGG

Control non-targeting gRNA for
CRISPRi

2.5.1 Materials and data availability
Plasmids generated in this study have been deposited to Addgene, where possible, and are
available to the community. Plasmids encoding the piggyBac transposase are not available
through Addgene due to licensing restrictions. These plasmids are available upon request to the
Lead Contact. Data generated in this study have been submitted to the Gene Expression Ominbus
(GEO) and are available at accession GSE148448. All code used to analyze the data is online at
https://github.com/arnavm/calling_cards. A complete listing of reagents, datasets, and software
used in this study is given in Table 2.5.
Table 2.5: Key Resources Table
Reagent or Resource
Antibodies
Brilliant Violet 421™ anti-human CD24 Antibody
(clone ML5)
Brilliant Violet 421™ Mouse IgG2a, κ Isotype Ctrl
Antibody (clone MOPC-173)
APC anti-human CD24 Antibody (clone ML5)
APC Rat IgG2a, κ Isotype Ctrl (clone RTK2758)
Bacterial and Virus Strains
AAV9-PB-SRT-tdTomato
AAV9-HyPBase
Lenti-dCas9-KRAB
Lenti-BRD4-CRISPRi
Lenti-NT-CRISPRi
Chemicals, Peptides, and Recombinant Proteins
DMEM
Antibiotic-Antimycotic (100X)
FBS
RPMI 1640 Medium
Lipofectamine™ 3000 Transfection Reagent
Trypsin-EDTA solution
DPBS, no calcium, no magnesium
RNAprotect Cell Reagent
2-Mercaptoethanol

Source

Identifier

BioLegend

Cat#311121; RRID:AB_10915556

BioLegend

Cat#400259; RRID:AB_10895919

BioLegend
BioLegend

Cat#311117; RRID:AB_1877150
Cat#400511; RRID:AB_2814702

Joseph D. Dougherty
(Cammack et al., 2020)
Joseph D. Dougherty
(Cammack et al., 2020)
This study
This study
This study

N/A

Gibco
Gibco
Peak Serum
Gibco
Invitrogen
Sigma-Aldrich
Gibco
QIAGEN
Gibco

Cat#11965-084
Cat#15240-062
Cat#PS-FB3
Cat#11875-085
Cat#L3000015
Cat#T4049
Cat#14190-136
Cat#76526
Cat#21985-023
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N/A
N/A
N/A
N/A

RNase-Free DNase Set
Maxima H Minus Reverse Transcriptase
Advantage® UltraPure PCR Deoxynucleotide Mix
RNaseOUT™ Recombinant Ribonuclease Inhibitor
TransIT®-LT1 Transfection Reagent
RNase H
HiFi HotStart ReadyMix (2X)
AMPure XP beads
Puromycin dihydrochloride
Crystal violet
Methanol
Formaldehyde
High Sensitivity D1000 Reagents
Ficoll PM400 (Dry Powder)
NxGen® RNAse Inhibitor
Dynabeads™ MyOne™ Silane
IDTE pH 8.0 (1X TE Solution)
High Sensitivity D5000 Reagents
NEBuffer™ 2
Buffer EB
Hibernate™-A Medium
D-(+)-Trehalose dihydrate
B-27™ Supplement (50X), serum free
0.5M EDTA, pH 8.0
Papain, Lyophilized
Deoxyribonuclease I, Filtered
Trypsin Inhbitor, Ovomucoid
Bovine Serum Albumin
OptiPrep™ Density Gradient Medium
HBSS (10X)
Magnesium chloride
Magnesium sulfate
Calcium chloride dihydrate
D-(+)-Glucose
Dimethyl sulfoxide (DMSO)
Cell Staining Buffer
Annexin V Binding Buffer
SuperScript™ VILO™ cDNA Synthesis Kit
PowerUp™ SYBR™ Green Master Mix
(+)-JQ1
Propidium iodide (PI)
Hoechst 33342

QIAGEN
Thermo Scientific
Takara Bio
Invitrogen
Mirus
New England BioLabs
Kapa Biosystems
Beckman Coulter
Sigma-Aldrich
Sigma-Aldrich
Fisher Scientific
Fisher Scientific
Agilent
GE Healthcare
Lucigen
Life Technologies
IDT
Agilent
New England BioLabs
QIAGEN
Gibco
Sigma-Aldrich
Gibco
Corning
Worthington
Biochemical
Worthington
Biochemical
Worthington
Biochemical
Sigma-Aldrich
Sigma-Aldrich
Gibco
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
BioLegend
BioLegend
Invitrogen
Applied Biosystems
Selleck Chemicals
Invitrogen
Thermo Scientific
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Cat#79254
Cat#EP0752
Cat#639125
Cat#10777019
Cat#MIR2304
Cat#M0297S
Cat#KK2601
Cat#A63880
Cat#P8833
Cat#C0775
Cat#A452-4
Cat#BP531-500
Cat#5067-5585
Cat#17030010
Cat#30281-1
Cat#37002D
Cat#11-05-01-13
Cat#5067-5593
Cat#B7002S
Cat#19086
Cat#A1247501
Cat#T9531
Cat#17504044
Cat#46-034-CI
Cat#LS003118
Cat#LS002060
Cat#LS003087
Cat#A9418
Cat#D1556
Cat#14185052
Cat#M4880
Cat#M2643
Cat#C7902
Cat#G7021
Cat#D2650
Cat#420201
Cat#422201
Cat#11754250
Cat#25742
Cat#S7110
Cat#P3566
Cat#62249

Annexin V-FITC
Blasticidin S HCl
Lenti-X™ Concentrator
Lipofectamine™ 2000 Transfection Reagent
Polybrene Infection / Transfection Reagent
Esp3I
T4 DNA Ligase
IMDM
Penicillin-Streptomycin (10,000 U/mL)
Imatinib mesylate
Lovastatin
Nocodazole
CVT-313
RO-3306
Critical Commercial Assays
Neon™ Transfection System 100 µL Kit
RNeasy Plus Mini Kit
Qubit™ RNA HS Assay Kit
Qubit™ dsDNA HS Assay Kit
Nextera XT DNA Library Preparation Kit
High Sensitivity D1000 ScreenTape
Chromium Single Cell 3’ Library & Gel Bead Kit v2
High Sensitivity D5000 ScreenTape
Nextera Mate Pair Library Prep Kit
Deposited Data
K562 CpG islands
HCT-116 SP1 ChIP-seq
HCT-116 CTCF ChIP-seq
HCT-116 ChIP-seq input control (SP1, CTCF)
HCT-116 BRD4 ChIP-seq
HCT-116 ChIP-seq input control (BRD4)
HCT-116 H3K27ac ChIP-seq

BioLegend
Gibco
Takara Bio
Invitrogen
Sigma-Aldrich
New England BioLabs
New England BioLabs
Gibco
Gibco
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich

Cat#640905
Cat#A1113903
Cat#631232
Cat#11668030
Cat#TR-1003
Cat#R0734S
Cat#M0202S
Cat#12440046
Cat#15140122
Cat#SML1027
Cat#M2147
Cat#M1404
Cat#238803
Cat#SML0569

Invitrogen
QIAGEN
Invitrogen
Invitrogen
Illumina
Agilent
10x Genomics
Agilent
Illumina

Cat#MPK10025
Cat#74134
Cat#Q32852
Cat#Q32851
Cat#FC-131-1024
Cat#5067-5584
Cat#PN-120267
Cat#5067-5592
Cat#FC-132-1001

Richard Myers
Richard Myers
Richard Myers
Richard Myers
Ron Firestein
Ron Firestein
Bradley Bernstein

HCT-116 H3K4me1 ChIP-seq

Bradley Bernstein

HCT-116 H3K4me2 ChIP-seq

Bradley Bernstein

HCT-116 H3K4me3 ChIP-seq

Bradley Bernstein

HCT-116 H3K9me2 ChIP-seq

Bradley Bernstein

HCT-116 H3K9me3 ChIP-seq

Bradley Bernstein

HCT-116 H3K27me3 ChIP-seq

Bradley Bernstein

GEO:GSM1014203
ENCODE:ENCFF000PCT
ENCODE:ENCFF000OZC
ENCODE:ENCFF000PBO
SRA:SRR2481799
SRA:SRR2481800
ENCODE:ENCFF082JPN;
ENCODE:ENCFF176BXC
ENCODE:ENCFF088BWP;
ENCODE:ENCFF804MJI
ENCODE:ENCFF936MMN;
ENCODE:ENCFF937OOL
ENCODE:ENCFF183OZI;
ENCODE:ENCFF659FPR
ENCODE:ENCFF760OZN;
ENCODE:ENCFF565FDP
ENCODE:ENCFF578MDZ;
ENCODE:ENCFF033XOG
ENCODE:ENCFF281SBT;
ENCODE:ENCFF124GII
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HCT-116 H3K36me3 ChIP-seq

Bradley Bernstein

HCT-116 H3K79me2 ChIP-seq

Bradley Bernstein

HCT-116 H4K20me1 ChIP-seq

Bradley Bernstein

HCT-116 ChIP-seq input control
Bradley Bernstein
(H3K27ac, H3K4me1, H3K4me2, H3K4me3, H3K9m
e2, H3K9me3, H3K27me3, H3K36me3, H3K79me2,
H4K20me1)
HCT-116 H3K9ac ChIP-seq
Bradley Bernstein
HCT-116 ChIP-seq input control (H3K9ac)
Bradley Bernstein
K562 BRD4 ChIP-seq
Bradley Bernstein
K562 H3K27ac ChIP-seq
Bradley Bernstein
K562 ChIP-seq input control (BRD4, H3K27ac)
Bradley Bernstein
K562 SP1 ChIP-seq
Michael Snyder
K562 ChIP-seq input control (SP1)
HepG2 FOXA2 ChIP-seq
HepG2 ChIP-seq input control (FOXA2)
OCM-1A HyPBase DNA calling cards
OCM-1A BAP1-HyPBase DNA calling cards
OCM-1A RNA-seq (BAP1 and control shRNA)
Mouse cortex H3K27ac ChIP-seq
Mouse cortex ChIP-seq input control (H3K27ac)
K562 RNA Pol II ChIA-PET
HCT-116 DNase-seq
HCT-116 ATAC-seq
HCT-116 ATAC-seq control
HCT-116 CpG islands
Sequencing data and processed output
Experimental Models: Cell Lines
Neuro-2a (N2a)
K-562
Hep G2
OCM-1A
HCT 116
293T/17 [HEK 293T/17]
Experimental Models: Organisms/Strains
Mouse: C57BL/6J
Oligonucleotides
Primers and oligonucleotides

ENCODE:ENCFF850EAH;
ENCODE:ENCFF312RKB
ENCODE:ENCFF865KPW;
ENCODE:ENCFF947YPU
ENCODE:ENCFF070JDY;
ENCODE:ENCFF334HHB
ENCODE:ENCFF048ZOQ;
ENCODE:ENCFF827YXC

ENCODE:ENCFF408RRT
ENCODE:ENCFF413RQG
ENCODE:ENCFF335PHG
ENCODE:ENCFF000BXH
ENCODE:ENCFF000BWK
ENCODE:ENCFF002DPL;
ENCODE:ENCFF002EGC
Michael Snyder
ENCODE:ENCFF002EGI;
ENCODE:ENCFF002EGA
Richard Myers
ENCODE:ENCFF000PIX
Richard Myers
ENCODE:ENCFF000POV
Michael Onken
DOI:10.1186/s12920-018-0424-0
Michael Onken
DOI:10.1186/s12920-018-0424-0
Michael Onken
GEO:GSE110193
Michael Greenberg
SRA:SRR6129714
Michael Greenberg
SRA:SRR6129695
Yijun Ruan
ENCODE:ENCFF000KYH
John Stamatoyannopou ENCODE:ENCFF001DCK
los
Sriharsa Pradhan
SRA:SRR5453778
Michael Guertin
GEO:GSE92674
Richard Myers
GEO:GSM1014209
This study
GEO:GSE148448
ATCC
ATCC
ATCC
Michael Onken (Yen et
al., 2018)
ATCC
ATCC

Cat#CCL-131
Cat#CCL-243
Cat#HB-8065
N/A
Cat#CCL-247
Cat#CRL-11268

Joseph D. Dougherty N/A
(Cammack et al., 2020)
This study, see Table
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N/A

2.4
Recombinant DNA
pRM1024: PBase
pRM1114: HyPBase
pRM1023: SP1-PBase
pRM1677: SP1-HyPBase
pRM1882: FOXA2-HyPBase
pRM1863: BAP1-HyPBase
pRM1304: PB-SRT-Puro
pRM1535: PB-SRT-tdTomato
pCMV(CAT)T7-SB100
pRM1665: SP1-SB100X
pRM1668: SB-SRT-Puro
pRM1217: AAV-HyPBase
pRM1648: AAV-PB-SRT-tdTomato
pUC19 Vector
Lenti-dCas9-KRAB-blast
sgOpti
pMD2.G
psPAX2
pRM1889: BRD4 CRISPRi plasmid
pRM1890: Non-targeting CRISPRi plasmid
Software and Algorithms
cutadapt 1.16
NovoAlign 3
Cell Ranger 2.1.0
scanpy 1.3.7
Drop-seq tools 1.11
astropy 3.2.1
WashU Human Epigenome Browser 46
MEME-ChIP 4.11.2
Tomtom 5.1.0
MACS 1.4.1
BEDTools 2.27.1
NumPy 1.17.2
SciPy 1.4.1
statsmodels 0.10.1
matplotlib 3.0.3

This study
This study
This study
This study
This study
This study
This study
This study
Zsuzsanna Izsvák
This study
This study
Joseph D. Dougherty
(Cammack et al., 2020)
Joseph D. Dougherty
(Cammack et al., 2020)
New England BioLabs
Gary Hon
Eric Lander & David
Sabatini
Didier Trono
Didier Trono
This study
Robi D. Mitra (Lalli et
al., 2019)

N/A
N/A
N/A
N/A
N/A
N/A
RRID:Addgene_154884
RRID:Addgene_154885
RRID:Addgene_34879
RRID:Addgene_154887
RRID:Addgene_154888
N/A

Martin, 2011
Novocraft
Technologies
10x Genomics
Wolf et al., 2018
Macosko et al., 2015
Robitaille et al., 2013
Zhou et al., 2011
Machanick and Bailey,
2011
Gupta et al., 2007
Zhang et al., 2008
Quinlan and Hall, 2010
Oliphant, 2015
Virtanen et al., 2020
Seabold and Perktold,
2010
Hunter, 2007

RRID:SCR_011841
RRID:SCR_014818
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RRID:Addgene_154889
Cat#N3041S
RRID:Addgene_89567
RRID:Addgene_85681
RRID:Addgene_12259
RRID:Addgene_12260
RRID:Addgene_154890
RRID:Addgene_154891

RRID:SCR_017344
RRID:SCR_018139
RRID:SCR_018142
RRID:SCR_018148
RRID:SCR_006208
RRID:SCR_001783
RRID:SCR_001783
RRID:SCR_013291
RRID:SCR_006646
RRID:SCR_008633
RRID:SCR_008058
RRID:SCR_016074
RRID:SCR_008624

deeptools 3.0.1
ChromHMM 1.15
liftOver
FlowCal 1.2.0
PANTHER 14.0
ROSE 0.1
FlowJo™ Software for Mac Version 10
Multcomp 1.4-12
Custom calling card code
Other
Qubit® 3.0 Fluorometer
4200 TapeStation System
E220 Focused-ultrasonicator
MasterCycler Pro PCR System
Attune NxT Flow Cytometer
CytoFLEX S
QuantStudio™
Protocol: Mammalian Calling Cards Quick Start
Guide
Protocol: Bulk Calling Cards Library Preparation
Protocol: Single Cell Calling Cards Library
Preparation
Protocol: Processing Bulk Calling Card Sequencing
Data
Protocol: Processing Single Cell Calling Card
Sequencing Data
Protocol: Calling Peaks on piggyBac Calling Card
Data
Protocol: Visualizing Calling Card Data on the
WashU Epigenome Browser

Ramírez et al., 2016
Ernst et al., 2011
Hinrichs et al., 2006
Castillo-Hair et al.,
2016
Mi et al., 2017
Whyte et al., 2013 &
Lovén et al., 2013
Becton, Dickson and
Company
Hothorn et al., 2008
This study

RRID:SCR_016366
RRID:SCR_018141
RRID:SCR_018160
RRID:SCR_018140

Thermo Fisher
Agilent
Covaris
Eppendorf
Thermo Fisher
Beckman-Coulter
Applied Biosystems
This study

Cat#Q33216
Cat#G2991AA
N/A
Cat#950030010
N/A
Cat#B75442
Cat#A28567
DOI:10.17504/protocols.io.xurfnv6

This study
This study

DOI:10.17504/protocols.io.xwhfpb6
DOI:10.17504/protocols.io.xwifpce

This study

DOI:10.17504/protocols.io.xwjfpcn

This study

DOI:10.17504/protocols.io.4phgvj6

This study

DOI:10.17504/protocols.io.bb9xir7
n
DOI:10.17504/protocols.io.bca8ish
w

This study

RRID:SCR_004869
RRID:SCR_017390
RRID:SCR_008520
RRID:SCR_018255
https://github.com/arnavm/calling_c
ards

2.5.2 Experimental model and subject details
HCT-116, N2a, HEK293T, and HepG2 cells were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% of either penicillinstreptomycin or antibiotic-antimycotic. K562 (unless otherwise indicated) and OCM-1A cells
were grown under the same conditions as described above, replacing DMEM with RPMI 1640
Medium. Cells were grown at 37ºC with 5% carbon dioxide (CO2). Media was replenished every
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2 days. HepG2 cells were a gift from the Genome Engineering iPSC Center (GEiC) at
Washington University in St. Louis School of Medicine. OCM-1A cells were a gift from Dr.
Michael Onken. For the CD24high/CD24low cell state analyses, K562 cells were grown in IMDM
containing 10% v/v FBS and 1% penicillin-streptomycin at 37 ºC with 5% CO2. Frozen aliquots
were thawed and passaged every 48 hours until they reached a maximum concentration of
800,000 cells/ml. For experiments, cells were seeded at mid-log phase concentrations, around
400,000 cells/ml. At this point, ratio of CD24high/CD24low cells was approximately 1:1, as
determined by flow cytometry.
All mouse experiments were done following procedures described in (Cammack et al.,
2020). In brief, we cloned the PB-SRT-tdTomato and HyPBase constructs into AAV vectors.
The Hope Center Viral Vectors Core at Washington University in St. Louis packaged each
construct in AAV9 capsids. Titers for each virus ranged between 1.1x1013 and 2.2x1013 viral
genomes/ml. We mixed equal volumes of each virus and performed intracranial cortical
injections of the mixture into newborn wild-type C57BL/6J pups (P0-2). As a gating control, we
injected one litter-matched animal with AAV9-PB-SRT-tdTomato only. After 2 to 4 weeks, we
sacrificed mice and dissected the cortex (8 libraries) or hippocampus (1 library). All animal
practices and procedures were approved by the Washington University in St. Louis Institutional
Animal Care and Use Committee (IACUC) in accordance with National Institutes of Health
(NIH) guidelines.

2.5.3 DNA- vs RNA-based recovery
Approximately 500,000 HCT-116 cells were plated in a single well of a 6-well plate. Cells were
transfected with 2.5 µg of the SP1-PBase plasmid and 2.5 µg of the PB-SRT-Puro plasmid using
Lipofectamine 3000 following manufacturer’s instructions. After 24 hours, cells were split and
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plated 1:10 in each of three 10 cm dishes. Puromycin was then added to a final concentration of
2 µg/ml and colonies were grown under selection for two weeks. We obtained approximately
2,300 colonies. All cells were pooled together and split into two populations. One half was
subjected to DNA extraction, self-ligation, and inverse PCR, as described previously (Wang et
al., 2012a), with the following modification: digestion with MspI was not performed as the SRT
construct contained an second MspI cut site near the terminal repeat. The other half of cells
underwent RNA extraction and SRT library preparation (see below).

2.5.4 In vitro bulk calling card experiments
We cotransfected 10-12 replicates of HCT-116 cells with 5 µg of PB-SRT-Puro plasmid and 5
µg PBase plasmid via Neon electroporation Each replicate contained 2x106 cells. As a negative
control, we transfected one replicate of HCT-116 cells with 5 µg PB-SRT-Puro plasmid only.
We used the following settings–pulse voltage: 1,530 V; pulse width: 20 ms; pulse number: 1. We
used the same experimental setup for experiments with PB-SRT-Puro and each of SP1-PBase,
HyPBase, and SP1-HyPBase plasmids, as well as with SB-SRT-Puro and SB100X plasmids.
After transfection, each replicate was plated into a 10 cm dish. For the OCM-1A library, we
transfected 1.25 µg of PB-SRT-Puro and 1.25 µg of either HyPBase or BAP1-HyPBase (a gift
from Dr. Michael Onken) using the TransIT-LT1 transfection reagent following manufacturer’s
protocol for 6-well plates. Puromycin was added after 24 hours to a final concentration of 2
µg/ml. Cells were grown under selection for one week, by which time almost all negative control
transfectants were dead. After 7 days, we dissociated each replicate with trypsin-EDTA and
created single cell suspensions in phosphate-buffered saline (PBS). Aliquots of each replicate
were cryopreserved in cell culture media (see above) supplemented with 5% DMSO. The
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remaining cells were pelleted by centrifugation at 300g for 5 minutes. Cell pellets were either
processed immediately or kept at -80ºC in RNAProtect Cell Reagent.

2.5.5 Isolation and RT of bulk RNA
Total RNA was isolated from each replicate using the RNEasy Plus Mini Kit following
manufacturer’s instructions. Briefly, cell pellets were resuspended in 600 µl of Buffer RLT Plus
with 1% 2-mercaptoethanol. Cells were homogenized by vortexing. DNA was removed by
running lysate through gDNA Eliminator spin columns, while RNA was bound by passing the
flow-through over RNEasy spin columns. An on-column treatment with DNaseI was also
performed. After washing, RNA was eluted in 40 µl RNase-free H2O. RNA was quantitated
using the Qubit RNA HS Assay Kit.
We performed first strand synthesis on each replicate with Maxima H Minus Reverse
Transcriptase. We mixed 2 µg of total RNA with 1 µl 10 mM dNTPs and 1 µl of 50 µM
SMART_dT18VN primer (Table 2.4), brought the total volume up to 14 µl, and incubated it at
65ºC for 5 minutes. After transferring to ice and letting rest for 1 minute, we added 4 µl 5X
Maxima RT Buffer, 1 µl RNaseOUT, and 1 µl of 1:1 Maxima H Minus Reverse Transcriptase
diluted in 1x RT Buffer (100 U). The solution was mixed by pipetting and incubated at 50ºC for
1 hour followed by heat inactivation at 85ºC for 10 minutes. Finally, we digested with 1 µl
RNaseH at 37ºC for 30 minutes. cDNA was stored at -20ºC.

2.5.6 Amplifying self-reporting transcripts from RNA
The PCR conditions for amplifying self-reporting transcripts (i.e. transcripts derived from selfreporting transposons) involved mixing 1 µl cDNA template with 12.5 µl Kapa HiFi HotStart
ReadyMix, 0.5 µl 25 µM SMART primer, and either 1 µl of 25 µM SRT_PAC_F1 primer (in the
case of puromycin selection) or 0.5 µl of 25 µM SRT_tdTomato_F1 primer (in the case of
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tdTomato screening). The mixture was brought up to 25 µl with ddH2O. Thermocycling
parameters were as follows: 95ºC for 3 minutes; 20 cycles of: 98ºC for 20 seconds–65ºC for 30
seconds–72ºC for 5 minutes; 72ºC for 10 minutes; hold at 4ºC forever. As a control, cDNA
quality can be assessed with exon-spanning primers for β-actin (Table 2.4; (Raff et al., 1997))
under the same thermocycling settings.
PCR products were purified using AMPure XP beads. 12 µl of resuspended beads were
added to the 25 µl PCR product and mixed homogenously by pipetting. After a 5-minute
incubation at room temperature, the solution was placed on a magnetic rack for 2 minutes. The
supernatant was aspirated and discarded. The pellet was washed twice with 200 µl of 70%
ethanol (incubated for 30 seconds each time), discarding the supernatant each time. The pellet
was left to dry at room temperature for 2 minutes. To elute, we added 20 µl ddH2O to the pellet,
resuspended by pipetting, incubated at room temperature for 2 minutes, and placed on a magnetic
rack for one minute. Once clear, the solution was transferred to a clean 1.5 ml tube. DNA
concentration was measured on the Qubit 3.0 Fluorometer using the dsDNA High Sensitivity
Assay Kit.

2.5.7 Generation of bulk RNA calling card libraries
Calling card libraries from bulk RNA were generated using the Nextera XT DNA Library
Preparation Kit. One nanogram of PCR product was resuspended in 5 µl ddH2O. To this mixture
we added 10 µl Tagment DNA (TD) Buffer and 5 µl Amplicon Tagment Mix (ATM). After
pipetting to mix, we incubated the solution in a thermocycler preheated to 55ºC. The
tagmentation reaction was halted by adding 5 µl Neutralization Tagment (NT) Buffer and was
kept at room temperature for 5 minutes. The final PCR was set up by adding 15 µl Nextera PCR
Mix (NPM), 8 µl ddH2O, 1 µl of 10 µM transposon primer (e.g. OM-PB-NNN) and 1 µl Nextera
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N7 indexed primer. The transposon primer anneals to the end of the transposon terminal repeat–
piggyBac, in the case of OM-PB primers, or Sleeping Beauty, in the case of OM-SB primers–and
contains a 3 base pair barcode sequence. Every N7 primer contains a unique index sequence that
is demultiplexed by the sequencer. Each replicate was assigned a unique combination of
barcoded transposon primer and indexed N7 primer, enabling precise identification of each
library’s sequencing reads.
The final PCR was run under the following conditions: 95ºC for 30 seconds; 13 cycles of:
95ºC for 10 seconds–50ºC for 30 seconds–72ºC for 30 seconds; 72ºC for 5 minutes; hold at 4ºC
forever. After PCR, the final library was purified using 30 µl (0.6x) AMPure XP beads, as
described above. The library was eluted in 11 µl ddH2O and quantitated on an Agilent
TapeStation 4200 System using the High Sensitivity D1000 ScreenTape.

2.5.8 In vitro single cell calling card experiments
All cell lines (HCT-116, K562, N2a, HepG2, and OCM-1A) were cultured as described above.
HCT-116 cells were transfected using Neon electroporation with the aforementioned settings.
K562 cells were electroporated with the following settings–pulse voltage: 1,450 V; pulse width:
10 ms; pulse number: 3. N2a cells were electroporated with the following settings–pulse voltage:
1,050 V; pulse width: 30 ms; pulse number: 2. HepG2 cells were electroporated with the
following settings–pulse voltage: 1,200 V; pulse width: 50 ms; pulse number: 1. Each replicate
for electroporation was comprised of 2x106 cells. All cells were allowed to recover for 24 hours
before undergoing puromycin selection. A negative control replicate, transfected only with PBSRT-Puro, was treated identically in parallel. Replicates were harvested once the negative
control cells had died. For the species mixing experiment, we transfected one replicate each of
HCT-116 and N2a cells with 5 µg PB-SRT-Puro and 5 µg HyPBase. For the cell line mixing
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experiment, we transfected four replicates each of HCT-116 and K562 cells with 5 µg PB-SRTPuro and 5 µg HyPBase. Cells were cultured independently and mixed immediately prior to
generating single cell emulsions. For single cell calling cards analysis of SP1 binding in HCT116 and K562 cells, we transfected four replicates each with 5 µg PB-SRT-Puro and 5 µg SP1HyPBase. These libraries were not mixed. We used the demultiplexed data from the cell line
mixing experiment with HyPBase as controls. For single cell calling cards analysis of FOXA2
binding in HepG2 cells, we transfected six replicates each with 5 µg PB-SRT-Puro; three of
these replicates were co-transfected with 5 µg HyPBase, while the other three were cotransfected with 5 µg FOXA2-HyPBase. We used the mouse ortholog of FOXA2, which has
97% primary sequence identity with human FOXA2. For single cell calling cards analysis of
BAP1 binding in OCM-1A cells, we lipofected (as described above) six replicates each with 1.25
µg PB-SRT-Puro; three of these replicates were co-transfected with 1.25 µg HyPBase, while the
other three were co-transfected with 1.25 µg BAP1-HyPBase.

2.5.9 Single cell RNA-seq library preparation
Single cell RNA-seq libraries were prepared using 10x Genomics’ Chromium Single Cell 3’
Library and Gel Bead Kit. Each replicate was targeted for recovery of 6,000 cells. Library
preparation followed a modified version of the manufacturer’s protocol. We prepared the Single
Cell Master Mix without RT Primer, replacing it with an equivalent volume of Low TE Buffer.
Gel-in-emulsion (GEM) generation and GEM-RT incubation proceeded as instructed. At the end
of Post GEM-RT cleanup, we added 36.5 µl Elution Solution I and transferred 36 µl of the eluted
sample to a new tube (instead of 35.5 µl and 35 µl, respectively). The eluate was split into two
18 µl aliquots and kept at –20ºC until ready for further processing. One fraction was kept for
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single cell calling cards library preparation (see next section), while the other half was further
processed into a single cell RNA-seq library.
We then added the RT Primer sequence to the products in the scRNA-seq aliquot. We
created an RT master mix by adding 20 µl of Maxima 5X RT Buffer, 20 µl of 20% w/v Ficoll
PM-400, 10 µl of 10 mM dNTPs, 2.5 µl RNase Inhibitor and 2.5 µl of 100 µM 10x_TSO. To this
solution we added 18 µl of the first RT product and 22 µl of ddH2O. Finally, we added 5 µl
Maxima H Minus Reverse Transcriptase, mixed by flicking, and centrifuged briefly. This
reaction was incubated at 25ºC for 30 minutes followed by 50ºC for 90 minutes and heat
inactivated at 85ºC for 5 minutes.
The solution was purified using DynaBeads MyOne Silane following 10x Genomics’
instructions, beginning at “Post GEM-RT Cleanup – Silane DynaBeads” step D. The remainder
of the single cell RNA-seq protocol, including purification, amplification, fragmentation, and
final library amplification, followed manufacturer’s instructions.

2.5.10 Single cell calling cards library preparation
To amplify self-reporting transcripts from single cell RNA-seq libraries, we took 9 µl of RT
product (the other half was kept in reserve) and added it to 25 µl Kapa HiFi HotStart ReadyMix
and 15 µl ddH2O. We then prepared a PCR primer cocktail comprising 5 µl of 100 µM
Bio_Illumina_Seq1_scCC_10X_3xPT primer, 5 µl of 100 µM Bio_Long_PB_LTR_3xPT, and
10 µl of 10 mM Tris-HCl, 0.1 mM EDTA buffer. One µl of this cocktail was added to the PCR
mixture and placed in a thermocycler. Thermocycling settings were as follows: 98ºC for 3
minutes; 20-22 cycles of 98ºC for 20 seconds–67ºC for 30 seconds–72ºC for 5 minutes; 72ºC for
10 minutes; 4ºC forever. PCR purification was performed with 30 µl AMPure XP beads (0.6x
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ratio) as described previously. The resulting library was quantitated on an Agilent TapeStation
4200 System using the High Sensitivity D5000 ScreenTape.
Single cell calling card library preparation was performed using the Nextera Mate Pair
Sample Prep Kit with modifications to the manufacturer’s protocol. The library was circularized
by bringing 300 fmol (approximately 200 ng) of DNA up to a final volume of 268 µl with
ddH2O, then adding 30 µl Circularization Buffer 10x and 2 µl Circularization Ligase (final
concentration: 1 nM). This reaction was incubated overnight (12-16 hours) at 30ºC. After
removal of linear DNA (following manufacturer’s instructions), we sheared the library on a
Covaris E220 Focused-ultrasonicator with the following settings–peak power intensity: 200; duty
factor: 20%; cycles per burst: 200; time: 40 seconds; temperature: 6ºC.
The library preparation was performed per manufacturer’s instructions until adapter
ligation. We designed custom adapters (Table 2.4) so that the standard Illumina sequencing
primers would not interfere with our library. Adapters were prepared by combining 4.5 µl of 100
µM scCC_P5_adapter, 4.5 µl of 100 µM scCC_P7_adapter, and 1 µl of NEBuffer 2, then heating
in a thermocycler at 95ºC for 5 minutes, then holding at 70ºC for 15 minutes, then ramping down
at 1% until it reached 25ºC, holding at that temperature for 5 minutes, before keeping at 4ºC
forever. One microliter of this custom adapter mix was used in place of the manufacturer’s
recommended DNA Adapter Index. The ligation product was cleaned per manufacturer’s
instructions. For the final PCR, the master mix was created by combining 20 µl Enhanced PCR
Mix with 28 µl of ddH2O and 1 µl each of 25 µM scCC_P5_primer and 25 µM
scCC_P7_primer. This was then added to the streptavidin bead-bound DNA and amplified under
the following conditions: 98ºC for 30 seconds; 15 cycles of: 98ºC for 10 seconds–60ºC for 30
seconds–72ºC for 2 minutes; 72ºC for 5 minutes; 4ºC forever. All of the PCR supernatant was
102

transferred to a new tube and purified with 35 µl (0.7x) AMPure XP beads following
manufacturer’s instructions. The final library was eluted in 25 µl Elution Buffer and quantitated
on an Agilent TapeStation 4200 System using the High Sensitivity D1000 ScreenTape.

2.5.11 Staining protocols for K562 cells
CD24 surface protein was quantified using monoclonal human antibodies. Cells were spun down
at 300g for 3 minutes and washed twice with 1 ml of Cell Staining Buffer. The cell pellet was
then resuspended in 50 µl of Cell Staining Buffer containing 0.2 µg of either CD24-APC or
CD24-BV421. The tube was rotated at 4 ºC in the dark for 30 minutes. After, cells were washed
twice (as before) and finally resuspended in 200 µl of Cell Staining Buffer. Cells were excited
with 450/45 and 660/20 lasers (wavelength/filter bandwidth, both in nm). For concomitant
analysis of DNA content, we used CD24-APC. Cells were incubated with 10 µg/ml Hoechst
33342 in 5 ml of growth medium for 30 minutes prior to the staining protocol. For simultaneous
assessment of apoptosis, cells were stained with CD24-BV421. After the final wash, instead of
resuspending in 200 µl of Cell Staining Buffer, cells were washed twice with Annexin V
Staining Buffer. Cells were then incubated in 50 µl Annexin V Staining Buffer containing 0.2 µg
Annexin V-FITC and 100 µg/ml propidium iodide (PI). The reaction was incubated for 15
minutes at room temperature in the dark. Afterwards, we added 150 µl of Annexin V Staining
Buffer and proceeded to flow cytometry. All samples were measured on a Beckman-Coulter
CytoFLEX S flow cytometer. Cells were excited with 450/45, 525/40, and 610/20 lasers. We
collected 10,000 events per sample. The resulting data were processed with FlowJo™ Software
for Mac Version 10.
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2.5.12 JQ1 treatment of K562 cells
For the longitudinal treatment of K562 cells with JQ1, we seeded cells at log phase growth and
treated them with growth medium containing DMSO (~0.4% final concentration) or 250 nM JQ1
(dissolved in DMSO). Medium was replaced every 48 hours without splitting. On days 1, 2, 3, 4,
and 7, cells were split in half: one half was stained for CD24 and DNA content, while the other
half was stained for CD24 and apoptosis (both described above). Experiments were performed
with three biological replicates.
For qRT-PCR, we cultured K562 cells in either DMSO or 250 nM JQ1, in triplicate, and
collected cells at 0, 3, 6, 9, 12, and 24 hours of treatment. Cells were pelleted, resuspended in
300 µl of RNA CellProtect, and stored at -80 ºC. When we were ready to extract RNA, we
thawed cells, prepared samples using QIAGEN RNEasy Plus Mini Kit, and quantitated with the
Qubit RNA High Sensitivity kit. We reverse transcribed 500 ng of RNA with the SuperScript
VILO cDNA Synthesis Kit in a 20 µl reaction, with the following thermocycling parameters: 25
ºC for 10 minutes; 42 ºC for 2 hours; 85 ºC for 5 minutes. We then performed PCR with 2 µl of
the RT product as template, 1 µl each of forward and reverse primer (10 µM), 6 µl ddH2O, and
10 µl PowerUp SYBR Green Master Mix. We ran the PCR on an ABI QuantStudio 3 with the
following settings: 2 minutes at 50 ºC, then 2 minutes at 95 ºC (hot start); 45 cycles of 95 ºC for
15 seconds followed by 60 ºC for 1 minute. We generated melt curves after each PCR and all
samples yielded a single peak. Gene-specific primers were obtained from PrimerBank (Wang et
al., 2012b). Data were normalized to the levels of β-actin.

2.5.13 BRD4 CRISPRi of K562 cells
For CRISPRi, we first made lentivirus expressing dCas9-KRAB from Addgene plasmid #89567,
a gift from Gary Hon, packaged in HEK 293T cells along with pMD2.G (Addgene plasmid
#12259) and psPAX2 (Addgene plasmid #12260), both gifts from Didier Trono. We cloned a
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BRD4 guide RNA, selected from the Dolcetto collection (Sanson et al., 2018), into the sgOpti
plasmid (Addgene plasmid #85681, a gift from Eric Lander & David Sabatini) using Golden
Gate assembly with Esp3I. We used an in-house pipeline to design a non-targeting gRNA
sequence, which was cloned into CROP-seq-opti (Lalli et al., 2019). Plasmids were transfected
into HEK 293T cells using Lipofectamine 2000. Media was collected after 24 and 48 hours, and
subsequently concentrated using Lenti-X™ Concentrator. Viral titers were functionally assed on
HEK 293T cells using the appropriate antibiotic (blasticidin or puromycin).
Next, we generated a polyclonal pool of dCas9-KRAB-expressing K562 cells. We seeded
each well of a 6-well plate with 200,000 cells each containing 2 ml of growth media
supplemented with 4 µg/ml polybrene and 1,000,000 infectious lentiviral particles for an
estimated multiplicity of infection (MOI) of 5. Plates were centrifuged at 2,000g for 30 minutes
and returned to the incubator. After 48 hours, cells were split to mid-log phase concentration
(~400,000 cells/ml) and selected on blasticidin (10 µg/ml) for 48 hours. We made frozen stocks
from these cells.
For the knockdown experiments, cells were thawed and allowed to recover for 4 days.
We confirmed that the proportions of CD24high/CD24low was approximately equal at this point.
We then seeded 200,000 cells into each well of a 6-well plate. Three wells received the BRD4
gRNA lentivirus, while the other three received the non-targeting gRNA lentivirus, at an MOI of
2.5. We followed the same transduction protocol described above. After 48 hours of incubation,
puromycin was added to the medium at a final concentration of 2 µg/ml. After a further 48 hours,
cells were passaged 1:1 into 10 cm dishes containing 10 ml of growth medium. The surviving
cells were allowed to expand for a further 5 days before being stained for CD24 (nine days after
gRNA transduction.)
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2.5.14 Imatinib treatments of K562 cells
Cells were challenged with imatinib either after JQ1 treatment or BRD4 CRISPRi. For the
former, we plated 200,000 cells each well of a 6-well plate with 2 ml of growth medium. Half of
the wells received DMSO while the other half received 250 nM JQ1. Cells were incubated for 5
days, with fresh media changes on days 1, 2, and 3. On day 5, a portion of each well was stained
for CD24 levels. The remaining cells in each well were split between two new wells. One well
continued to receive medium supplemented with DMSO, while the other was treated with
medium containing imatinib mesylate at a concentration of 1 µM. After 48 hours, every well was
stained for CD24 levels and apoptotic activity, as previously described. Cells undergoing BRD4
or non-targeted CRISPRi were split in two and treated with either DMSO or imatinib (1 µM) as
described and in triplicate. The resulting data were processed with FlowJo™. We set gates such
that we could exclude debris but that we would capture both live and dying cells. This gate was
used to calculate levels of annexin V and PI.

2.5.15 Cell cycle perturbation of K562 cells
The cell cycle inhibitors lovastatin, nocodazole, CVT-313 and RO-3306 were purchased from
Sigma-Aldrich. All drugs were dissolved in DMSO except nocodazole, which was dissolved in
ethanol. We treated 200,000 cells per well in 6-well plates with either DMSO, ethanol (~0.4%
final concentration), 250 nM JQ1, 12 µM lovastatin, 40 ng/µl nocodazole (in ethanol), 2 µM
CVT-313, or 4.5 µM RO-3306. Media was refreshed every 48 hours. After 36 hours of
treatment, we stained for CD24 levels and nuclear DNA content. We gated for live, single cells
using the forward scatter (FSC) and side scatter channels (SSC). Univariate cell cycle analysis
was performed with FlowJo™. After 5 days of treatment, we stained for CD24 levels and
apoptotic activity. As before, we set gates to exclude debris to quantitate annexin V and PI, and
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measured CD24 in live cells gated on FSC and SSC. The G2 inhibitors, in particular, had very
few cells in the FSC/SSC gate (typically below 5%).

2.5.16 SRT-tdTomato fluorescence validation
To test the fluorescence properties of the SRT-tdTomato construct, we transfected K562 cells as
previously described with either 1 µg of pUC19 plasmid; 0.5 µg of PB-SRT-tdTomato plasmid
and 0.5 µg pUC19; 0.5 µg of PB-SRT-tdTomato and 0.5 µg pBase plasmid; and 0.5 µg of PBSRT-tdTomato and 0.5 µg HyPBase plasmid. Cells were allowed to expand for 8 days, after
which fluorescence activity was assayed on an Attune NxT Flow Cytometer with an excitation
wavelength of 561 nm. Flow cytometry data were visualized using FlowCal (Castillo-Hair et al.,
2016). We also performed bulk RNA calling cards on HEK293T cells transfected with SRTtdTomato with or without HyPBase plasmid. While these cells were not sorted based on
fluorescence activity, the SRT library from cells transfected with both SRT and transposase were
more complex and contained many more insertions than the library from cells receiving SRT
alone (Figure 2.2A).

2.5.17 In vivo scCC experiments
Mouse cortical tissues were dissociated to single suspensions following a modification of
previously published methods (Avey et al., 2018; Saxena et al., 2012). We incubated samples in
a papain solution containing Hibernate-A with 5% v/v trehalose, 1x B-27 Supplement, 0.7 mM
EDTA, 70 µM 2-mercaptoethanol, and 2.8 mg/ml papain. After incubation at 37ºC, cells were
treated with DNaseI, triturated through increasingly 2narrow fire-polished pipettes, and passed
through a 40-micron filter prewetted with resuspension solution: Hibernate-A containing 5% v/v
trehalose, 0.5% Ovomucoid Trypsin Inhibitor, 0.5% Bovine Serum Albumin (BSA), 33 µg/ml
DNaseI (Worthington), and 1x B-27 Supplement. The filter was washed with 6 ml of
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resuspension solution. The resulting suspension was centrifuged for 4 minutes at 250 g. The
supernatant was discarded. The pellet was then resuspended in 2 ml of resuspension solution and
resuspended by gentle pipetting.
We eliminated subcellular debris using gradient centrifugation. We first prepared a
working solution of 30% w/v OptiPrep Density Gradient Medium mixed with an equal volume
of 1x Hank’s Balanced Salt Solution (HBSS) with 0.5% BSA. We then prepared solutions of
densities 1.057, 1.043, 1.036, and 1.029 g/ml using by combining the working solution with
resuspension solution at ratios of 0.33:0.67, 0.23:0.77, 0.18:0.82, and 0.13:0.87, respectively. We
layered 1 ml aliquots of each solution in a 15 ml conical tube beginning with the densest solution
on the bottom. The cell suspension was added last to the tube and centrifuged for 20 minutes at
800g at 12ºC. The top layer was then aspirated and purified cells were isolated from the
remaining layers. These cells were then resuspended in FACS buffer: 1x HBSS, 2 mM MgCl2, 2
mM MgSO4, 1.25 mM CaCl2, 1 mM D-glucose, 0.02% BSA, and 5% v/v trehalose. Cells were
centrifuged for 4 minutes at 250 g, the supernatant was discarded, and the pellet was resuspended
in FACS buffer by gentle pipetting.
Cells were then sorted based on fluorescence activity. As a gating control, we analyzed
cells from cortices injected with AAV9-PB-SRT-tdTomato only. We then collected cells from
brains transfected with AAV9-PB-SRT-tdTomato and AAV9-HyPBase whose fluorescence
values exceeded the gate. After sorting, cells were centrifuged for 3 minutes at 250 g. The
supernatant was discarded and cells were resuspended in FACS buffer at a concentration
appropriate for 10x Chromium 3’ scRNA-seq library preparation.
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2.5.18 Quantification and statistical analysis
Statistical analyses were performed in Python 3.7.3 using SciPy (Virtanen et al., 2020)
and statsmodels (Seabold and Perktold, 2010) as well as R 3.5.3 using the multcomp package
(Hothorn et al., 2008). Flow cytometry figures were created with FlowJo™. All other figures
were created with Python using matplotlib (Hunter, 2007). Statistical details for individual
experiments have been provided in the main text, figure legends, and Method Details. In general,
we used 10-12 replicates for bulk RNA calling cards experiments; at least three separate libraries
for single cell calling cards experiments; and three biological replicates for the K562 cell state
experiments.

2.5.19 Sequencing and analysis: bulk DNA CC libraries
DNA calling card libraries were sequenced on the Illumina HiSeq 2500 platform. To increase the
complexity of the library, PhiX was added at a final loading concentration of 50%. Reads were
demultiplexed by the 3 base-pair barcode TAG followed by the end of the transposon terminal
repeat, culminating with the piggyBac insertion site motif TTAA. Reads that had exact matches
to these sequences were hard trimmed using cutadapt (Martin, 2011) with the following settings:
-g "^TAGTTTACGCAGACTATCTTTCTAGGGTTAA" --minimum-length 1 --discarduntrimmed -e 0 --no-indels. Reads passing this filter were then trimmed of vector sequence along
read 2 using cutadapt with the following settings: -g "^ATCACTTAAGCCGGTAC"" -minimum-length 1 --discard-untrimmed -e 0 --no-indels. The remaining reads were aligned to
the human genome (build hg38) with NovoAlign and the following settings: -n 40 -o SAM -o
SoftClip. Aligned reads were validated by confirming that they mapped adjacent to the insertion
site motif. Successful reads were then converted to calling card format (.ccf; see
http://wiki.wubrowse.org/Calling_card) using custom programs (available at
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https://github.com/arnavm/calling_cards) and visualized on the WashU Epigenome Browser v46
(Zhou et al., 2011) (http://epigenomegateway.wustl.edu/legacy/).

2.5.20 Sequencing and analysis: bulk RNA CC libraries
Multiple calling card libraries were pooled together for sequencing on the Illumina HiSeq 2500
platform with 50% phiX. Reads were demultiplexed by the N7 index sequences added during the
final PCR. Read 1 began with the 3 base-pair barcode followed by the end of the transposon
terminal repeat, culminating with the insertion site motif (TTAA in the case of piggyBac; TA in
the case of Sleeping Beauty) before entering the genome. piggyBac reads were checked for exact
matches to the barcode, transposon sequence, and insertion site at the beginning of reads before
being hard trimmed using cutadapt with the following settings: -g
"^NNNGCGTCAATTTTACGCAGACTATCTTTCTAGGGTTAA" --minimum-length 1 -discard-untrimmed -e 0 --no-indels, where NNN is replaced with the primer barcode. Sleeping
Beauty libraries were trimmed with the following settings: -g
"^NNNTAAGTGTATGTAAACTTCCGACTTCAACTGTA" --minimum-length 1 --discarduntrimmed -e 0 --no-indels. Reads passing this filter were then trimmed of any trailing Nextera
adapter sequence, again using cutadapt and the following settings: -a
"CTGTCTCTTATACACATCTCCGAGCCCACGAGACTNNNNNNNNNNTCTCGTATGCC
GTCTTCTGCTTG" --minimum-length 1. The remaining reads were aligned to the human
genome (build hg38) with NovoAlign and the following settings: -n 40 -o SAM -o SoftClip.
Aligned reads were validated by confirming that they mapped adjacent to the insertion site motif.
Successful reads were then converted to calling card format (.ccf) and visualized on the WashU
Epigenome Browser v46 (Zhou et al., 2011) (http://epigenomegateway.wustl.edu/legacy/).
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2.5.21 Sequencing and analysis: scRNA-seq libraries
scRNA-seq libraries were sequenced on either Illumina HiSeq 2500 or NovaSeq machines.
Reads were analyzed using 10x Genomics’ Cell Ranger with the following settings: --expectcells=6000 --chemistry=SC3Pv2 --localcores=16 --localmem=30. The digital gene expression
matrices from 10x were then further processed with scanpy (Wolf et al., 2018) for identification
of highly variable genes, batch correction, dimensionality reduction, and Louvain clustering.
Processed scRNA-seq datasets were stored as .loom files (http://loompy.org). We crossreferenced gene expression data with published datasets (Rosenberg et al., 2018; Rouillard et al.,
2016; Saunders et al., 2018; Tasic et al., 2018; Zeisel et al., 2018) to assign cell types. The
species mixing analysis was performed using Drop-seq_tools (Macosko et al., 2015)

2.5.22 Sequencing and analysis: scCC libraries
scCC libraries were sequenced on Illumina NextSeq 500 machines (v2 Reagent Cartridges) with
50% PhiX. We used the standard Illumina primers for read 1 and index 2 (BP10 and BP14,
respectively), and custom primers for read 2 and index 1 (Table 2.4). Read 1 sequenced the cell
barcode and unique molecular index of each self-reporting transcript. Read 2 began with
GGTTAA (end of the piggyBac terminal repeat and insertion site motif) before continuing into
the genome. Reads containing this exact hexamer were trimmed using cutadapt with the
following settings: -g "^GGTTAA" --minimum-length 1 --discard-untrimmed -e 0 --no-indels.
Reads passing this filter were then trimmed of any trailing P7 adapter sequence, again using
cutadapt and with the following settings: -a
"AGAGACTGGCAAGTACACGTCGCACTCACCATGANNNNNNNNNATCTCGTATGCC
GTCTTCTGCTTG" --minimum-length 1. Reads passing these filters were aligned using 10x
Genomics’ cellranger with the following settings: --expect-cells=6000 --nosecondary -chemistry=SC3Pv2 --localcores=16 --localmem=30. This workflow also managed barcode
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validation and collapsing of UMIs. Aligned reads were validated by verifying that they mapped
adjacent to TTAA tetramers. Reads were then converted to calling card format (.ccf). Finally, to
minimize the presence of intermolecular artifacts, we required that each insertion must have been
tagged by at least two different UMIs. We used the set of validated cell barcodes from each
scRNA-seq library to demultiplex library-specific barcoded insertions from the scCC data. This
approach requires no shared cell barcodes between individual scCC (and scRNA-seq) libraries.
As a result, we excluded insertions from non-unique cell barcodes, which represented a very
small number of total cells lost (< 1% per multiplexed library). More details on these steps are
also provided in the associated protocols. For the species mixing experiment, cells were
classified as either human or mouse if at least 80% of self-reporting transcripts in that cell
mapped to the human or mouse genome, respectively, and as a multiplet. The estimated multiplet
rate was calculated by doubling the observed percentage of human-mouse multiplet, to account
for human-human and mouse-mouse doublets.

2.5.23 Peak calling on calling card data
We called peaks in calling card data using Bayesian blocks (Scargle et al., 2013), a noise-tolerant
algorithm for segmenting discrete, one-dimensional data, using the astropy implementation
(Robitaille et al., 2013; The Astropy Collaboration et al., 2018). Bayesian blocks segments the
genome into non-overlapping blocks where the density of calling card insertions is uniform. By
comparing the segmentation against a background model, we were able to use Poisson statistics
to assess whether a given block shows statistically significant enrichment for insertions. Let
represent the set of blocks found by performing Bayesian block segmentation
on all insertions from a TF-directed experiment (e.g. SP1-PBase). For each block
number of insertions in that block in the TF-directed experiment. Similarly, let
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, let

be the

be the number

of insertions in that block in the undirected experiment (e.g. PBase) normalized to the total
number of insertions found in the TF-directed experiment. Then, for each block we calculated
the Poisson p-value of observing at least
expectation

:

insertions assuming a Poisson distribution with

. We accepted all blocks that were significant beyond a

particular p-value threshold.
For the analysis of TF-directed insertions, either in bulk or in single cells, we added a
pseudocount of 1 to

, the number of insertions in block

in the undirected experiment. We

selected all blocks whose p-values were significant at a Benjamini-Hochberg false discovery rate
of 5% (Benjamini and Hochberg, 1995). We polished peak calls by merging statistically
significant blocks that were within 250 bases of each other and by aligning block edges to
coincide with TTAAs.
To identify BRD4 binding sites from undirected piggyBac insertions, we segmented those
insertions using Bayesian blocks. For each block
insertions in that block. We also calculated

, we let

denote the number of undirected

, the expected number of insertions in block

assuming piggyBac insertions were distributed uniformly across the genome. We did this by
dividing the total number of TTAAs in the genome by the total number of undirected insertions,
then multiplying this value by the number of TTAAs in block
calculated the Poisson p-value

. Then, for each block we

. We accepted all blocks that were significant

beyond a particular p-value threshold. Finally, we merged statistically-significant blocks that
were within 12,500 bases of each other (Pott and Lieb, 2014; Whyte et al., 2013).
For the bulk PBase and HyPBase analysis, we used p-value cutoffs of 10-30 and 10-62,
respectively. (We chose these stringent thresholds to better resolve super-enhancers, which is our
primary focus here.) For both in vitro and in vivo single cell HyPBase analyses, we used a p113

value cutoff of 10-9. To identify the differentially-bound loci between CD24high/CD24low K562
cells, as well as between upper and lower cortical layer neurons (i.e. Pou3f2/Brn-2,
Bcl11b/Ctip2, and Foxp2), we used the same framework as described above for TF-directed
analysis but did reciprocal enrichment analyses, where one dataset was used as the “experiment”
track and the other as the “control” track, and vice-versa. This results in two one-sided
hypothesis tests. When analyzing differential binding between upper and lower cortical layer
neurons, we used a p-value cutoff of 10-9. For the CD24high/CD24low K562 analysis, we restricted
our hypothesis testing to BRD4-bound peaks found in the cell line mixing experiment that had at
least 20 insertions between both groups. For each peak, we normalized the number of insertions
from each population by a library-specific scaling factor and calculated the fold change in
binding as

. We then took the smaller of the two p-values and

adjusted for multiple hypotheses at a Benjamini-Hochberg false discovery rate of 10%. This was
plotted against the fold change values to generate the volcano plot.
Density tracks were generated by taking the Bayesian blocks segmentation of each
calling card dataset and, for each block, calculating the normalized number of insertions and
dividing by the length of the block in kilobases (insertions per kilobase per million mapped
insertions, or IPKM). This was plotted as a bedgraph file with smoothing applied in the WashU
Epigenome Browser (25 pixel windows).
Custom code to facilitate these analyses is available online
(https://github.com/arnavm/calling_cards). Detailed instructions on how to analyze calling card
data are provided in Appendices 4-6.
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2.5.24 TF binding analysis
We compared our TF-directed calling card peaks to publicly available ChIP-seq datasets. See
below for more details on aligning and analyzing ChIP-seq data. We collated a list of unique
TSSs by taking the 5’-most coordinates of RefSeq Curated genes in the hg38 build (UCSC
Genome Browser). A list of CpG islands in HCT-116 and K562 cells and their methylation
statuses were derived from previously-published Methyl-seq data (Brunner et al., 2009). We
used the liftOver tool (Hinrichs et al., 2006) to convert coordinates from hg18 to hg38. We tested
for enrichment in SP1-directed insertions at TSSs, CpG islands, and unmethylated CpG islands
with the G test of independence. We used the same test when testing enrichment of BAP1directed insertions at TSSs. For motif discovery, we restricted our analysis to peaks less than 5
kb in length. We then used MEME-ChIP (Machanick and Bailey, 2011) with a dinucleotide
shuffled control and the following settings: -dna -nmeme 600 -seed 0 -ccut 250 -meme-mod
zoops -meme-minw 4 -meme-nmotifs 10. Motifs were aligned on the web version of Tomtom
(Gupta et al., 2007) querying the “Vertebrates (In vivo and in silico)” database. We crossreferenced BAP1 scCC binding sites with publicly available BAP1 shRNA data (Yen et al.,
2018), focusing on genes that showed a significant change in gene expression (adjusted p-value
< 0.05).

2.5.25 BRD4 sensitivity, specificity, and precision
We used a published BRD4 ChIP-seq dataset (McCleland et al., 2016) to identify BRD4-bound
super-enhancers in HCT-116 cells, following previously-described methods (Lovén et al., 2013;
Whyte et al., 2013). We first called peaks using MACS 1.4.1 (Zhang et al., 2008) at p < 10-9
(using the parameters -p 1e-9 --keep-dup="auto" -f BAM -g hs -w -S --space=50), then fed this
into ROSE. We discarded artifactual loci less than 2,000 bp in size, yielding a final list of 162
super-enhancers. To evaluate sensitivity, we used BEDtools (Quinlan and Hall, 2010) to ask
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what fraction of piggyBac peaks, at various p-value thresholds, overlapped the set of BRD4bound super-enhancers. To measure specificity, we created a list of regions predicted to be
insignificantly enriched (p > 0.1) for BRD4 ChIP-seq signal. We then sampled bases from this
region such that the distribution of peak sizes was identical to that of the 162 super-enhancers.
We sampled to 642x coverage, sufficient to cover each base with one peak, on average. We then
asked what fraction of our piggyBac peaks overlapped these negative peaks and subtracted that
value from 1 to obtain specificity. Finally, we calculated precision, or positive predictive value,
by dividing the total number of detected super-enhancer peaks by the sum of the super-enhancer
peaks and the false positive peaks.

2.5.26 Downsampling and replication analysis
When performing downsampling analyses on calling card insertions, we randomly sampled
insertions without replacement and in proportion to the number of reads supporting each
insertion. Peaks were called on the downsampled insertions at a range of p-value cutoffs. Linear
interpolation was performed using NumPy (Oliphant, 2015) and visualized using matplotlib
(Hunter, 2007). Replication was assessed by splitting calling card insertions into two,
approximately equal, files based on their barcode sequences. Each new file was treated as a
single biological experiment. For each peak called from the joint set of all insertions, we plotted
the number of normalized insertions (IPM) in one replicate on the x-axis and the other replicate
on y-axis.

2.5.27 Analysis of external datasets
For ChIP-seq, ATAC-seq, and DNase-seq data, we aligned raw reads using Novoalign with the
following settings for single-end datasets: -o SAM -o SoftClip; while paired-end datasets were
mapped with the additional flag -i PE 200-500. To calculate and visualize the fold enrichment in
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ChIP-seq signal at calling card peaks, we used deeptools (Ramírez et al., 2016). We tested for
significant mean enrichment in BRD4 ChIP-seq signal at piggyBac peaks over randomly shuffled
control peaks with the Kolmogorov-Smirnov test. Chromatin state analysis was performed using
ChromHMM (Table 2.6) as previously described (Ernst et al., 2011). For each chromatin state,
we plotted the mean and standard deviation of the rate of normalized insertions (IPKM). We
called peaks on SP1 ChIP-seq, DNase- and ATAC-seq data using MACS 2 with the following
settings: -q 0.05 --keep-dup="auto". For the analysis of “super-enhancers” from ATAC-seq data,
we used control data derived from ATAC-seq on deproteinized human genomic DNA (Martins
et al., 2018) and followed the same steps for calling super-enhancers from BRD4 ChIP-seq data
(above). If necessary, files were converted to hg38 using liftOver (Hinrichs et al., 2006).
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Chroma states

H3K4me2

H3K9me3
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Emission
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Table 2.6: ChromHMM chromatin state annotations in HCT-116 cells
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28
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2.5.28 Cell state analyses of K562: scRNA-seq and scCC
Cell state analysis was performed on batch-corrected K562 scRNA-seq data derived from the
HyPBase cell mixing experiment. We observed that the top genes in PC1 (VIM, CD24, TMSB4X,
LYZ, and LGALS1) and PC2 (HBE1, HBG2, HBG1, HBZ, and HBA2) were anticorrelated with
each other (Figure 2.18A-B), implying the existence of two mutually exclusive states. We scored
cells based on the expression of VIM, TMSB4X, HBG1, and HBG2. We then modeled the
distribution of this state score as a 3 component Gaussian mixture model, drawing cutoffs where
adjacent Gaussian distributions intersected (Figure 2.18C). These cutoffs were then used to label
cells as either stem-like (CD24high), differentiated (CD24low), or intermediate (Figure 2.18D). The
expression levels of CD24 and HBZ, which were not used to score cells, showed high specificity
for the stem-like and differentiated clusters (Figure 2.18E). Differentially bound peaks were
called as described above.

2.5.29 Analysis of K562 experiments
We analyzed the JQ1 time course experiment using a two-way ANOVA with treatment and day
as the independent variables and the percentage of CD24low cells as the dependent variable. For
the analysis of annexin V levels in either JQ1- or DMSO-treated CD24high and CD24low cells, we
used a three-way ANOVA with treatment, cell state, and day as independent variables. The
imatinib experiments following either JQ1 or BRD4 CRISPRi pretreatment were analyzed using
a two-way ANOVA with pretreatment (JQ1/DMSO or NT/BRD4 gRNA) and treatment as the
independent variables. Multiple hypothesis correction was performed using Tukey’s honestly
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significant difference. For the cell cycle inhibitor experiment, data were analyzed using a oneway ANOVA with Dunnett’s post-hoc test using either DMSO or EtOH (for RO-3306) as
controls.

2.5.30 In vivo scCC analysis and validation
Single cell RNA-seq and single cell calling card libraries were prepared, sequenced, and
analyzed as described above. Cell types were assigned based on the expression of key marker
genes and cross-referenced with recent cortical scRNA-seq datasets (Rosenberg et al., 2018;
Saunders et al., 2018; Tasic et al., 2018; Zeisel et al., 2018). BRD4-bound peak calls were
validated by comparing to a previously published cortical H3K27ac ChIP-seq dataset (Stroud et
al., 2017). Read alignment and statistical analysis were performed as described above.
The specificity of BRD4-bound gene expression in astrocytes and neurons was analyzed
by first identifying all genes within 10,000 bases of astrocyte and neuronal BRD4 peaks.
Although assigning an enhancer to its target gene is a difficult problem, using the nearest gene is
common practice (Gasperini et al., 2019). To control for sensitivity of gene detection, we
downsampled the neuron insertions to the same number of astrocyte insertions, then called peaks
and identified nearby genes in this subset. We used gene expression data from a bulk RNA-seq
dataset (Zhang et al., 2014) to compute the specificity of gene expression between astrocytes and
neurons. We first discarded genes whose expression was not measured, and then set the value for
genes with 0.1 FPKM to zero (to better distinguish non-expressed genes from lowly-expressed
genes). Finally, for each gene

, we calculated the specificity as
. Thus, a value of 0 denotes a gene purely expressed in neurons,

a value of 0.5 for a gene equally expressed in both cell types, and a value of 1 for a gene purely
expressed in astrocytes. We plotted distributions of gene expression specificity for the set of
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astrocyte-bound genes and the downsampled astrocyte-bound genes. Gene Ontology analysis
was performed on the same sets of genes using PANTHER (Mi et al., 2017) on the “GO
biological process complete” database. Fisher’s exact test was used to compute p-values, which
were then subject to Bonferroni correction.

2.5.31 Additional resources
We have created a number of protocols describing how to perform all aspects of bulk and single
cell calling cards, from molecular biology and sequencing through data analysis and
visualization. While these are listed in the Key Resources Table (Table 2.5) and reproduced in
the appendices, we have also created a publicly accessible portal for easy access to all our
workflows: https://www.protocols.io/groups/calling-cards/. Moving forward, this folder should
contain the most up-to-date information.
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Chapter 3: The qBED track: a novel genome
browser visualization for point processes
(A version of this chapter was published in Bioinformatics 37(8), pp. 1168-1170)

3.1 Abstract
3.1.1 Summary
Transposon calling cards is a genomic assay for identifying transcription factor binding sites in
both bulk and single cell experiments. Here we describe the qBED format, an open, text-based
standard for encoding and analyzing calling card data. In parallel, we introduce the qBED track
on the WashU Epigenome Browser, a novel visualization that enables researchers to inspect
calling card data in their genomic context. Finally, through examples, we demonstrate that qBED
files can be used to visualize non-calling card datasets, such as CADD scores and GWAS/eQTL
hits, and may have broad utility to the genomics community.

3.1.2 Availability and Implementation
The qBED track is available on the WashU Epigenome Browser
(http://epigenomegateway.wustl.edu/browser), beginning with version 46. Source code for the
WashU Epigenome Browser with qBED support is available on GitHub
(http://github.com/arnavm/eg-react and http://github.com/lidaof/eg-react). A complete definition
of the qBED format is available as part of the WashU Epigenome Browser documentation
(https://eg.readthedocs.io/en/latest/tracks.html#qbed-track). We have also released a tutorial on
how to upload qBED data to the browser (dx.doi.org/10.17504/protocols.io.bca8ishw).

3.2 Introduction
Advances in genomic technologies often lead to new data formats and new platforms to visualize
those data. The Human Genome Project originated the popular Browser Extensible Data (BED)
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standard for describing genomic intervals (Kent et al., 2002). Routine next-generation
sequencing projects, such as whole-genome sequencing and RNA-seq, use the SAM format to
store and visualize data (Li et al., 2009). Epigenetic modifications detected by bisulfite
sequencing can be visualized using methylC tracks (Zhou et al., 2014). The bedGraph and
wiggle (.wig/.bigWig) formats have emerged as flexible standards for encoding pseudocontinuous integer- and real-valued signals across the genome, such as from normalized ChIP- or
ATAC-seq assays (Huy Hoang and Sung, 2014; Kent et al., 2010; Rosenbloom et al., 2010).
Finally, the .hic and .cool formats (Abdennur and Mirny, 2019; Durand et al., 2016) encapsulate
intra-chromsomal contact frequencies and have contributed to our understanding of chromatin
organization.
Over the past several years, we have introduced, and developed, transposon calling cards
to identify genome-wide transcription factor (TF) binding sites (TFBS) (Wang et al., 2007, 2008,
2011, 2012). This approach uses a TF of interest fused to a transposase. The fusion construct
deposits transposons into the genome near TFBS, which can be recovered from either DNA or
RNA libraries. Significantly enriched clusters of transposons indicate putative TFBS. Instead of
plotting read coverage, as would be done in more traditional TF studies like ChIP-seq, we plot
each insertion as a discrete point along the (genomic) x-axis and the number of reads supporting
that particular insertion on the y-axis. The result resembles a scatterplot in which an increased
density of insertions is typically observed near TFBS.
Historically, raw insertion data were visualized using GNASHY, an in-house file format
and genome browser custom built for calling card data. While useful, the GNASHY browser
suffered from two major limitations: first, it was restricted to visualizing one track–and therefore,
one sample or experiment–at a time; and second, it did not support conventional genomic
145

formats like bedGraph or bigWig. Thus, any comparative analysis of calling card data with, say,
ChIP-seq or ATAC-seq relied on manually aligning images from different browsers (Wang et al.,
2012).
Calling card technology is currently undergoing a renaissance. We have recently used
calling cards to study TF binding in bulk populations of cells in vivo (Cammack et al., 2020), and
we have also combined calling cards with single cell RNA-seq to simultaneously profile cell
identity in complex organs and heterogenous disease states (Moudgil et al., 2020). Calling cards
has also been used to dissect TF binding in both steady state and dynamic contexts (Mayhew and
Mitra, 2014; Shively et al., 2019). As the scope and application of the calling card technique
grows, we anticipate greater interest and increasingly complex visualization demands. Here, to
better support existing and future users, we describe the qBED format, a new text-based genomic
data format for storing calling card data. We also describe the qBED track, an interface for
visualizing calling card data on the WashU Epigenome Browser. Finally, we present examples of
non-calling card genomic data visualized using the qBED standard to demonstrate the format’s
flexibility.

3.3 Implementation
We christened our format qBED because it stores multidimensional, quantitative information
about quantized events, such as calling card transpositions. Formally, qBED follows a BED3+3
standard (Figure 3.1A). For calling card data, the first three columns denote the chromosome,
start, and end coordinates of the transposon insertion. The width of the interval depends on the
transposase used: mammalian calling cards, which employs the piggyBac transposase, uses a
four base-pair width for the insertion coordinate as piggyBac overwhelmingly inserts into TTTA
tetramers (Wang et al., 2012); whereas yeast calling cards uses single base-pair intervals as these
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assays use the motif-agnostic Ty5 retrotransposon (Wang et al., 2007). qBED files inherit the
BED format’s 0-based, half-open intervals and are compatible with programs like bedtools
(Quinlan and Hall, 2010) and bedops (Neph et al., 2012) for intersection analysis. The fourth
column encodes a numerical value–in this case, the number of reads supporting each insertion–
and is the last column required in qBED files. The fifth and sixth columns are optional, but
recommended, as the former denotes the strand (+/-, or . if unspecified) that was targeted, while
the latter encodes an annotation string. For calling card experiments, this is where samplespecific barcodes are registered (Figure 3.1A). Like BED files, qBED files can be compressed
and indexed with bgzip and tabix, respectively (Li et al., 2009).
To visualize qBED files, we have created the qBED track and implemented it in the
WashU Epigenome Browser (Li et al., 2019; Zhou et al., 2011), a leading portal for analyzing
epigenomic data such as ChIP-seq, ATAC-seq, and Hi-C. (Prior to version 51.0.3, the qBED
track was known as the calling card track). qBED tracks display circular markers for genomic
features in two dimensions: genomic position along the x-axis and numerical value along the yaxis (Figure 3.1Bi). For calling card experiments, these represent transposon insertions and read
counts, respectively. When the insertion coordinate spans more than one base, the marker is
drawn at the midpoint of the interval. Moreover, as multiple insertions may occur at the same
insertion site (e.g. from different replicates), multiple markers can co-occur at the same xcoordinate and stratify across the y-axis. qBED tracks support interactive exploration of data. As
a cursor approaches a data point, a rollover pane appears (Figure 3.1Bii), displaying the read
count, strand, and annotation (columns 4, 5 and 6, respectively). Near the top of the rollover pane
is the track name and an approximate (to the nearest pixel) genomic location.
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Figure 3.1: Overview of the qBED format and qBED tracks. (A) Example of a qBED file encoding transposon
calling card data. The first three columns are inherited from the BED standard and encode the location of the
insertion site. The fourth column stores the number of reads observed for each entry, while the fifth denotes strand.
The sixth and final column is an annotation recording the sample-specific barcode for each insertion in the library.
(B) Screenshot of qBED tracks depicting calling card data in the WashU Epigenome Browser. (i) qBED features
appear on two-dimensional tracks, with genomic position along the x-axis and a numerical value on the y-axis (here,
log-transformed read counts). (ii) An informational panel appears upon rollover of a calling card insertion, revealing
read count, strand, barcode, and approximate location. (iii) Right-clicking on a qBED track pulls up a configuration
panel. Tracks can be customized with respect to color, size, y-axis limits and transformations, marker size (iii-iv),
opacity (v), and sample size (vi). (vii) Orthogonal datasets like transcription factor and histone ChIP-seq data can be
directly displayed alongside calling card data.

Right-clicking on a qBED track leads to a customization panel (Figure 3.1Biii).
Individual tracks can be shaded in any RGB color (Figure 3.1Biii-vi), to better delineate different
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samples. The size of the calling card marker can be made larger (Figure 3.1Biii) or smaller
(Figure 3.1Biv), depending on user preference. The opacity of the track can also be adjusted
(Figure 3.1Bv), which may help reveal structure in regions of pronounced insertion density. For
very large datasets, a random subsample of the data can be displayed (Figure 3.1Bvi). This
prevents overplotting of markers and can reduce the browser’s memory consumption. Finally,
and most importantly, the WashU Epigenome Browser enables calling card data to be natively
visualized alongside other genomic datasets, such as ChIP-seq from the same cell type (Figure
3.1Bvii).

3.4 Applications
qBED files present genomic data as a discrete point process as opposed to a pseudo-continuous
function of sequencing coverage. In addition to analyzing calling card experiments, this format
may also be useful for existing genomic data types. Here we present two such examples.
Combined Annotation Dependent Depletion (CADD) scores integrate multiple streams of
information to predict the deleteriousness of single nucleotide polymorphisms (SNPs) and indels
(Kircher et al., 2014; Rentzsch et al., 2019). These are typically displayed as vertical lines
depicting the maximum score observed for each base (Figure 3.2A). This approach, while useful
as a summary statistic, does not allow for interactive exploration of individual mutations. We
converted CADD scores for indels from variant call format (VCF) to a qBED file, using the
numeric column to store the CADD score and the annotation column to store the mutation. When
viewed on the WashU Epigenome Browser, individual polymorphisms can be inspected. A view
of the homeobox gene CRX reveals a cluster of strongly deleterious indels in the terminal exon
(Figure 3.2A). The qBED display emphasizes the density of variants along both the genomic (x)
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and CADD (y) axes, offering an unvarnished look at the complete spectrum of deleteriousness in
a dataset.

Figure 3.2: Application of the qBED specification to other genomic datasets. (A) Top: CADD scores for the
gene CRX, as visualized on the UCSC Genome Browser. Bottom: CADD scores visualized on the WashU
Epigenome Browser after conversion to qBED. Genomic position is along the x-axis and Phred-style CADD scores
are along the y-axis. The mouseover pane reveals more information on an individual variant. (B) eQTLs for CD20+
B cells visualized as calling card tracks. The top track shows all significant eQTLs in view plotted as a BED
(density) track, followed by a qBED representation of the same data. The y-axis represents the negative base-ten
logarithm of the p-value. The next three tracks show significant eQTLs for the genes GSDMB, ORMDL3, and
ZPBP2, respectively. Finally, we show H3K27ac ChIP-seq (coverage on the y-axis) and a super-enhancer for this
cell type. A mouseover pane can reveal further details stored in the qBED file, including Reference SNP ID and
mutation.
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A second application of qBED files is in genome wide association studies (GWAS) and
expression quantitative trait locus (eQTL) mapping, which aim to identify SNPs that are
significantly correlated with either phenotypes or gene expression, respectively. Most significant
SNPs fall in noncoding regions and their functional significance can be unclear (Gloss and
Dinger, 2018; Tak and Farnham, 2015). One way to prioritize variants is by considering their
regulatory and epigenetic context (Gloss and Dinger, 2018; Tak and Farnham, 2015); however, a
quantitative view of SNPs is not supported by most genome browsers. Investigators either
manually align separate views of SNPs with views of epigenetic profiles, or encode SNPs as
BED tracks, which shows position but sacrifices the quantitative measure–usually the negative
base-ten logarithm of the p-value–of the association (Farh et al., 2015).
We reasoned that the qBED track could display both the density and the quantitative
value of SNPs in association studies. We used a publicly available eQTL dataset from CD20+ B
cells (Schmiedel et al., 2018) and converted it to qBED format, storing the negative base-ten
logarithm of the p-value of the eQTL association in the numeric column; and storing the
reference SNP, mutation, and linked gene in the annotation field. We simultaneously plotted
H3K27ac ChIP-seq data (Davis et al., 2018; The ENCODE Project Consortium, 2012) and a
track of super-enhancers for the same cell type (Figure 3.2B). Such data would either have to be
manually aligned with another browser shot or plotted as a BED track (shown) that only
emphasizes the local density of variants. The qBED visualization shows both the density of
variants and the significance of each variant, alongside epigenetic context, all in a single pane.
We can also separate eQTLs by target gene and assign them to individual tracks, revealing how
genes in close proximity to each other can have different eQTL effect sizes from the same
genomic sequence. In particular, eQTLs associated with GSDMB and ORMDL3 expression span
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a large swath of flanking DNA, including overlapping an adjacent super-enhancer, while eQTLs
associated with ZPBP2 expression are constrained to a much narrower segment. This example
demonstrates how the qBED track can bridge the fields of association studies and epigenomics,
simplifying certain kinds of analyses for researchers.
The qBED track is best positioned for exploring dense, quantitative data driven by highresolution point processes. As such, it can be a useful complement to the popular lollipop track
(Jay and Brouwer, 2016; Lee et al., 2019), either as a way to publish figures of raw data without
the clutter of lollipop stems; or as a way to inspect data before choosing individual points for
further annotation and emphasis. Moreover, by first specifying the x- and y- (columns 1-3 and 4,
respectively) values, the qBED format prioritizes the two-dimensional relationship of the data.
This may also have some advantages for data compression as the strand and annotation columns
are not required and can be added if additional specificity is required. In contrast, interval-based
formats like BED and ENCODE’s tagAlign would require six fields to store the same data.
Finally, where tagAlign stores the actual sequence of each read, qBED defers to sequence in the
reference genome at the x coordinate. The annotation field can be used to record departures from
the reference, similar to the way Variant Call Format (VCF) files encodes SNPs, but remains
broadly flexible for the end user.

3.5 Conclusion
The qBED specification and the accompanying qBED track offer researchers the ability to
visualize genomic point processes–such as transposon insertions, polymorphism deleteriousness,
or phenotypic associations–by adding a numerical y-axis for stratifying features on the genomic
x-axis. We envision investigators using this format not only for analyzing calling card
experiments, but any data involving relatively small, quantitatively separable genomic features.
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While we feel the six-column format presented here is complete enough for existing analyses, we
leave open the possibility for future enhancements. In particular, extra columns could be added
to encode secondary and/or tertiary information for each entry. These could be visualized,
pending browser support, with either a numerical color scale, in the case of quantitative data, or
different marker shapes, for categorical data.
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Chapter 4: Fast and optimal genome
segmentation with Bayesian blocks
4.1 Abstract
Genome segmentation and peak calling are common tasks to identify regions enriched in a signal
of interest. Typically, the signal is a dependent function of genomic position; examples include
epigenetic marks assayed by ChIP-seq and accessible loci by ATAC-seq. Less common is the
determination of peaks based on the local density of genomic features. Here, we present
Bayesian blocks, an algorithm for optimally segmenting intervals based on the underlying
density of data. While this algorithm was initially developed for astrophysics, we have adapted it
for use in genomics. We first explain the mathematical foundations of the algorithm, including a
linear runtime optimization. We next demonstrate Bayesian blocks on two genomic datasets:
first, to call peaks in transposon calling cards data and identify transcription factor binding sites;
and second, to identify CpG islands based on genomic sequence. We conclude that Bayesian
blocks may be generally useful in genomics and have released an accompanying Python package
(blockify) implementing support for genomic data formats.

4.2 Introduction
Genomic analysis frequently involves segmenting the genome into regions, often termed peaks,
enriched for signals of interest. Peaks can identify fine-grained features, such as protein-bound
DNA detected using chromatin immunoprecipitation and sequencing (ChIP-seq), or accessible
loci detected by the assay for transposase-accessible chromatin (ATAC-seq) (Zhang et al., 2008).
On a broader scale, segmentation can be used to identify open reading frames (Cleynen et al.,
2014) and transcriptionally active regulatory elements (Wang et al., 2019) from RNA sequencing
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(RNA-seq) data as well as larger domains of organized chromatin (Hansen et al., 2010; Keough
et al., 2020) and structural variants such as duplications and deletions (Fan and Mackey, 2017).
Peak callers often look for a statistical enrichment of coverage, or read depth, relative to a
control dataset or against flanking sequence (Zhang et al., 2008). Transcription factor (TF) ChIPseq, for example, uses an antibody to pull down DNA crosslinked to a TF on interest (Johnson et
al., 2007). Peaks are then called by comparing the relative amount of reads in the experimental
track compared to the input control, which is typically the same sample but without antibody
enrichment. Coverage is a pragmatic metric for assays that generate random genomic fragments,
though read depth can be skewed by technical artifacts such as skewed representation and
chimeras (Cha and Thilly, 1993; Kanagawa, 2003).
Over the past few years, we have developed transposon calling cards as an alternative
assay to map TF binding sites (Wang et al., 2007, 2012). This technique uses a TF of interest
fused to a transposase. As the TF visits its binding sites, the transposase deposits transposons
nearby. Loci that show a high density of transpositions in the TF-transposase condition, but not
in the undirected transposase dataset, represent sites likely bound by the TF. In contrast to ChIPseq, we do not visualize our data as function of coverage. Rather, each transposition is drawn as
a distinct marker (Figure 4.1). While insertions are stratified across two dimensions for
visualization, we only consider the genomic coordinates for downstream analysis using countbased statistics.
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Figure 4.1: Example calling cards tracks. Two representative tracks from calling cards experiment. The top track
are insertions from a Cbf1p-directed yeast calling cards experiment and the bottom track are insertions from the
negative control. Insertions are drawn as circular markers with genomic coordinate on the x-axis and log10transformed read count on the y-axis. n denotes the total, genome-wide library size.

While calling cards can generate highly specific binding profiles, there are challenges
with calling peaks on calling cards data. Mammalian calling cards uses the piggyBac
transposase, which almost exclusively inserts into TTAA tetramers (Wang et al., 2012). As a
result, the insertion profile can be sparse. Yeast calling cards can be deposited without such
constraint, resulting in very smooth peaks. However, our analyses only looked for differences
over entire promoters (Shively et al., 2019). One drawback of this is that we are not able to
distinguish between sharp, TF-directed insertions against a diffuse background of undirected
transpositions, leading to false negatives (Figure 4.1). Finally, while mammalian and yeast
calling cards are philosophically identical and generate similar kinds of data, their analytical
pipelines are divorced. We therefore set out to develop a new strategy for calling peaks that
would be flexible enough to work with both yeast and mammalian datasets, but robust enough to
handle sparsity.
We turned to Bayesian blocks, an algorithm developed by astrophysicists for counting
photons (Scargle, 1998; Scargle et al., 2013). Among its strengths is the ability to generate a
mathematically optimal segmentation of one-dimensional data by globally maximizing a
piecewise Poisson likelihood function. It can also tolerate gaps, repeated values, and noise,
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which makes it attractive for analyzing calling cards experiments. Calling card transpositions
also share certain features with photons that make them appropriate for this approach, namely
that they are discrete, independent events and can be aptly described by Poisson-based counting
processes. We realized, as we began exploring Bayesian blocks, we that this algorithm may be
generally useful in genomics. Indeed, Bayesian blocks has already made a few appearances in
the genomics literature (Cang and Nie, 2020; Chan et al., 2017; Ish-Horowicz and Reid, 2017;
Stumpf et al., 2017). However, we have not yet seen an introduction or implementation
specifically tailored to the genomics community.
The remainder of the manuscript is structured as follows. We start by reviewing the
mathematical foundations of the algorithm and implement an optimization strategy that greatly
improves the runtime complexity. Next, we demonstrate how Bayesian blocks, in conjunction
with control and experimental datasets, can be used as a peak caller for calling cards to identify
TF binding sites. Finally, we turn Bayesian blocks onto a classic problem, identifying CpG
islands from genomic sequence. We find that Bayesian blocks can be competitive with hidden
Markov models (HMMs), the dominant paradigm for segmenting genomic data. We conclude
that Bayesian blocks may have broad utility in genomics as a general-purpose approach to
segmentation.

4.3 Results
4.3.1 Review of Bayesian blocks
Bayesian blocks seeks to segment a one-dimensional dataset into a series of contiguous blocks
where the rate of events per block is piecewise-constant (Scargle et al., 2013). In doing so, it
optimizes the global likelihood of the partition assuming a regularized Poisson likelihood
function.
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Figure 4.2: Overview of Bayesian blocks. (A) Sample dataset and terminology. Nearby data points are drawn
arbitrarily stacked on top of each other. (B) Schematic of the Optimal Partitioning (OP) algorithm. (C) Explanation
of the pruned exact linear time (PELT) optimization scheme. (D) Runtime comparison between OP and PELT on
real-world calling cards datasets.

Formally, Bayesian blocks considers a set of ordered data points

along a

one-dimensional interval (Figure 4.2A). The interval is divided into cells such that each unique
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belongs to a cell , which is bounded by edges
tessellation of X:

, with

cells; we denote a block

and

and

. The cells form a Voronoi
. Blocks are composed of consecutive

, where

. For a given block

represent the number of data points in the block, and let

, let
be the length of the

block. The edges of blocks demarcate sites where the local density of events changes. Thus,
Bayesian blocks fits into the class of change point detection algorithms. While change point
detection is commonly performed on a time- or position-dependent signal, Bayesian blocks is
distinct in that it operates on the underlying density of data along the interval itself.
Bayesian blocks proceeds using a dynamic programming strategy called Optimal
Partitioning (OP) (Jackson et al., 2005) (Figure 4.2B). For a point
the optimal location of the last change point containing
log-likelihood function for block

as

, the algorithm determines

. We denote the Poisson maximum

. (The objective function must be additive across

blocks, which is why the likelihood is log-transformed. A complete derivation is provided in the
Proofs section). We define the global log-likelihood of a partition containing

as

. Thus, for each data point, Bayesian blocks works backwards,
considering each previous data point as possible block members and storing the index
maximizes
containing

, i.e.

that

is the location of the optimal last change point

. After all points have been considered, the algorithm performs a traceback: the first

change point to be emitted corresponds to the index maximizing the log-likelihood function of
the last data point ( for

in Figure 4.2B), the next change point corresponds to the index
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maximizing the log-likelihood function for the data point immediately preceding
and proceeding so forth until we reach

(

for

),

.

This scheme offers two key benefits. First, by iterating through the interval in this
manner, the algorithm performs

calculations, which is a significant improvement over the

total possible combinations of change points. Second, by maximizing the log-likelihood at
every iteration, the algorithm is guaranteed to find the globally optimal log-likelihood partition.
The proof for this relies on mathematical induction and is described in (Jackson et al., 2005).
While Bayesian blocks’ quadratic runtime is tolerable for many applications, genomes
readily span millions to billions of base pairs and our capacity to generate sequencing data grows
exponentially. Even within our own lab, calling cards datasets have grown two orders of
magnitude in the last five years. To keep pace with technological advances, we have
implemented an optimization scheme called Pruned Exact Linear Time (PELT) (Killick et al.,
2012) into Bayesian blocks (Figure 4.2C). The intuition here is that we can reduce how far back
we search if, at some point, the log-likelihood function monotonically decreases. To take
advantage of this, we have to show that there exists a constant
, for

such that

. (We show that that the objective function

satisfies this criterion in the Proofs section). Next, if there exists
is true for all points up to and including
change point for all points

, then the last optimal

and beyond will not be found beyond

optimal change point is bounded by
points up to and including

such that

. Put differently, the last

for the remaining data points. As such, we can prune all

. This optimization achieves linear runtime in practice on real-world

genomic datasets (Figure 4.2D).
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Finally, to prevent overfitting, Bayesian blocks incorporates a regularization term. This
penalty takes the form of a prior on the total number of change points. We use the original
formulation of
in the dataset and

, where
represents a false positive rate in the interval

alters the sensitivity of block detection. Modest values (e.g.

is the total number of points
. Tuning the value of
) can yield generally good

segmentations but may fail to segment subtle differences in densities (Figure 4.3A). Conversely,
a more aggressive value may excel at detecting fine structure but may also be more likely to
spuriously partition noise (Figure 4.3B). Regardless, we note that both outputs look remarkably
similar and partition the data in a manner that accords with our intuition. This example
demonstrates the core strengths of Bayesian blocks: a minimal number of hyperparameters;
robustness to hyperparameter choice; and block widths that adapt to local variability in signal-tonoise ratio.

Figure 4.3: Effect of varying p0 on segmentation. (A) Segmentation resulting from a modest choice of p0 on
multimodal data. (B) Same as (A) but with a more aggressive p0. The asterisk marks a potential false positive block.
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4.3.2 Calling peaks using Bayesian blocks
We next use Bayesian blocks to call peaks in calling cards data. As mentioned earlier, calling
cards are similar to photons in that they are discrete, independent events and can be appropriately
described by Poisson-based counting processes. Furthermore, as calling cards data can be sparse
in certain contexts, Bayesian blocks’ ability to tolerate noise makes it a practical choice as the
basis for a peak caller. We have previously used Bayesian blocks to call peaks in mammalian
calling cards (Cammack et al., 2020; Moudgil et al., 2020a). Here, we demonstrate Bayesian
blocks on publicly available yeast calling cards data and provide a thorough benchmark of the
algorithm’s performance.

Figure 4.4: Calling peaks on calling cards data with Bayesian blocks. (A) Overview of the peak calling
workflow. (B) Example of Cbf1p calling cards peak. Raw insertions in the Cbf1p-directed and negative control
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datasets are drawn in the top-most tracks. Output of the Bayesian blocks segmentation is shown toward the bottom,
scaled by unadjusted p-value on the y-axis. Peaks were formed by merging significant adjacent blocks. Peak
summits denote blocks where the peak achieves maximum significance. (C) Sensitivity, specificity, and precision of
Cbf1p peak calls as a function of varying p0. Dashed line represents the default value of 0.05. (D) Motif analysis of
peaks identified from Cbf1p calling cards elicits the core Cbf1p motif.

Calling cards experiments rely on comparing data from a TF-directed transposase against
a control dataset from the undirected transposase (Figure 4.4A). Since the signal we are most
interested in are TF-directed densities, we begin by segmenting the TF-directed data using
Bayesian blocks. As yeast and mammalian chromosomes are linear, each chromosome is
partitioned independently. The resulting blocks are candidate peaks. To account for variable
numbers of insertions between the control and experimental datasets, we scale the number of
insertions in the control track to equalize library sizes. This scalar is then applied per block ( )
to the control dataset (subject to a small pseudocount), which then establishes a block-specific
mean ( ) parameterizing a block-specific Poisson process.
We then consider the data from the TF-directed experiment. For each block
perform a one-tailed Poisson hypothesis test on observing
is the number of insertions within

, we

events or greater in the block, where

in from the TF-directed experiment, i.e.

. In other words, for each block, the null hypothesis is that insertions are
distributed according to a Poisson process inferred from the control experiment. We then
perform multiple hypothesis correction on these p-values, accepting those beyond a specified
threshold. These candidates are then polished, such as by merging significant blocks within a
small distance window, before generating a final set of peaks.
We analyzed the data from the basic-helix-loop-helix (bHLH) TF Cbf1p in this manner
(Figure 4.4B), finding that our peak calling strategy accurately characterizes Cbf1p binding. We
observed that the global likelihood of the segmentation was relatively invariant as a function of
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(Figure 4.5A), which highlights Bayesian blocks’ ability to robustly find an optimal
segmentation. Moreover, while the number of significant blocks increased slowly as
increased, the number of significant peaks remained constant (Figure 4.5B). Here, we polished
peaks by only merging significant adjacent blocks. This suggests that much of the increased
partitioning from raising

is likely occurring under Cbf1p peaks, where we would expect to

see signal, rather than at unbound loci with sparser insertion densities.

Figure 4.5: Additional benchmarking of peak calling. (A) Global negative log-likelihood from segmenting Cbf1p
calling cards as a function of p0. (B) Total numbers of significant blocks and significant peaks in Cbf1p calling
cards as a function of p0. Here, as in (A), dashed line represents the default value of 0.05. (C) Raw insertion data,
block representation, peaks, and peak summits from Leu3p calling cards data. (D) Motif analysis of Leu3p peaks
elicits the core Leu3p motif.

Finally, we measured the accuracy of our peaks by comparing them to a set of goldstandard set of promoters predicted to be either bound or not bound by Cbf1p (Shively et al.,
2019). We called peaks using a default

of 0.05 and calculated their sensitivity, specificity,
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and precision as 98.1%, 99.6%, and 90.3%, respectively. Varying

had little effect on

sensitivity and precision and only affected specificity at the highest values. A motif analysis of
our peaks returned a near-perfect match to the Cbf1p motif, confirming the biological validity of
our peak calls. To generalize across TF families, we also analyzed data generated from the zinc
finger TF Leu3p. As with Cbf1p, we identified stark peaks enriched for Leu3p-directed
insertions (Figure 4.5C). Our sensitivity, specificity, and precision were 85.8%, 99.7%, and 89%,
respectively (Shively et al., 2019), and we were able to elicit the Leu3p motif from our peak calls
(Figure 4.5D). We conclude that Bayesian blocks can accurately identify TF binding sites from
transposon calling cards data.
One limitation of calling peaks using Bayesian blocks is that it may generate relatively
broad peaks (Figure 4.4B, 4.5C). By design, calling cards experiments use a TF-transposase
fusion. When bound at its motif, the TF may sterically hinder the transposase, blocking it such
that the transposase targets the flanking genomic sequence. This can result in doublets flanking
the TF motif (Figure 4.5D). Similarly, high local concentrations of TF-transposase fusion
proteins, such as through cooperative binding (Shively et al., 2019), can cause “spillover” of
insertions into adjacent DNA (Figure 4.4B). Peaks are built from the underlying structure of
blocks. In general, block sizes scale inversely with the relative enrichment of TF-directed
insertions over background (Figure 4.6A), which reflects focal redirection to TF binding sites.
This effect is also observed in mammalian calling cards on a coarser scale (Figure 4.6B-C),
though there are important biological and technical considerations: the human genome is 250
times larger than that of yeast; the transposase targets a specific motif which may be less
frequent in certain sequence contexts (Wang et al., 2012); and recovery of insertions can be
sparse, particularly in single cell assays (Moudgil et al., 2020a). While we have successfully used
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Bayesian blocks to map well-resolved TF binding sites in mammalian systems (Cammack et al.,
2020; Moudgil et al., 2020a), there are opportunities for informatic and molecular improvements
to further sharpen our analyses.

Figure 4.6: TF-directed block sizes are a function of relative enrichment. (A) Block widths in yeast calling cards
experiments plotted as a function of log2 fold change in normalized insertions between the TF and control datasets.

170

(B-C) Same as in (A) but for human cell line calling cards experiments with SP1 (B) and BAP1 (C). Data from
matched bulk and single cell (sc) experiments are shown. Contours are drawn to emphasize the density of data
points. Lines are LOESS-smoothed curves.

4.3.2 Identifying CpG islands using Bayesian blocks
Finally, we consider an application of Bayesian blocks beyond transposon calling cards. CpG
islands represent clusters of CG dinucleotides in the genome. These base pairs decay over
evolutionary time due to spontaneous cytidine deamination into thymine. Their occurrence,
particularly in clusters, suggests functional selection, and CpG islands are often observed at gene
promoters (Tahir et al., 2019). Identifying CpG islands from genomic sequence is a classic
segmentation problem in genomics, with methods ranging from sliding window analyses
(Gardiner-Garden and Frommer, 1987; Ponger and Mouchiroud, 2002; Takai and Jones, 2002) to
more complex Markov models (Byung-Jun Yoon, 2004; Kakumani et al., 2012; Wu et al., 2010).
We noted that the task of identifying CpG islands is a density detection problem similar to
calling peaks in calling cards data. Therefore, we investigated whether Bayesian blocks could be
used to find CpG islands.
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Figure 4.7: Detecting CpG islands with Bayesian blocks. (A) Representative CpG islands as derived from UCSC
(Gardiner-Garden and Frommer, 1987), a hidden Markov model (HMM; Wu et al. 2010), and Bayesian blocks. n
represents the total number of called islands. (B) Overlap between the Bayesian blocks annotations and the UCSC
and HMM datasets, respectively. The number indicates the percent of CpG islands called by Bayesian blocks that
overlap the respective comparison set. (C) Mean methylation status of CpG islands in H1 human embryonic stem
cells by dataset. kb: kilobase.

We first segmented the genome based on the locations of CpG dinucleotides, a feat that
was greatly aided by the PELT optimization. A block was considered a CpG island if it met the
criteria laid out by (Gardiner-Garden and Frommer, 1987), whose own annotations form the
default set of CpG islands in the UCSC Genome Browser and thus have considerable visibility to
researchers. Since many repetitive elements are also rich in CG dinucleotides (Tahir et al., 2019;
Wu et al., 2010), we performed our analysis on a repeat-masked genome. Our Bayesian blocksbased CpG islands showed strong overlap with the UCSC set (Figure 4.7A), with over 90% of
our calls overlapping a UCSC CpG island (Figure 4.7B). This suggests that Bayesian blocks can
be used sensitively and specifically detect CpG islands.
We were curious as to how Bayesian blocks compares to hidden Markov models
(HMMs), which is a well-established method for genome segmentation (Chou and Danko, 2019;
Durbin et al., 1998; Ernst et al., 2011; Ha et al., 2012; Keough et al., 2020; Malekpour et al.,
2017; Munch and Krogh, 2006). We cross-referenced our CpG islands against a published set of
HMM-based CpG islands (Wu et al., 2010) (Figure 4.7A-B). Once again, we observed high
specificity of overlap, with over 97% of our CpG islands overlapping an HMM-based CpG
island. However, there was a large fraction of HMM CpG islands that did not overlap the
Bayesian blocks set, which may indicate that the latter is susceptible to false negatives. To
investigate further, we looked at the average methylation status of these called CpG islands
(Stevens et al., 2013). While CpGs are generally methylated, CpG islands show decreased
methylation relative to surrounding sequence (Greenberg and Bourc’his, 2019). All three
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datasets followed this pattern, though the UCSC and Bayesian blocks sets had markedly less
methylation on average than the HMM set (Figure 4.7C). We conclude that the Bayesian blocks
approach to calling CpG islands is not likely prone to false negatives.
To close, we looked at the size distribution of these called CpG islands. HMMs use
transition probabilities to mark changes in state. As such, the probability of staying in the same
state decreases exponentially and so HMMs should be more likely to generate short
segmentations. We found that the HMM-based CpG islands had a greater enrichment for smaller
segments over Bayesian blocks (Figure 4.8). CpG islands from Bayesian blocks also appear to
avoid the short segment bias seen in the UCSC dataset. The tendency toward longer features is
one key difference between HMMs and Bayesian blocks. For some applications, this may be a
desirable feature.
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Figure 4.8: Length distributions of CpG islands. For this analysis, block lengths were log-transformed. In
addition, we removed the 200 bp minimum length requirement for the Bayesian blocks dataset to better visualize the
entire distribution.

4.4 Discussion
Segmentation is a common task in biology. PELT, for example, has been used to segment twodimensional signals, such as coverage across the genome (Burke et al., 2018; Weinberg et al.,
2019), neuronal firing over time (Gouwens et al., 2019; Jewell et al., 2019), and fluorescence
intensity over spatial trajectories (Desai et al., 2019). Its adoption was facilitated by the R
package changepoint (Killick and Eckley, 2014). However, there was no analogous software for
segmenting one-dimensional data, such as the location of exogenous transposons or CG
dinucleotides.
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We fill that gap by introducing Bayesian blocks as a density-based approach to
partitioning genomic features. In addition to this manuscript, we have released a Python package,
blockify (https://github.com/arnavm/blockify), for analyzing genomic datasets with Bayesian
blocks. Blockify directly operates on BED files, a popular standard for encoding genomic
features; incorporates the PELT-based optimization for fast segmentation; comes with a peak
caller to facilitate discriminative analyses; and is globally available via the Python Package
Index. We have also created an online notebook illustrating Bayesian blocks, OP, and PELT
within an interactive framework (https://observablehq.com/d/d2cafaa7d8c1e018). In particular,
this allows users to see how changing the underlying distribution of data and hyperparameters
affects segmentation.
We demonstrated how Bayesian blocks can be used to call peaks in transposon calling
cards, comparing information from a TF-directed experiment against a control dataset to identify
binding sites. That Bayesian blocks can find peaks with high accuracy and precision, tolerates
noise, and is robust to hyperparameters makes it an attractive algorithm for this purpose.
However, peak widths can be broad, for a variety of reasons outlined above. One strategy that
could enrich for smaller peaks is to set a relatively lax size filter and accept all blocks with a
minimum enrichment threshold. For example, one might draw quadrants on a plot like Figure
4.6B and take all blocks in the lower right corner. This would reduce the number of multiple
comparisons when assessing statistical significance, which in turn may identify loci with weaker
TF-directed signal. Adjusting the prior on the number of change points may also lead to sharper
peaks. While we adopted a global prior per chromosome, a more sophisticated approach could be
to dynamically vary the prior based on local genomic features. Information about chromatin
state, derived from ChIP-seq and ATAC-seq, could be incorporated into a context-specific prior
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that favors more aggressive segmentation in promoters and enhancers–where TF binding sites
are more likely to reside–and decreases sensitivity in heterochromatin. This would balance the
desire to pinpoint binding sites while minimizing the risk of false positives.
Our investigation of CpG islands suggests that Bayesian blocks can be competitive with
HMMs, which is a standard technique for genome segmentation. However, we do not see
Bayesian blocks replacing HMMs. HMMs can support multiple states, making them arbitrarily
customizable, and they can encode additional layers of information, such as sequence
composition. Bayesian blocks is responsive to data density and is better suited for relatively
simple classifications, such as peak and non-peak regions. Additionally, the speed of the
algorithm makes it ideal for exploratory analyses that can inform more complex models.
There are a number of future directions to develop the core algorithm. While here we use
a piecewise-constant density function as a first-order approximation for TF binding, this
simplification may not necessarily reflect biological reality. Bayesian blocks, at least with the OP
algorithm, can also accommodate piecewise linear and exponential density functions. In our
current implementation, blockify assumes linear chromosomes. However, Bayesian blocks can
also operate on circular intervals, and this could be applied to analyzing metagenomic and
mitochondrial genomes. Bayesian blocks can also be extended to two- or even multidimensional datasets (Scargle, 2002), which could prove useful in clustering single cell RNA-seq
data. Expanding blockify to use non-Poisson likelihoods could also be useful, as long as blockadditivity is preserved. Many RNA-seq datasets, for example, use the negative binomial
distribution to model count distributions. A negative binomial likelihood function could be apt
for discovering genomic “dark matter” like cryptic open reading frames (Wang et al., 2021).
Finally, as ATAC-seq is another transposase-based assay, Bayesian blocks may be able to infer
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the optimal width of accessible loci, increasing resolution and possibly better revealing dynamic
changes.

4.5 Methods
All segmentation and peak calling were performed with blockify 0.1.0, which is available at
https://github.com/arnavm/blockify. The Bayesian blocks algorithm was originally forked from
astropy 3.2.1 (Robitaille et al., 2013; The Astropy Collaboration et al., 2018) and expanded with
custom code. We have also implanted Bayesian blocks in JavaScript at
https://observablehq.com/d/d2cafaa7d8c1e018. The OP and PELT timing analyses were
performed on a MacBook Pro with a 2.9 GHz Quad-Core Intel Core i7 processor with 16 GB of
RAM. General data analysis was performed with numpy 1.17.2 (Oliphant, 2015), matplotlib
3.0.3 (Hunter, 2007), statsmodels 0.11.1 (Seabold and Perktold, 2010), and Python 3.6.
Yeast Cbf1p, Leu3p, and control calling cards datasets were obtained from (Shively et
al., 2019). Bulk mouse neuron and astrocyte piggyBac calling cards datasets were obtained from
(Cammack et al., 2020). We also downloaded all bulk and in vitro calling cards datasets from
(Moudgil et al., 2020a), as well as in vivo astrocyte and neuron data. Unless otherwise specified,
segmentation was performed with

. For the yeast dataset, peaks were called by

merging adjacent significant blocks (after Bonferroni correction with an adjusted p-value cutoff
of 0.05) with a pseudocount of 1: -d 0 -a 0.05 --correction “bonferroni" -c 1. For the sensitivity,
specificity, and precision analysis of Cbf1p and Leu3p peaks, we used data from (Shively et al.,
2019). Specifically, we used p-value cutoffs of < 1e-5 to call true positive promoters and p > 0.1
to call true negative promoters. Sensitivity was defined as TP / (TP + FN), specificity was TN /
(TN + FP), and precision as TP / (TP + FP). Motif locations were found by scanning the sacCer3
genome with PWMScan (Ambrosini et al., 2018) using the recommended Cbf1p and Leu3p
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motifs and PWM scores from ScerTF (Spivak and Stormo, 2012). Motif analysis was performed
using meme-chip (Machanick and Bailey, 2011) with the following settings: “-dna -nmeme 600 seed 0 -ccut 250 -meme-mod zoops -meme-minw 4 -meme-nmotifs 5.” Calling card datasets
were visualized as qBED tracks on the WashU Epigenome Brower (Li et al., 2019; Moudgil et
al., 2021).
For the analysis of CpG islands, we first generated a list of all CG dinucleotides in a
repeat-masked hg19 assembly using kmer.cc
(https://gist.github.com/arnavm/039e76a34a386a4f29b82682bc8e6c72). We then segmented this
using blockify (

). Finally, a block was considered a CpG island if it met the following

criteria: length greater than 200 bp; minimum GC content of 50%; and a ratio of observed to
expected CG dinucleotides of at least 0.6 (Gardiner-Garden and Frommer, 1987). When
comparing length distributions (Figure 4.8), we dropped the first restriction from the Bayesian
blocks set. A reference set of CpG islands in hg19 was downloaded from the UCSC Genome
Browser. An orthogonal set of HMM-derived CpG islands in hg19 was obtained from (Wu et
al., 2010). CpG methylation data in H1 human embryonic stem cells were derived from (Stevens
et al., 2013). Mean methylation levels were calculated using deeptools 3.0.1 (Ramírez et al.,
2016).

4.6 Proofs
4.6.1 Properties of Poisson point processes
Let

be a Poisson random variable with value

value of . Thus,
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parameterized by an expected

From this, we see that

and

. If

is a Poisson process

defined on the interval and with rate parameter , the probability of

events within the interval

is

We can use this equation to calculate the instantaneous probability of an event over an
infinitesimal interval

As

:

, the exponential term goes to 1, leaving

. This can also

be seen from the Taylor series expansion of

As

, the nonleading terms rapidly go to zero, resulting in

4.6.2 Derivation of the Bayesian blocks likelihood function
Bayesian blocks finds the segmentation that maximizes the global Poisson likelihood.
The likelihood of a Poisson process parameterized by a mean of
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is given by

.

Let

denote the intervals between data points within a block, where

the likelihood is the product of the instantaneous probabilities at

. Then,

and zero events in the

intervals :

We can generalize simplify this by noting that the sum of the intervals

is the length of

the block and the rest of the terms depend only on the number of data points within the block
. Thus,

Bayesian blocks requires that the objective function be additive, which we achieve by
taking the logarithm of the likelihood.

We now need to find the value of

that maximizes the likelihood function. We obtain

this value by taking the derivative of the likelihood function and solving for zero.

The only nontrivial root of this equation is at
likelihood equation:
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. Substituting this into the log-

This matches Equation 19 from (Scargle et al., 2013). To simplify calculations, we note
that

and so use the right-hand side of this relationship as the Bayesian

blocks likelihood function:

4.6.3 Adapting Bayesian blocks to PELT
PELT enables us to dynamically prune data points, improving the runtime from quadratic to
linear. To take advantage of this, we have to show that there exists a constant
that

, where
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such

. The proof of this is as follows:

Thus, exists and equals 0. Note that this inequality holds as long as

and

so must be taken into consideration when implemented.
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Chapter 5: Self-reporting transposons reveal
chromosomal compartmentalization
5.1 Introduction
The three-dimensional conformation of chromatin can influence gene expression (Fullwood et
al., 2009; Le Dily et al., 2014). To better understand this process, a number of sequencing-based
techniques have been developed measuring DNA-DNA contacts and reconstructing spatial
relationships within the genome (Dekker, 2002; Dostie et al., 2006; Simonis et al., 2006; Zhao et
al., 2006). Perhaps most well-known is Hi-C (Lieberman-Aiden et al., 2009), a high-throughput
method to sequence proximal contacts in an unbiased manner. In addition to inspiring several
derivative techniques (Hsieh et al., 2015; Krietenstein et al., 2020; Quinodoz et al., 2018), Hi-C
has revealed higher-order chromosomal structures such as compartments (Lieberman-Aiden et
al., 2009) and topologically-associated domains (Dixon et al., 2012).
Hi-C, like all bulk assays, creates an averaged representation of genome conformation
and is therefore most appropriate when studying a pure population of cells. Newer techniques
have emerged that barcode and capture genomic interactions in individual cells (Arrastia et al.,
2022; Nagano et al., 2013; Ramani et al., 2017). While these methods are revealing
organizational heterogeneity within nuclei, they only recover conformation information and are
still restricted to predefined cell types. Single cell RNA sequencing (scRNA-seq) can be used to
discover cell types (Cao et al., 2017; Klein et al., 2015; Macosko et al., 2015; Plasschaert et al.,
2018; Zheng et al., 2017) and has fueled multi-omic technologies that link gene expression to
other genomic processes (Angermueller et al., 2016; Cao et al., 2018; Rooijers et al., 2019;
Stoeckius et al., 2017). The ability to directly connect transcriptome to genome conformation
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would greatly advance our understanding of regulatory mechanics in individual cell types,
especially if this could be deployed in vivo. Unfortunately, no such method currently exists.
Here we offer one approach to bridging this gap. We have previously developed single
cell calling cards to map transcription factor binding sites in a cell-type-specific manner
(Moudgil et al., 2020). This technique relies on self-reporting transposons (SRTs), exogenous
transposable elements that transcribe their genomic coordinates as mRNA. Thus, transpositions
can be mapped from scRNA-seq libraries, which also contain cellular transcripts to identify cell
type. We have shown that this method can be used both in vitro, with plasmid transfection, as
well as in vivo via viral transduction.
In our prior work, we focused primarily on the piggyBac transposase. Now, we analyze
the distribution of Sleeping Beauty (SB) SRTs in HCT-116 cells. We find that SB transposition is
non-uniform across the genome, but this only becomes apparent at the megabase scale. Variation
in SB activity follows the same pattern as chromosomal compartmentalization, with greater
transposition seen in the transcriptionally active compartment A. This correlation is strong
enough that we can call compartments from SB transposition itself. We provide several
benchmarks to confirm the precision of our assignments. Finally, we quantify how accurately we
can identify compartments in the limit of sparse data. These analyses lay the foundation for a
potentially powerful, albeit unconventional, method for jointly measuring gene expression and
genome topology at the single cell level.

5.2 Results
5.2.1 Sleeping Beauty SRTs are not uniformly distributed across the genome
Sleeping Beauty (SB) has previously been shown to have little chromatin preference (Yoshida et
al., 2017), a finding we confirmed with a much larger dataset generated from self-reporting
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transposons (SRTs) (Moudgil et al., 2020). However, at that time our analysis was focused on
enhancers and super-enhancers, which are found at a scale of 103 to 105 bases (Whyte et al.,
2013). Genomic DNA is hierarchically organized into organizational layers such as nucleosome
clutches and chromatin fibers which are dynamically modulated by transcription and during
differentiation (Ricci et al., 2015). Moreover, the nucleus is itself a highly heterogenous
organelle containing numerous phase-separated subdivisions (Hnisz et al., 2017; Klein et al.,
2020; Padrón et al., 2019; Sabari et al., 2018) . Thus, while SB may have little transpositional
variation at small length scales, it was unclear if this uniformity was preserved more globally.
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Figure 5.1: SB insertion densities are correlated with chromosomal compartment. (A) Raw insertions and
insertion density profiles for SB SRTs in HCT-116 cells. (B) ChIP-seq for post-translationally modified histones.
(C) Blocks of genomic DNA statistically enriched and depleted for SB insertions can be used to reconstruct
chromosomal compartments. Hi-C compartmentalization and contact matrix are also shown.

We re-analyzed the SRT dataset and found that, on large length scales (106 to 107 bases),
SB transposition is indeed non-uniform (Figure 5.1A). Insertions appear to fall into alternating
regions of high and low, with graded transitions between them visible in the insertion track.
While the density of insertions within a region seems constant, the variegation between adjacent
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regions is only apparent when juxtaposed on such a large scale. Finally, it is worth noting that
these high- and low-SB regions form relatively long and contiguous segments, with few
interruptions.
To better understand factors contributing to this non-uniform transposition, we crossreferenced our insertion data against published modified histone chromatin immunoprecipitation
sequencing (ChIP-seq) data. We observed that regions with high SB insertion frequency tended
to also have higher levels of the epigenetic marks H3K27ac, H3K4me1, and H3K36me3. These
modifications are frequently associated with actively transcribed regions of the genome
(Lawrence et al., 2016). Conversely, regions with comparatively lower transposition rates were
enriched for the repressive marks H3K9me3 and H3K27me3, with the latter most prominently
seen flanking the former. We conclude that, in a broad sense, the local density of SB
transposition is positively correlated with whether genomic DNA is likely to be transcribed.

5.2.2 Densities of Sleeping Beauty SRTs reveal chromosomal compartments
One level of nuclear organization binarizes chromosomal sequences into one of two
compartments, “A” and “B”. These states are typically inferred from high-throughput assays,
such as Hi-C, and reflect intrachromosomal contact frequencies (Lieberman-Aiden et al., 2009).
Namely, “A” compartment sequences are more likely to be in close spatial proximity to one
another (similarly for “B” compartment sequences) and are less likely to be near “B”
compartment sequences. Moreover, compartment A tends to be centrally located in the nucleus
and transcriptionally active, while the compartment B is found along the nuclear periphery and is
less likely to be transcribed (Therizols et al., 2014).
Since SB insertions show density changes on the megabase scale, and these changes
correlate with transcriptionally informative epigenetic marks, we hypothesized that the variation
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seen in SB insertion density reflects the underlying chromosomal compartmentalization. To test
this, we analyzed published Hi-C data (Rao et al., 2017) and identified chromosomal
compartments (Durand et al., 2016). We then measured the distribution of insertion densities in
A and B compartments. We observed that the density of insertions is indeed higher in A
compartments over B compartments (Figure 5.2A). Although the magnitude of this effect is
modest, the differences are not likely by chance (Mann-Whitney U p-value < 10-9). Thus, we
conclude that SB is biased by chromosomal compartmentalization.

Figure 5.2: Comparison of SB insertion densities by compartment. (A) Distribution of insertions per kilobase
per million mapped insertions (IPKM) in A and B compartments as inferred by Hi-C. (B) Distribution of IPKM in
SB+ and SB– compartments. Horizontal lines represent medians of the distributions. * Mann-Whitney U p-value <
10-9.

Since we observed such a striking connection between compartment state and insertion
density, we wondered whether it was possible to identify chromosomal compartments from SB
insertions alone. We first used a density-based approach (Chapter 4) to segment the genome into
regions of extreme enrichment or depletion for SB insertions (Figure 5.1C). We then smoothed
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these data using the same fixed-width bins as the Hi-C chromosomal compartments. To
differentiate our analysis from the Hi-C-based compartments, we annotate our states as either
SB+ or SB–, to reflect high- and low-density regions, respectively.
Visual inspection of SB compartments reveals close concordance with Hi-C
compartments (Figure 5.1C). The Rand index, a metric used to evaluate the similarity between
two segmentations (Truong et al., 2020), was 0.757 between SB and Hi-C compartments,
considerably better than chance (0.5). In addition, the distributions of insertion densities within
SB compartments is both qualitatively similar to those within Hi-C compartments and
significantly different between SB+ and SB– states (Figure 5.2B; Mann-Whitney U p-value < 109

). To functionally validate our findings, we compared the genome-wide enrichments in ChIP-

seq signals between SB+ and SB– compartments. The latter showed greater average intensities
for the repressive marks H3K9me3 and H3K27me3 (Figure 5.3A-B) than the former. We
observed the opposite trend for activating marks, with SB+ being enriched for H3K27ac,
H3K4me1, and H3K36me3 (Figure 5.3C-E). Thus, SB compartments appear to demarcate
transcriptionally active and inactive domains.
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Figure 5.3: Functional validation of SB compartments. Differential enrichment in SB+ and SB– compartments
for (A) H3K9me3 ChIP-seq, (B) H3K27me3 ChIP-seq, (C) H3K27ac ChIP-seq, (D) H3K4me1 ChIP-seq, (E)
H3K36me3 ChIP-seq, (F) LaminB1-DamID, (G) early replicating DNA, and (H) late replicating DNA. The units for
the y-axis in A-F is log2 fold-change; in G-H, it is normalized coverage.

The B compartment is often associated with the nuclear lamina, which serves to anchor
and organize chromatin (van Schaik et al., 2019). We quantitated the enrichment of LaminB1, a
major lamina component, in SB+ and SB– compartments. LaminB1 signal was greater in SB–
compartments than SB+ (Figure 5.3F), suggesting that former is likely to be interacting with the
nuclear lamina. Lamina-associated domains are among the last regions of the genome to replicate
(Hansen et al., 2010). Cross-referencing our annotations with replication timing data revealed
that SB+ compartments are more likely to replicate early and SB- compartments more likely to
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replicate late (Figure 5.3G-H). This is additional evidence that SB transposition rates can
discriminate chromosomal compartments. Furthermore, it supports the notion that SB densities
reflect genome organization.
In addition to the nuclear lamina, the nucleolus is also an organizational focus for the
nucleus. In particular, nucleolus organizer regions (NORs) on the short arms of the acrocentric
autosomes help form the nucleolus (van Sluis et al., 2019). We investigated if SB can access
NORs and whether insertion densities would resemble SB+ or SB– compartments. NORs are
rich in ribosomal DNA (rDNA) repeats and therefore difficult to assemble. As such, only one
NOR is present in the human reference genome. Our analysis revealed few insertions, classifying
it as part of an SB– compartment (Figure 5.4). This suggests that SB does not readily penetrate
the nucleolus, though we consider this finding preliminary. The repetitive nature of NORs makes
it difficult to align reads to them, which would also result in reduced insertion densities. As
genome assemblies and aligners continue to improve (Miga et al., 2020), it may be possible to
confirm this finding with across multiple NORs.

Figure 5.4: SB compartment analysis of a nucleolus organizing region (NOR). Left, NOR on chromosome 21.
Right, euchromatic locus in SB+ compartment for comparison.
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5.2.3 Inferring compartmentalization from sparse Sleeping Beauty data
We have recently shown that SRTs can be recovered from single cell RNA-seq (scRNA-seq)
libraries and can be stratified by cell type (Moudgil et al., 2020). This raises the possibility that
SB SRTs could also be recovered from scRNA-seq libraries, enabling simultaneous
identification of cell identity and cell-type-specific chromosomal compartmentalization.
However, single cell genomic libraries tend be much sparser than their bulk counterparts. To
predict how accurately single cell SB libraries could identify compartments, we downsampled
our bulk SB dataset and measured the Rand index against a range of Hi-C compartment
resolutions (Figure 5.5A). We were able to call compartments with greater accuracy than
chance–corresponding to a Rand index above 0.5–with as few as 30,000 insertions, though in
practice we expect this to be an extreme lower bound. SB is a highly active transposase and we
should be able to routinely collect at least 100,000 insertions per single cell library, yielding a
minimum Rand index of 0.68. As single cell technologies improve, or by increasing the number
of cells analyzed, we may be able to push the Rand index closer to 0.75 at the coarsest scales.
We also quantitated, separately, our sensitivity to A and B compartments (Figure 5.5B-C). In the
range of a few hundred thousand insertions, SB insertions are about equally sensitive to A and B
compartments (69-77% and 66-69%, respectively). We conclude that in single cells SB insertion
profiles can be a reasonably accurate way to measure cell type-specific genome organization.
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Figure 5.5: Downsampling analysis of SB compartments. (A) Rand index of similarity between Hi-C and SB
compartments at a range of resolutions and library sizes. (B) Sensitivity of downsampled SB insertions to
compartment A. (C) Sensitivity of downsampled SB insertions to compartment B.

5.3 Discussion
While Sleeping Beauty (SB) has previously been reported to have little chromatin preference
(Yoshida et al., 2017), a more recent analysis claims that it has a modest bias towards
transcriptionally active regions (Sultana et al., 2019). Here, we confirm the latter trend, finding
that SB insertion profiles tend to align with chromosomal compartments. Regions with increased
SB density tend to overlap with compartment A, which itself is positively correlated with gene
expression. Conversely, we observed that regions depleted for SB insertions coincided with
compartment B. What is remarkable about these findings is that we were able to infer twodimensional spatial correlations from one-dimensional transposition data. Interestingly, other
groups have also attempted to reconstruct compartments from epigenetic data but from more
established techniques like ChIP-seq and the assay for transposase-accessible chromatin (ATACseq) (Fortin and Hansen, 2015; Zhu et al., 2016).
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Figure 5.6: Model of transposase activity as function of sub-nuclear localization. White line represents genomic
DNA.

Compartment A has been previously found to be more centrally located in the nucleus,
enabling it to, among other things, replicate earlier in the cell cycle (Therizols et al., 2014).
Compartment B, in contrast, tends to accumulate around the periphery, associating with the
nuclear lamina (Ramani et al., 2016). Our data further suggests a spatial model of transposase
activity, with transposition efficiency decreasing radially away from the nucleus’s center (Figure
5.6). Indeed, this has already been suggested for LINE-1 retrotransposons (Sultana et al., 2019).
We reanalyzed published piggyBac transposition data in light of our findings. Although
piggyBac has particular localization preferences at the sub-compartmental level (Moudgil et al.,
2020; Yoshida et al., 2017), globally it deposits transposons in a similar pattern to SB (data not
shown). Thus, this framework may be generally applicable to many transposases. Quantitatively
developing this model may enhance our understanding of native transposases and could better
inform analyses of exogenous assays, such as transposon calling cards (Wang et al., 2012).
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SRTs can be recovered from scRNA-seq libraries, which enables joint identification of
cell type and cell-specific transpositions. Aggregated piggyBac transposition profiles have led to
new insights into cell-type-specific regulatory processes (Moudgil et al., 2020). In a similar
fashion, single cell recovery of SB SRTs could illuminate chromosomal compartmentalization
resolved by cell type. Compartments can be dynamic, switching over the course of cellular
differentiation (Criscione et al., 2016; Dixon et al., 2015). While our downsampling analysis
suggests that single cell analyses of SB compartments can be reasonably accurate, these metrics
were measured in a single cell line at steady state. Future work should explore whether SB
transposition, particularly from single cells, is sensitive to changes in compartmentalization. The
most straightforward approach would be in vitro perturbation with a small molecule (Kantidze et
al., 2019) or in a cell culture model of differentiation (Reimer et al., 2021).

5.4 Methods
Sleeping Beauty SRT data in HCT-116 cells were obtained from (Moudgil et al., 2020). Raw
insertion data were first segmented using blockify 0.2.1 (Chapter 4) to identify contiguous blocks
with piecewise-constant density. We next determined whether a block was either enriched or
depleted for insertions by performing one-tailed Poisson hypothesis tests. Specifically, we ran
“blockify call,” using a Bonferroni-adjusted p-value threshold of 0.05, a pseudocount of 0, and a
merge window of 0, and setting the “measure” parameter to either “enrichment” or “depletion.”
The null hypothesis we used was that insertions should be uniformly distributed with respect to
all TA dinucleotides (SB’s insertion motif) across the genome. Finally, to determine SB+ and
SB– compartments, we partitioned the genome into non-overlapping, fixed width windows;
intersected each window with the sets of enriched and depleted blocks; and calculated an average
score per window. The score was calculated by assigning to each base a value: 1 if it overlapped
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an enriched block, –1 if it overlapped a depleted block, and 0 otherwise. The window score was
then the sum of all scored bases divided by the length of the window. From this, SB+ windows
were those with positive scores and SB– windows were those with negative scores. For the
sparsity analysis, downsampling was performed using blockify using a random seed of 0.
Hi-C data were obtained from GEO datasets SRR6107782-SRR610781 and were
processed using juicer (Durand et al., 2016) with the following settings: “-q general -l general -s
MboI -Q 10080 -L 10080.” Data were aligned to the hg38 human genome assembly and
visualized on the UCSC Genome Browser. ChIP-seq data and processing steps were taken from
(Moudgil et al., 2020). Processed DamID and LMNB1-DamID data were downloaded from the
4D Nucleome Data Portal (the 4D Nucleome Network et al., 2017), accession numbers
4DNFI9XJQPIZ and 4DNFIMFJN73W, respectively (van Schaik et al., 2020). Aligned early and
late Repli-seq datasets were also downloaded from the 4D Nucleome Data Portal, accession
numbers 4DNFIBQM2JE2 and 4DNFIA5J1HN7, respectively. Epigenomic profile plots were
generated using deeptools 3.0.0 (Ramírez et al., 2016). General data analysis and visualization
was performed using numpy 1.16.2 (Oliphant, 2015), scipy 1.2.1 (Virtanen et al., 2020),
matplotlib 3.0.3 (Hunter, 2007), statsmodels 0.8.0 (Seabold and Perktold, 2010), and Python
3.6.5.
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Chapter 6: Future directions
The self-reporting transposon (SRT) is fascinating in that it broadcasts a traditional, DNA-based
signal–genomic location–into mRNA, allowing it to be detected, mapped, and read out alongside
bulk and single RNA-seq data. There are several future directions and potential applications for
this technology. While some of these have been mentioned in previous chapters, they are
collected here, expanded in scope and number.

6.1 Future directions for piggyBac transposon calling cards
In its current form, SRTs rely on the constitutive expression of a strong promoter (EF-1a) to
generate self-reporting transcripts. This is useful for maximizing sensitivity across a range of cell
types (Cammack et al., 2020) but could perturb local gene expression. Strong promoters can
function as local enhancers (Medina-Rivera et al., 2018). The number of calling cards deposited
per cell is relatively small (50-100) and while we do not expect widespread dysregulation of
gene expression, we cannot eliminate the possibility of calling cards altering transcription of
native genes. One way to mitigate this concern would be to use an inducible promoter (Qin et al.,
2010), pulsing with the inducer just before collecting cells to minimize perturbation.
Silencing of promoters is another concern with sustained transcription of transgenes.
Long-term expression can lead to methylation of promoters, decreasing expression over time.
We did not suffer from appreciable silencing in either our short-course in vitro experiments
(Moudgil et al., 2020) nor in long-term experiments with intracranial calling cards (Cammack et
al., 2020). However, we were not specifically looking for silencing nor can we guarantee that it
will not happen in the future. Ubiquitous chromatin-opening elements (UCOEs) are cis212

regulatory sequences that are resistant to DNA methylation and have been used to counteract
silencing of lentiviral transgenes (Nair et al., 2011; Saunders et al., 2015; Zhang et al., 2007,
2010). Including a UCOE in the SRT could help maintain expression over longer time courses.
Finally, it may be worth considering non-Pol II promoters to drive SRTs. The simplest
solution is to include a viral T7 RNA polymerase (RNAP) promoter just before the terminal
repeat. Libraries could then be prepared from genomic DNA following an in vitro transcription
reaction. This approach, already in use to amplify single cell genomes (Chen et al., 2017a),
would evade the issues of ectopic enhancement and promoter silencing. The inclusion of the T7
RNAP promoter in Ty5 retrotransposons could also help bring SRTs to yeast calling cards
(Mayhew and Mitra, 2016). There may also be uses for SRTs containing RNA polymerase III
promoters, such as the popular U6 sequence for synthesizing Cas9 guide RNAs (Cong et al.,
2013; Mali et al., 2013). However, this would only work with transposons that do not have
polythymidine tracts in their terminal repeats.
One of the drawbacks of bulk RNA calling cards is the necessity for multiple biological
replicates to build up statistical power. In DNA calling cards, this was accomplished using a
polyclonal pool of donor plasmids containing different internal barcodes. This feature was
dropped in our initial development of the SRT because of the prohibitive distance between the
barcode and the transposon-genome junction. Recent work by Matthew Lalli demonstrates that
the piggyBac terminal repeat can be mutated to generated barcoded vectors (Lalli et al., 2021).
Moreover, structural analysis of the piggyBac transpososome revealed partial duplication of the
terminal repeat can increase transposition efficiency (Chen et al., 2020). While these plasmids
will immediately benefit bulk calling cards protocols, they may eventually be useful in single
cell calling cards to further enhance our ability to recover SRTs.
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Individual transcription factors often bind in complexes. For example, we showed that
BAP1 calling cards can recover the motif of YY1, a known binding partner (Moudgil et al.,
2020). Multiplexing calling cards to record the binding of several TFs would provide further
mechanistic insight into the binding and activity of TF collectives. One way to achieve this is to
use multiple transposase families, with each transposase fused to a different TF. Since
transposons are specifically transposed by their cognate transposase, the localization of a given
transposon would unequivocally reflect a single TF’s binding specificity. This strategy may be
difficult in practice because not all transposases tolerate fusion (see below). Alternatively,
multiple TF-piggyBac fusions could be deployed at once in vitro and deconvolved with single
cell calling cards. This approach requires each fusion to be barcoded by a TF-specific barcode
sequence in the 3’ untranslated region (UTR) downstream of the transposase (assuming the TF is
fused at the N-terminus). Viral transduction of these fusions at a low multiplicity of infection
(MOI) would ensure that a cell surviving selection received a single TF-piggyBac fusion. Single
cell RNA-seq analysis of the piggyBac transcripts would be able to detect the TF barcode and
identify which construct was delivered to each cell. SRT insertions could then be stratified by
cells sharing the same TF. This would reveal TF co-binding patterns at a pseudobulk level.
Similar approaches are already used in single cell CRISPR perturbation experiments (Datlinger
et al., 2017; Dixit et al., 2016).
We and others have characterized piggyBac’s inordinate affinity for bromodomain
proteins, particularly the coactivator BRD4 (Gogol-Döring et al., 2016; Moudgil et al., 2020;
Yoshida et al., 2017). Western blot analysis of bromodomain truncations showed that it is the Cterminal domains of the bromodomain and extra-terminal motif (BET) proteins BRD2, BRD3,
and BRD4 that directly interact with piggyBac (Gogol-Döring et al., 2016). Intriguingly, this is
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the same part of BRD4 that is intrinsically disordered and is thought to play a role in
cooperatively forming intranuclear transcriptional condensates (Sabari et al., 2018). Even more
provocative is that piggyBac itself has disordered regions at its N- and C-termini (Figure 1). This
suggests a potential target to wean piggyBac of its bromodomain affinity. If successful, these
new transposases would have greater redirectability by TFs and resolve sharper peaks. They may
also be useful for gene therapy, a field that has been frustrated by the inability of transposases to
deliver transgenes with targeted site specificity (Tipanee et al., 2017; Vargas et al., 2016).

Figure 6.1: Predicted disorder for the hyperactive piggyBac transposase. The core catalytic domain lies between
residues 130-522 (Morellet et al., 2018).

The C-terminal domain of piggyBac, while predicted to be disordered (Figure 6.1), is
necessary for binding the terminal repeat sequences (Morellet et al., 2018). In contrast, little is
known about the N-terminus and its function. In addition to the first 110 residues being
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disordered, the first 80 or so resemble an acidic activation domain (Alex Holehouse, personal
communication). Based on these observations, there are number of possible experiments to try.
First, generating a set of N-terminal piggyBac truncations would elucidate which residues, if any,
are necessary for transposition. Similar work has already been done but was complicated by the
inclusion of additional peptide tags (Lalli, personal communication). Arginines are thought to
favor condensation and the N-terminus of piggyBac is rich in them (Holehouse, personal
communication). To see if they contribute to piggyBac’s bromodomain affinity, they could be
mutated to lysines. Hydrophobicity is another sequence property that contributes to disorder
(Holehouse, personal communication), so to test its contribution to piggyBac’s behavior, the
hydrophobic amino acids can be mutated to either serine or glycine would abolish. Collectively,
these experiments should provide a reasonable starting point for understanding the role of
piggyBac’s N-terminus.
It is curious that N-terminus of piggyBac should resemble an acidic activation domain
such as that of the yeast TF Gcn4p (Staller et al., 2018). From where did this domain originate?
Was it part of an ancestral piggyBac transposase or was it co-opted from gene shuffling over
evolutionary time? Molecular evolutionary analyses of various piggyBac-like and piggyBacderived genes showed poor conservation of the N-terminal domain (Bouallègue et al., 2017;
Sarkar et al., 2003). Intrinsically disordered regions, however, are challenging for multiple
sequence alignment algorithms (Vriend et al., 2016). A more sophisticated approach, taking into
account the disordered behavior, may prove more fruitful. Then there is the question of function:
what fitness advantage does such a domain confer to piggyBac? It is not unreasonable that
transposing into highly transcribed regions, especially in the germline, maximizes the chances of
propagating to the next generation. Interestingly, two of the point mutations used to generate
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hyperactive piggyBac (I30V and S103P; (Yusa et al., 2011)) fall within the N-terminal
disordered region. These residues may have been under balancing selection in wild type
piggyBac to minimize mutagenic burden. Finally, we can ask whether this domain has any ability
to transactivate expression. Why the transposase should benefit from such activity is not clear,
but neither is the possibility something we can rule out. Perhaps piggyBac has evolved a
transcriptionally inactive mimic to other activation domains, leading it to active loci without
necessarily perturbing gene expression itself. Complementation assays involving the exchange of
piggyBac’s and Gcn4p’s acidic domain, coupled to either growth assays or a reporter gene (Liu
et al., 2020; Shively et al., 2019), would be one approach to answering this question.
Murine leukemia virus (MLV) also has an insertion profile strongly biased by
bromodomain proteins (Gogol-Döring et al., 2016; Yoshida et al., 2017). MLV and other
retroviruses have been extensively scrutinized because of their promise to deliver gene therapies
and the notable adverse reactions they have caused in clinical trials (Bushman, 2007; HaceinBey-Abina, 2003; Hacein-Bey-Abina et al., 2003). Recently, a comparative analysis across
gammaretroviruses revealed a conserved motif at the integrase C-terminus that mediated the
association with bromodomains (El Ashkar et al., 2014). Deletion of these residues, or a single
point mutation (W390A), largely abrogated the bromodomain preference (El Ashkar et al.,
2014). Furthermore, fusing other chromatin-binding domains to this mutant MLV could redirect
integrations (El Ashkar et al., 2017). These achievements are viral parallels to our goal of
redirecting piggyBac. Out of curiosity, we aligned the conserved BET interaction motif of
Moloney MLV (MMLV) against the first 110 residues of piggyBac and hyperactive piggyBac
(Figure 2). We found that the end of piggyBac’s N-terminus does contain residues resembling
MMLV’s BET interaction motif. Most intriguing is the preserved tryptophan residue (denoted by
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the asterisk) that is critical for MMLV’s association with bromodomains. Therefore, targeted
mutagenesis of these residues may offer an alternative path to disassociating piggyBac from
BETs and, consequently, enhancing redirection by TFs.

Figure 6.2: Alignment of MMLV's BET interaction motif against piggyBac. Multiple sequence alignment of
Moloney murine leukemia virus’s (MMLV) BET interaction motif against a portion of the N-termini of piggyBac
(PBase) and hyperactive piggyBac (HyPBase) transposases. Conserved residues are colored using the ClustalX
palette (blue: hydrophobic; red: positively charged). The asterisk denotes the critical tryptophan necessary for
MMLV’s BET interaction.

6.2 Future directions for Sleeping Beauty transposon calling
cards
We used Sleeping Beauty’s broad and considerably (though not completely) uniform insertion
profile to identify patterns of chromosomal compartmentalization. There is certainly room for
continued computational and biological work to, respectively, improve compartment assignment
and study dynamic changes in genome organization. There is also the opportunity to
simultaneously multiplex both piggyBac and Sleeping Beauty SRTs in the same cells, leading to
triple measurements characterizing cell identity, enhancer usage and/or TF binding sites, and
compartmentalization.
Furthermore, Sleeping Beauty’s ability to deposit transposons so widely across the
genome may have additional applications. One long-standing question regarding SRTs is
whether there exist cryptic polyadenylation signals in intergenic regions that terminate RNA
polymerase II transcription. Distributing Sleeping Beauty SRTs widely, amplifying self-reporting
transcripts, and then sequencing full-length molecules (Gonzalez-Garay, 2016; Gupta et al.,
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2018) would determine if, and to what extent, non-templated adenines are being added posttranscriptionally. Genomic sequence near the start of such tails could then be analyzed for
cryptic polyadenylation signals. This approach could also be used to screen for cryptic splicing
signals. Finally, full-length reads from single cell Sleeping Beauty libraries may yield sufficient
coverage to identify structural variants, offering another option to connect genotype to
transcriptome.

6.3 Industrial applications for SRTs
While we developed SRTs in an academic setting, it is a useful exercise to consider whether
SRTs have any applications in industry. One can view SRTs as a set of positional, heritable
barcodes. Collectively, they should uniquely identify individual clones. One biological use for
this is in lineage tracing, which is discussed in detail further below. A related application may be
as a way of confirming the provenance of biological samples.
In recent years, synthetic yeast strains have been created capable of synthesizing
pharmaceuticals and other commercially important chemicals at scale (König et al., 2015; Liu et
al., 2019; Walker and Pretorius, 2018). As the central reagent here is a living, replicating
organism, there are concerns about how to protect it as intellectual property (König et al., 2015).
With the cost of sequencing ever decreasing accompanied by efforts to expand the scope of DNA
synthesis (Boeke et al., 2016), there may come a time when copying and printing DNA on
demand is trivially easy, enabling the theft and counterfeiting of genomic commodities. A small
number of SRTs distributed across a genome may offer some protection as these elements could
serve as a randomly generated checksum. The probability that two yeast strains independently
tagged with SRTs sharing identical insertion coordinates is virtually zero. This would make it
easier for manufacturers to prove the authenticity of their creations. Moreover, copying and
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synthesizing SRTs may be prohibitively expensive since they naturally contain repetitive
sequences. Clinical samples could similarly be tagged with SRTs to generate sample-specific
ensemble barcodes. Instead of sequencing genomic variants, which can be used to uniquely
identify individuals (Erlich et al., 2018; Harmanci and Gerstein, 2018), the locations of SRTs
would authenticate patient-derived DNA. Without context, these data are simply random
numbers. Thus, SRTs may add a layer of additional security around potentially sensitive
information.

6.4 Tagmentation-free SRTs
One of the bottlenecks of preparing bulk RNA calling cards libraries is the tagmentation of selfreporting transcripts. Commercial Tn5 enzyme is expensive and while there are protocols for inhouse purification (Picelli et al., 2014), it is a non-trivial process. Generating cost efficient, highquality libraries that precisely map the transposon-genome junction would make calling cards
even more approachable to new users and allow us to increase the scale of our experiments. Here
are three proposals for tagmentation-free alternatives for mapping SRTs.
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Figure 6.3: Alternative SRT library strategies without tagmentation. (A) Reverse transcription with tailed
random hexamers. (B) Random chain termination of in vitro transcription. (C) Next-generation or in situ sequencing
with semi-random padlock probes.

The first strategy involves reverse transcription (RT) with random hexamers instead of a
polythymidine primer (Figure 6.3A). The hexamers would be tailed with a constant sequence
that forms a universal priming site (Mäki and Tiirola, 2018). The other primer would bind near
the end of the terminal repeat to minimize the risk of PCR template switching (Kanagawa,
2003). Since libraries are random, a smear of product sizes should be seen on a gel. Shorter
products can be enriched by increasing the concentration of hexamers (2006). Advantages of this
approach are cost, ease, and detection of the entire transcriptome if bulk RNA-seq is
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simultaneously needed. The latter is also a major drawback as SRT-specific amplification would
be occurring against a background of all RNA. This could necessitate more amplification cycles,
increasing the risk of PCR artifacts.
Another idea is to transcribe in vitro from an internal T7 RNAP promoter but use chain
termination to create a random library (Figure 6.3B). This approach is inspired by bio-orthogonal
click chemistry approaches for generating RNA-seq libraries (Routh et al., 2015, 2017). A small
amount of rNTPs containing a 3’ azide group (AzNTPs) would be mixed into the reaction. The
elongating T7 polymerase would incorporate one of these at random and be unable to extend
further. A second oligonucleotide, encoding a universal priming sequence and capped with a 5’
alkyne moiety, would then be introduced. The click reaction would selectively and efficiently
ligate the azide group to the alkyne, resulting in a triazole linkage. RT proceeds from the
universal priming site upstream to the SRT followed by a junction-specific PCR. Advantages of
this approach include the basal amplification of SRTs by T7 and the robustness of the click
reaction. One downside is that the concentration of AzNTPs would have to be carefully titrated
to get libraries that are long enough to capture the junction but short enough to sequence.
Polymerase read-through of the triazole linkage is not particularly efficient (Routh et al., 2017),
but this could be addressed by designing the RT primer to extend past the linkage with a small
number of degenerate bases, acting as a splint oligonucleotide (Datlinger et al., 2019).
A third approach, aimed at integrating single cell calling cards with in situ sequencing
techniques (Alon et al., 2020; Fürth et al., 2019; Lee et al., 2015), is to generate rolling circle
colonies (rolonies) that linearly amplify the transposon-genome junction (Figure 6.3C). In situ
sequencing typically uses highly specific padlock probes to achieve this (Chen et al., 2017b),
which rely on two arms that hybridize to known sequences with or without a gap between them.
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These ends are then ligated together and amplified with phi29. The problem for SRTs is that only
one end, the transposon terminal repeat, has a fixed sequence, while the other is unknown. The
solution we propose is to create a semi-random padlock probe: one end anneals near the end of
the SRT while the other ends in a random hexamer. RT would start at the hexamer, proceed
toward the 5' end of the probe which is phosphorylated and ligate it closed into a loop of single
stranded DNA (ssDNA). To ensure that the hexamer binds at some minimum distance from the
end of the transposon, dSpacer (abasic) residues could be added to the 5' end, then removed with
Endonuclease VIII or APE1. The rolony can be used directly for in situ sequencing, enabling
simultaneous readout of the transcriptome, SRTs, and spatial position of single cells; or,
alternatively, the probe could be used to generate next-generation sequencing libraries from
universal priming sites. To our knowledge, such a padlock design has not been reported, making
it a riskier way to proceed.

6.5 Expanding the palette of self-reporting transposons
In this work, we developed self-reporting piggyBac and Sleeping Beauty transposons. That we
were able to readily create these modified transposons suggests that the self-reporting paradigm
may generalize to several transposases systems, provided that the terminal sequences do not
contain a polyadenylation signal. We discuss several specific options below.

6.5.1 Mos1
Mos1 is a widely-used transposase for invertebrate transgenesis, particularly in Caenorhabditis
elegans (Frøkjær-Jensen et al., 2008). Like Sleeping Beauty, it transposes into TA dinucleotides.
Unlike Sleeping Beauty, however, Mos1 tolerates peptide fusions and can be redirected
(Maragathavally et al., 2006). Rational design of Mos1 mutants identified a variant that is up to
800 times more active than wild-type Mos1 (Germon et al., 2009). Sequence changes to the
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canonical Mos1 transposon can also lead to more efficient transposition (Jaillet et al., 2012):
replacing the 5' inverted terminal repeat (ITR) with another copy of the 3' ITR increased
transposition rates 20-fold. However, Mos1 shows markedly reduced activity in mammalian cells
(Germon et al., 2009), though there are conflicting reports (Trubitsyna et al., 2017). One culprit
could be post-translational modifications Specifically, phosphorylation of S170 alters subcellular
localization and drastically decreases transposition rate (Bouchet et al., 2014). The S170A
mutant showed some activity but the pseudophosphorylated S170D mutant did not. It is not clear
how the S170A mutant would behave in mammalian cells. Milder substitutions like S170V or
S170C that better preserve the size of the residue and prevent phosphorylation could also be
effective, especially in conjunction with the rationally designed hyperactive version (Germon et
al., 2009).

6.5.2 Tol2
Tol2 is a popular transposase for zebrafish transgenesis (Ni et al., 2008). The transposase itself
would likely not tolerate fusions as even small peptide tags abolish activity (Meir et al., 2011).
However, undirected Tol2 appears to preferentially insert into regions enriched for the epigenetic
marks H3K4me3 and H3K27me3 (Yoshida et al., 2017). These loci are thought to mark bivalent
domains termed “poised” enhancers that are being primed for future activation (Bernstein et al.,
2006). Single cell calling cards with Tol2 SRTs could identify poised loci during development or
other dynamic processes. Such an analysis would likely have to be performed simultaneously
with piggyBac single cell calling cards as it also has an affinity for H3K4me3 but not for
H3K27me3 (Yoshida et al., 2017). Therefore, Tol2 peaks that do not overlap piggyBac peaks
would most likely represent bivalent loci. Although we started developing Tol2 SRTs, molecular
refinements to the protocol are necessary (Nicolas Ledru, personal communication).
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6.5.3 LINE-1
Until now, we have focused on cut-and-paste transposases. However, copy-paste transposases
can be uniquely powerful for certain applications. The best-known example is likely the LINE-1
(L1) retrotransposon (Garcia-Perez et al., 2015; Han and Boeke, 2005; Paço et al., 2014; Singer
et al., 2010), which has been engineered for increased activity (An et al., 2006; Han and Boeke,
2004). The copy-paste activity of LINE-1 allows it to monotonically increase in number over
time. This can be valuable for TF binding studies, particularly those at steady-state equilibrium,
as it means donor elements are no longer limiting in number. This property may also make it
easier to work in difficult-to-transfect systems: in theory, as long as few copies are introduced,
they can be propagated indefinitely.
One of the challenges facing self-reporting L1 transposons is that, upon reintegration into
the genome, the transposon truncates toward the 5’ end, often in the middle of the ORF2 gene
(An et al., 2006; Sultana et al., 2019). This breakpoint would indicate the junction between the
transposon and the genome (SRTs could not point in the opposite direction due to the presence of
a polyadenylation signal). Unfortunately, the lack of a constant sequence for priming the SRT
PCR makes it difficult to enrich for insertions. One potential solution is inspired by our single
cell calling cards protocol for piggyBac (Figure 6.4).
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Figure 6.4: Proposed workflow for mapping L1 SRTs. pA: polyadenylation signal; PAS: polyadenine stretch.
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The parental L1 SRT contains a reporter gene split by an artificial intron in the opposite
orientation. Transcription of L1 removes the intron in derived copies; upon integration, the
reporter gene can be properly transcribed and translated. The reporter’s transcripts would contain
the truncated ORF2 gene as part of its 3’ UTR before encountering either a cryptic
polyadenylation signal or a genomic polyadenine stretch (PAS). RT would proceed as per our
bulk RNA calling card protocol (Appendix 2) followed by a few cycles of SRT amplification.
One difference is that we would use a biotinylated primer at one end. The resulting products
would then be captured on streptavidin-coated beads where they would be tailed with a
dideoxynucleotide triphosphate (ddNTP). Since all sequence upstream of the breakpoint is
unnecessary, we could direct Cas9 in vitro to cut these with a set of tiled gRNAs (Gu et al.,
2016). This would eliminate most ORF2 sequence but preserve a small portion next to the
breakpoint for quality control. We then would ligate a splinkerette adapter containing a nextgeneration sequencing primer onto the molecule. Due to the ddNTP, the adapter is added at the
5’ end, ensuring we only sequence from ORF2 into the genome. A series of nested PCRs
finalizes the library. Although involved, putting this protocol into practice would maximize the
information yield of L1 SRT libraries.

6.5.4 Helraiser
Helraiser is a new transposase and the only known functional member of the Helitron family
(Grabundzija et al., 2016, 2018). Helitrons are thought to replicate in a copy-paste fashion but,
unlike retrotransposons, they do not proceed through an RNA intermediate (Feschotte and
Wessler, 2001; Kapitonov and Jurka, 2001, 2007; Pritham and Thomas, 2015). Instead, the
transposase nicks one strand of transposon DNA at one of the terminal sequences and use a
rolling circle strategy to peel off a single strand of transposon DNA (Grabundzija et al., 2018).
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This circular ssDNA intermediate can either transpose into genomic DNA, inserting into AT
dinucleotides, or can be used to generate a complementary strand, creating a double-stranded
transposon circle (Grabundzija et al., 2018; Kosek et al., 2021). Repeated cycles of peeling and
pasting into the genome increase copy number over time.
One application for which Helraiser may be uniquely suited is lineage tracing. Since
SRTs are vertically transmitted, their genomic coordinates can be seen as a heritable barcode of
clonal origin. The cumulative set of self-reporting Helitrons in a cell should, in theory,
completely describe its lineage. With cut-and-paste transposases, the risk is that SRTs may move
around during the recording window, degrading clonal information (Figure 6.5A). We simulated
lineage reconstruction with copy-paste SRTs, cut-and-paste SRTs, and binary CRISPR-based
recorders (McKenna et al., 2016). We found that copy-paste SRTs were the most accurate,
especially as the per-generation mutation rate increased (Figure 6.5B). Cut-and-paste SRTs,
assuming a fixed population without re-transfection, came second and were slightly better than
CRISPR recorders. Thus, copy-paste SRTs can be an accurate way to infer lineages and may be
worth pursuing, particularly for whole organism cellular phylogenies. One advantage that
Helraiser may have over LINE-1 is that, since the former was derived from the bat genome
(Grabundzija et al., 2016), it may face fewer endogenous genome defense mechanisms in human
or mouse cells (Ariumi, 2016).
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Figure 6.5: Lineage tracing with self-reporting transposons. (A) Schematic of binary CRISPR recorders, cutand-paste SRTs, and copy-paste SRTs during lineage recording. (B) Accuracy of computational simulations
modeling mutation of CRISPR recorders, cut-and-paste SRTs, and copy-paste SRTs. X-axis is the per-generation
mutation rate. Accuracy, as measured by the Robinson-Foulds distance (Salvador-Martínez et al., 2019), is on the yaxis.

Although we have created a self-reporting Helitron, there is some concern about
transposition rate. For lineage tracing, ideally there would be exactly one new insertion per cell
cycle. However, in our hands, transposition is much slower. Our calling cards experiments in cell
culture typically last only a few days, while other groups characterized Helraiser activity over a
month-long time course (Grabundzija et al., 2016, 2018). Perhaps Helitron transposition starts
slow but ramps up over time. Another open question is what components regenerate the Helitron
strand complementary to the single stranded circular intermediate. If that is a rate-limiting step,
finding ways to accelerate its synthesis may lead to faster transposition and, consequently, better
resolved lineages.

6.5.5 Final thoughts
There are a number of other transposases active in vertebrate systems, such as Minos, Passport,
and Himar1 (Ni et al., 2008). The latter has recently been shown to tolerate fusions and can be
strongly redirected in bacteria but additional validation is needed in mammalian cells. (Chen and
Wang, 2019). Tn7 is a bacterial transposase with exquisite site specificity with reduced, but
incompletely characterized, activity in human cells (Bainton, 1993; Kuduvalli, 2005). Tn5, the
bacterial transposase used in the assay for transposase-accessible chromatin (ATAC-seq)
(Buenrostro et al., 2013) has very low activity in live mammalian cells but synthetic dimers can
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increase transposition efficiency (Blundell-Hunter et al., 2018). Finally, it is possible that the set
of transposases we know of represents a fraction of the diversity present in nature. A shotgun
metagenomics approach (Quince et al., 2017) to discover new enzymes may uncover even more
redirectable, versatile, or otherwise intriguing transposases to explore.

6.6 The ecology of chromatin
The “ecology of the genome” was coined over twenty years ago, and later expounded upon, to
describe how endogenous transposable elements live in, and interact with, the genome in ways
akin to how plants and animals engage with ecosystems (Brookfield, 2005; Kidwell and Lisch,
1997). I argue there also exists an ecology of chromatin, encompassing the multifaceted and
heterogeneous interactions between proteins and DNA. Euchromatin and heterochromatin, for
example, are populated by different sets of proteins, are rooted by different post-translational
epigenetic marks, and support different regulatory activities. Here, we employed transposases,
tethered and free-range, to traverse this landscape. This work suggests the need to reevaluate
what “accessibility” means for a transposase. Individual enzymes clearly show varying affinities
for genomic regions at scales larger than traditionally “accessible” loci. To add, both piggyBac
and Sleeping Beauty demonstrate how careful analyses of undirected transpositions can reveal
distinct aspects of genomic regulation. As researchers embrace these tools, and as the tools
become increasingly refined, it will be exciting to see what genomic wonders transposases, these
navigators of the nucleus, discover.
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Appendix 1: Mammalian Calling Cards
Quick Start Guide
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.xurfnv6)

A1.1Abstract
Transposon calling cards can identify transcription factor (TF) binding sites. This involves fusing
your favorite TF (YFTF) to the hyperactive piggyBac transposase (HyPBase). This is delivered
to cells in conjunction with a piggyBac transposon. The TF will visit sites in the genome and
YFTF-HyPBase will deposit transposons near binding sites. We then generate sequencing
libraries to map the genome-wide localization of transposons. Finally, we identify significant
clusters of insertions to identify TF binding sites.

A1.2Guidelines
These experiments are intended to introduce you to the calling cards assay. We recommend
following them to establish baseline confidence in your transcription factor constructs before
proceeding to your favorite model system. Alternatively, if you just wish to use the
directed piggyBac transposase, you can use this protocol to familiarize yourself with our
molecular workflow.

A1.3Materials
Name
Lipofectamine 3000
•

Catalog #
L3000015

Vendor
Thermo Fisher Scientific

pRM1258/pENTR_myc-hypPBase: This Gateway entry vector contains the HyPBase
gene. It is convenient to make the YFTF-HyPBase fusions in this vector because you can
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easily port the fusion into a variety of other plasmids for AAV packaging, homologous
recombination into the Rosa26 locus, etc.
•

pRM1114/CMV_HyPBase: This is our standard positive control transposase plasmid.
For some experiments it may be more convenient to make your YFTF-HyPB fusion in
this construct.

•

pRM1304/PB_SRT_Rz_Puro: This is a piggyBac self-reporting transposon (SRT)
encoding a puromycin resistance gene. Cells transfected with this plasmid and HyPBase
survive puromycin selection.

•

pRM1535/SRT_tdTtomato. This is a piggyBac self-reporting transposon (SRT) donor
encoding a tdTomato fluorescent reporter. Cells transfected with this plasmid and
HyPBase can be sorted for based on high fluorescence signal.

•

pRM1294/BrokenHeart: This plasmid is a reporter of piggyBac transposase activity. It
encodes the DsRed fluorescent protein gene interrupted by a piggyBac transposon. When
cells are co-transfected with BrokenHeart and piggyBac, the transposon is removed and
the DsRed reading frame is restored. These cells fluoresce brightly, while cells
transfected with BrokenHeart alone will not fluoresce.

•

A non-fluorescent control, or "empty," plasmid. This can be something you use regularly
in-house or a commercially available plasmid, such as NEB's pUC19 vector (#N3041S).

•

Optional: a GFP expression plasmid as a transfection control. This can be something used
routinely in your lab or a commercially available vector, such as Addgene #54767.

•

HCT-116 cells. Stocks may be obtained from ATCC (#CCL-247) if necessary.
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A1.4Steps
A.1.4.1

Cloning and Sequence Validation of YFTF-HyPBase Fusions

1. Make C- and N- terminal fusions of your favorite transcription factor (YFTF) with HyPBase.
It is important to include a linker sequence between these genes. We strongly recommend the
following amino acid linker sequence: KLGGGAPAVGGGPKAADK. We have tested many and
have found this sequence works best. It is often convenient to make these fusion constructs by
using In-Fusion (Clontech/Takara) or Gibson (NEB) cloning to drop YFTF into
pRM1258/pENTR_myc-hypPBase. We do not have good antibodies to the piggyBac
transposase, so we recommend designing your construct so that the chimeric protein is tagged
with myc.
2. Validate the constructs. Perform restriction digest analysis on the plasmid with at least 3
restriction enzymes to make sure there were no gross rearrangements. Next, Sanger sequence the
full chimeric gene, or alternatively perform Illumina sequencing on the whole plasmid. It is
important to do the restriction digest and EITHER of the sequencing stratgies.
3. (Only required for Gateway strategy). Move the chimeric gene from the pENTR vector to an
expression vector.

A1.4.2

Functional Validation of YFTF-HyPBase Fusions

4. After creating the YFTF-HyPBase and HyPBase-YFTF fusions, the next steps are to validate
them. First we will assess whether the fusions retain piggyBac transposase activity. We
recommend transforming HCT-116 cells with the YFTF fusions and the BrokenHeart transposon
along with appropriate controls. BrokenHeart plasmid is available from Addgene (#86950).
Empty plasmid can be any vector that does not have transposase or transposon sequence, e.g.
pUC19, pBluescript, etc. We recommend using Lipofectamine 3000 (following manufacturer's
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instructions) to deliver 1 µg total DNA to approximately 200,000 cells in each well of a 6-well
plate. The following table summarizes each condition and the expected results.
Condition
Negative
control
Positive
control
YFTFHyPBase
HyPBaseYFTF

Empty
plasmid

pRM1294
BrokenHeart

pRM1114
CMV_HyPBase

YFTFHyPBase- Red
Notes
HyPBase YFTF
cells?

0.5 µg

0.5 µg

NA

NA

NA

None

NA

0.5 µg

0.5 µg

NA

NA

Many

NA

0.5 µg

NA

0.5 µg

NA

Some

NA

0.5 µg

NA

NA

0.5 µg

Perform in
duplicate
Perform in
Some
duplicate

Optional control #1 -- a "lipofection only" negative control. This is not a bad idea, particularly if
you are new to lipofections or are testing a new cell line and are concerned about toxicity. These
cells should show high viability and no fluorescence signal. If these cells are viable but cells
transfected with DNA are not, it may indicate issues with plasmid isolation (e.g. endotoxin
contamination).
Optional control #2 -- a GFP expression plasmid could be transfected in parallel to estimate
overall transfection efficiencies.
5. The second validation will test whether the YFTF-fusions successfully redirect piggyBac
insertions near YFTF binding sites. Since piggyBac inserts into TTAAs, we would like to be able
to distinguish unique insertions into the same TTAA. For this reason, we recommend 6
replicates per condition, at least for your two “test” samples, and the unfused piggyBac (1 6-well
plate each, 3 total). In addition, we recommend running one well as a transposon-only negative
control and one well as a mock lipofection negative control. Here we will use puromycin
selection to obtain cells with transpositions. Once again, we will work with HCT-116 cells.
Condition

Empty pRM1304
plasmid PB_SRT_Rz_Puro

pRM1114
YFTF- HyPBase- Alive
Notes
CMV_HyPBase HyPBase YFTF
cells?
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No
transfection 1 µg
control

NA

NA

NA

NA

None

SRT only
control

0.5 µg

0.5 µg

NA

NA

NA

None

NA

0.5 µg

0.5 µg

NA

NA

Many

NA

0.5 µg

NA

0.5 µg

NA

Some

NA

0.5 µg

NA

NA

0.5 µg

Some

Positive
control
YFTFHyPBase
HyPBaseYFTF

No
colonies
after
selection
No
colonies
after a few
days
Perform 6
replicates
Perform 6
replicates
Perform 6
replicates

We typically split each well 1:1 and transfer to a 10 cm dish after 24 hours. We add puromycin
to a final concentration of 2 µg/ml after cells have seeded, typically 6-8 hours after transferring.
Media is replenished every two days. All replicates are cultured separately. Cells are harvested
after the SRT-only control transfectants are dead.

A1.4.3

Calling Card Library Preparation

6. Calling card libraries can now be made from successfully selected cells. For first-time users,
we recommend following the bulk calling card protocol for making libraries (Appendix 2).
7. (Advanced) Depending on your application, you may also be interested in making single cell
calling card libraries (Appendix 3).

A1.4.4

Sequencing, Analyzing, and Visualizing Calling Card Data

8. If your library preparation has been successful, you are ready to sequence your calling card
libraries. We have successfully sequenced libraries on the Illumina MiSeq, MiniSeq, HiSeq, and
NextSeq platforms. Due to relatively low sequence complexity, we typically run our libraries
with 50% PhiX genome spiked in.
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A1.4.5

Next Steps

9. If you've made it this far and your data look great, congratulations! One or both of the YFTF
fusions have worked and successfully enriched for insertions near YFTF binding sites. You may
now wish to repeat the above experimental workflow with your model systems, or try different
transgenesis techniques (e.g. electroporation, nucleofection, viral transduction). Otherwise, you
are now ready to move into your model system and study YFTF binding. Please let us know if
you have any difficulties and we will do our best to provide assistance.
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Appendix 2: Bulk Calling Cards Library
Preparation
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.xwhfpb6)

A2.1Abstract
This protocol describes how to create calling card libraries from bulk RNA. This protocol
assumes you have successfully transformed cells with piggyBac self-reporting transposons and
either undirected piggyBac transposase or your favorite transcription factor (YFTF) fused
to piggyBac. Your cells are now ready for RNA extraction, SRT amplification, and library
preparation.

A2.2Guidelines
Please read this protocol in its entirety before starting. For several steps, it may help to preprogram your thermocycler with the listed settings.
Please read and familiarize yourself with the manuals for the QIAGEN RNEasy Plus
Mini Kit and the Nextera XT Tagmentation Kit. The instructions are meant to summarize those
workflows; however, when in doubt, please refer to the manufacturer's instructions for guidance.
Ensure that you have performed multiple (i.e. 8-12), independent replicates of your
experiment before proceeding. The calling card assay relies on the clustering of multiple nearby
insertions to identify TF binding sites. Some regions of the genome may have relatively few
insertion sites for the transposase. Therefore, doing multiple independent replicates increases the
statistical power to discriminate between a true binding site and background noise.
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This protocol is meant to describe how we prepare calling card libraries. While it is
possible that another kit or component could equally suffice, we have not tested any substitutions
and do not officially support deviations from this protocol. This document enumerates what we
have had success with and is a starting point from which we can best help troubleshoot.

A2.3Materials
Name
Agencourt Ampure XP
dNTP
2x Kapa HiFi Hotstart Readymix
Maxima H Minus Reverse Transcriptase (200
U/uL)
Qubit dsDNA HS Assay Kit

Catalog #
A63880
639125
KK2602
EP0752
Q32851

Capillary electrophoresis instrument (e.g. Agilent
Tapestation 4200)
RNEasy Plus Mini Kit
2-mercaptoethanol
Qubit RNA HS Assay Kit

74134
21985023
Q32852

RNaseOUT™ Recombinant Ribonuclease Inhibitor

10777019

RNase H
Nextera XT DNA Library Preparation Kit
High Sensitivity D1000 Reagents
High Sensitivity D1000 ScreenTape

M0297S
FC-131-1024
5067-5585
5067-5584

Vendor
Beckman Coulter
Takara
Kapa Biosystems
Thermo Fisher
Scientific
Thermo Fisher
Scientific
Qiagen
Gibco - Thermo Fisher
Thermo Fisher
Scientific
Thermo Fisher
Scientific
New England Biolabs
Illumina, Inc.
Agilent Technologies
Agilent Technologies

Primers
>SMART_dT18VN
AAGCAGTGGTATCAACGCAGAGTACGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
VN
>SRT_PAC_F1
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CAACCTCCCCTTCTACGAGC
>SRT_tdTomato_F1
TCCTGTACGGCATGGACGAG
>SMART
AAGCAGTGGTATCAACGCAGAGT
>Raff_ACTB_F
CCTCGCCTTTGCCGATCCG
>Raff_ACTB_R
GGATCTTCATGAGGTAGTCAGTCAGGTCC
Barcoded piggyBac primers, for example:
>OM-PB-ACG (barcode sequence is underlined)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGA
TCTACGTTTACGCAGACTATCTTTCTAG
You should have multiple barcoded primers. See Table 2.4 for more examples.
Indexed Nextera N7 primers, for example:
>Nextera_N701 (index sequence is underlined)
CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGG
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You should have multiple indexed primers. These can be either official Nextera indexes
or custom, lab-specific indexes. For a comprehensive list of official Nextera indexes, consult the
Illumina Adapter Sequences Document.
These primers can be ordered purified by standard desalting.
Other reagents
•

Ethanol (96-100%)

•

Ethanol (70%)

•

Molecular biology grade water (ddH2O)

A2.4Steps
A2.4.1

RNA Extraction with QIAGEN's RNEasy Plus Mini Kit

1. Harvest cells. Process each replicate independently. Do not overload gDNA Eliminator
columns. If you have more than 107 cells, split cells in half and process on two columns, then
merge the RNA pools. Adherent cells may have to be dissociated using trypsin or a cell scraper.
Pellet cells by centrifuging at 300g for 5 minutes. Aspirate all of the supernatant.
2. Add Buffer RLT Plus (with added 2-mercaptoethanol) to the pellet. Use the following table as
a guide.
# cells

Buffer RLT Plus

< 5e6
350 µl
5e6 to 1e7 600 µl

Note the volume used here
Mix by vortexing or pipetting.
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3. Homogenize the lysate by vortexing briefly, then letting rest on bench for 1 minute.
Alternatively, cells can be homogenized using QIAshredder spin columns or by repeatedly
passing through a 20-gauge needle.
4. Transfer lysate to a gDNA Eliminator spin column placed in a 2 ml collection tube. Centrifuge
for 30 seconds at ≥ 8,000g. Ensure no liquid remains on the column membrane. Repeat
centrifugation if necessary. Keep the flow-through and discard the column.
5. Add 1 volume (i.e. 350 or 600 µl) 70% ethanol to the flow-through and mix by pipetting.
6. Transfer up to 700 µl of the sample to an RNEasy spin column placed in a 2 ml collection
tube. Spin for 15 seconds at ≥ 8,000g. Discard the flow-through. If sample volume was greater
than 700 µl, centrifuge sample in successive batches on the same column, discarding the flowthrough at every step.
7. Add 700 µl of Buffer RW1 to the column and spin for 15 seconds at ≥ 8,000g to wash.
Discard flow-through.
8. Prepare DNase solution by adding 10 µl of DNaseI to 70 µl of Buffer RDD for each sample.
Add 80ul of DNase solution to each column. Incubate at room temperature for 15 minutes.
9. Add 350 µl of Buffer RW1 to the column and spin for 15 seconds at ≥ 8,000g to wash.
Discard flow-through.
10. Add 500 µl of Buffer RPE to the column. Spin for 15 seconds at ≥ 8,000g. Discard flowthrough.
11. Repeat Step 9 but spin for 2 minutes. Discard the flow-through and the collection tube.
12. Place the spin column in a new collection tube and centrifuge for 1 minute at ≥ 8000g.
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13. Place the spin column in a new 1.5 ml collection tube. Add 40 µl RNase-free water to the
column and spin for 1 minute at ≥ 8,000g to elute RNA. RNA can be stored at –80ºC.
14. Dilute 1 µl of RNA in 9 µl of ddH2O and quantitate using the Qubit RNA HS Assay Kit.

A2.4.2

cDNA Synthesis

15. For cDNA synthesis, continue processing each replicate separately. Prepare the reverse
transcription (RT) reaction mix:
•

2 µg total RNA

•

1 µl of 50 µM SMART_dT18VN primer

•

1 µl of 10 mM dNTPs

•

Raise to 14 µl with ddH2O
Incubate RT mix at 65 °C for 00:05:00
Place on ice for 1 minute

16. Create 1x Maxima RT buffer:
•

For 5 or fewer samples, combine 1 uL of 5X Maxima RT buffer with 4 uL of ddH2O.

•

Mix by pipetting and store on ice.

17. Create a 0.5x Maxima RT H Minus enzyme dilution:
•

Mix an equal volume of Maxima RT H Minus Enzyme with the 1x Maxima RT buffer
made in step 16 (e.g. 2 uL of Enzyme + 2 uL of 1x buffer).
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You will need 1 uL of the 0.5x enzyme dilution for every sample being processed. Avoid
pipetting volumes < 1 uL.
18. Add the following to the RT mix:
•

4 µl 5X Maxima RT Buffer

•

1 µl RNaseOUT

•

1 µl of 0.5X Maxima RT H Minus enzyme (1:1 mixture of 1X Maxima RT Buffer and
Maxima RT H Minus enzyme = 100 U)
Mix by pipetteing and incubate at 50 °C for 01:00:00

19. Heat inactivate the reaction by incubating at 85 °C for 00:10:00
20. Clean up reaction using 1 µl RNase H and incubating at 37 °C for 00:30:00
Digestion with RNase H removes the complementary RNA strand from the DNA-RNA
first strand duplex. This is thought to aid amplification of longer cDNA molecules (> 1 kb)
21. cDNA can be stored at –20ºC

A2.4.3

Amplification of Self-Reporting Transcripts

22. This PCR will specifically amplify self-reporting transcripts from cDNA libraries. Prepare
the following solution:
•

25 µl 2X Kapa HiFi HotStart ReadyMix

•

1 µl of 25 µM Reverse Primer (SMART)

•

2 µl of cDNA
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•

21 µl of ddH2O

•

1 µl of Forward Primer, either:

•

25 µM SRT_PAC_F1 primer, if using PB-SRT-Puro

•

25 µM SRT_tdTomato_F1, if using PB-SRT-tdTomato
This PCR can be run as half-size reactions by halving each of the listed volumes. If you

find yourself doing this PCR repeatedly, this can be a way to decrease costs.
If you have multiple replicates, amplify them separately.
23. Perform PCR using the following thermocycling parameters:
•

95ºC for 3 minutes

•

20 cycles of:
o

98ºC for 20 seconds

o

65ºC for 30 seconds

o

72ºC for 5 minutes

•

72ºC for 10 minutes

•

4ºC forever

24. At this point, gel electrophoresis can be performed to check the quality of amplification. We
recommend running 5 uL of the PCR product from step 23 on 1% TAE agarose gel. The
expected product is a smear extending from ~1 kb up to 5 kb.
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Figure A2.1: Representative products of SRT amplification. 1% TAE gel showing expected products of SRT
amplification. Left: the first 12 lanes are biological replicates of a calling card experiment, while the thirteenth is a
no template control. The calling card libraries appear as smears extending up to 5 kb. Right: amplification of β-actin
with Raff_ACTB_F and Raff_ACTB_R from the same RT product as the SRT samples produces the expected 626bp product. The ladder is NEB's 1 kb Plus (previously, 2-Log) DNA Ladder (#N3200S).

As a control, we recommend that the constitutive β-actin gene be amplified in parallel to
the calling card libraries in steps 22 and 23. The control amplification uses the same PCR mix
and thermocycler settings as step 22 and 23, but replaces the calling card forward and reverse
primers with human β-actin primers (sequence provided in Materials as Raff_ACTB_F and
Raff_ACTB_R). The expected product of the B-actin amplification is 626 bp (see Figure 1
in https://doi.org/10.2144/97233st02).

A2.4.4

Purification of PCR Products

25. Vortex AMPure XP beads to resuspend them. Beads should be brought to room temperature
for at least 30 minutes prior to use.
26. Add 30 µl beads to each 50 µl PCR mixture (0.6x ratio; if you did a half-size PCR, add 15 µl
beads). Mix by pipetting 10 times until evenly dispersed.
27. Incubate at room temperature for 00:05:00
28. Place on a magnetic rack for 2 minutes. Aspirate supernatant and discard.

255

29. Add 200 µl of freshly-prepared 70% ethanol and incubate ≥ 30 seconds. Aspirate supernatant
and discard.
30. Repeat Step #29.
31. Air dry the pellet at room temperature for 2 minutes.
32. Remove the tube from the magnetic rack. Add 20 µl ddH2O to elute PCR products. Mix by
pipetting until evenly dispersed. Incubate off the rack for 2 minutes.
33. Place on magnetic rack for 1 minute, or until supernatant is clear.
34. Transfer supernatant to new tube. Create a 1:10 dilution and quantitate using the Qubit
dsDNA HS Assay Kit.
Expected concentration of product should be 10-20 ng/µl.

A2.4.5

Generation of Bulk Calling Card Libraries

35. The tagmentation protocol fragments the long PCR products into libraries suitable for
sequencing. This protocol is based on the standard Drop-seq library preparation workflow.
Continue processing each replicate independently.
36. Preheat thermocycler to 55 °C
37. Take 1 ng of PCR product and resuspend in a total of 5 µl ddH2O in a PCR strip tube.
38. Add 10 µl of Nextera Tagment DNA (TD) Buffer and 5 µl of Amplicon Tagment Mix
(ATM). Pipette to mix and briefly spin down; bubbles are normal. Incubate at 55 °C for 00:05:00
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39. Add 5 µl of Neutralization Tagment (NT) Buffer. Pipette to mix and briefly spin down;
bubbles are normal. Incubate at room temperature for 00:05:00
40. Add the following to each PCR tube in order:
•

15 µl Nextera PCR Mix (NPM)

•

8 µl ddH2O

•

1 µl of 10 µM barcoded piggyBac primer (e.g. OM-PB-ACG)

•

1 µl of 10 µM indexed Nextera N7 primer (e.g. Nextera_N701)
Each replicate should be identifiable by its barcode-index combination. It would be ideal

if each replicate had a unique barcode and a unique index assigned to it. For some experimental
setups, that may not be feasible. One option might be to assign a different index for different
conditions/treatments, and within a condition/treatment, assign different barcodes to each
replicate.
41. Perform PCR using the following thermocycling parameters:
•

95ºC for 3 minutes

•

13 cycles of:
o

95ºC for 10 seconds

o

50ºC for 30 seconds

o

72ºC for 30 seconds

o

72ºC for 5 minutes
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•

4ºC forever

42. Purify PCR libraries using AMPure XP beads. Vortex AMPure XP beads to resuspend them.
Beads should be brought to room temperature for at least 30 minutes prior to use.
43. Add 35 µl beads to each 50 µl PCR mixture (0.7x ratio). Mix by pipetting 10 times until
evenly dispersed.
44. Incubate at room temperature for 00:05:00
45. Place on a magnetic rack for 2 minutes. Aspirate supernatant and discard.
46. Add 200 µl of freshly-prepared 70% ethanol and incubate ≥ 30 seconds. Aspirate supernatant
and discard.
47. Repeat Step #46.
48. Air dry the pellet at room temperature for 2 minutes.
49. Remove the tube from the magnetic rack. Add 11 µl ddH2O to elute PCR products. Mix by
pipetting until evenly dispersed. Incubate off the rack for 2 minutes.
50. Place on magnetic rack for 1 minute, or until supernatant is clear. Transfer supernatant to
new tube.

A2.4.6

Final Quantitation and Sequencing

51. Create a 1:10 dilution of each final library. Measure concentrations using the Qubit dsDNA
HS Assay Kit or on a TapeStation device with a High Sensitivity D1000 ScreenTape. Libraries
should be smoothly distributed between 300-60 bp.
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Expected concentration of product should be 2-4 ng/µl.

Figure A2.2: Representative TapeStation trace of bulk calling card libraries. This sample was run on a High
Sensitivity D5000 ScreenTape.

52. Libraries can be sequenced on any Illumina sequencing platform. Due to the low complexity
nature of calling card libraries, we recommend adding PhiX at a final concentration of 50%.
Bulk calling card libraries only use the information from read 1 for mapping insertions.
Therefore, single-end sequencing should be sufficient, with at least 75 bp for read 1. An index 1
read will also be necessary for demultiplexing samples.
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Appendix 3: Single Cell Calling Cards
Library Preparation
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.xwifpce)

A3.1Abstract
This protocol describes how to create calling card libraries from single cell RNA. We assume
you have successfully transformed cells with piggyBac self-reporting transposons and either
undirected piggyBac transposase or your favorite transcription factor (YFTF) fused to piggyBac.
We also assume you have optimized the dissociation protocol for your specific cells or tissues
and can generate single cell suspensions.

A3.2Guidelines
Please read this protocol in its entirety before starting. For several steps, it may help to preprogram your thermocycler or heat block with the listed settings. While single cell calling card
(scCC) libraries can, in principle, be generated from any poly(A)-based scRNA-seq method, this
protocol specifically describes how to proceed from 10x Chromium 3' scRNA-seq libraries.
Please obtain all additional kits, reagents, and equipment as specified in the 10x Chromium
Single Cell 3' User Guide.
The components in this protocol are sensitive to repeated freeze-thaw cycles, specifically
the modified primers for amplifying self-reporting transcripts and the components of the Nextera
Mate Pair Library Prep kit. We recommend pipetting the primers (at 100 µM) and kit buffers
(CB: Circularization Buffer 10X; ERP3: End Repair Mix; ATL2: A-Tailing Mix; LIG2: Ligation
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Mix; STL: Stop Ligation Buffer; EPM: Enhanced PCR Mix) into five-use aliquots and storing at
–20ºC until needed. Sterilize the Axygen 1.7 ml tubes in an autoclave.
In bulk calling cards, we recommend collecting 8-12 independent biological replicates to
ensure sufficient statistical power for identifying true binding sites. This is not necessary in
single cell calling cards, where each cell is barcoded and is thus considered an independent
replicate.
This protocol is meant to describe how we prepare calling card libraries. While it is
possible that another kit or component could equally suffice, we have not tested any substitutions
and do not officially support deviations from this protocol. This document enumerates what we
have had success with and is a starting point from which we can best help troubleshoot.

A3.3Materials
Name
dNTP
2x Kapa HiFi Hotstart Readymix
Dynabeads M-280 Streptavidin

Catalog #
639125
KK2602
11205D

Maxima RT 5X Buffer
Maxima H Minus Reverse Transcriptase (200 U/uL)

Provided with
EP0752
EP0752

High Sensitivity D5000 ScreenTape
High Sensitivity D5000 Reagents
RNaseOUT™ Recombinant Ribonuclease Inhibitor

5067-5592
5067-5593
10777019

High Sensitivity D1000 Reagents
High Sensitivity D1000 ScreenTape
Chromium Single Cell 3′ Library & Gel Bead Kit v2
Chromium Single Cell A Chip Kit
Chromium i7 Multiplex Kit
Nextera Mate Pair Library Prep Kit
1.7 ml Axygen Maxymum Recovery Microcentrifuge
Tubes
Covaris T6 (6 x 32 mm) glass tubes
Covaris Snap-Cap - Teflon Silicone Septa 8 mm
Ficoll PM-400

5067-5585
5067-5584
120267
1000009
120262
FC-132-1001
MCT-175-L-C
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520031
520042
17030010

Vendor
Takara
Kapa Biosystems
Thermo Fisher
Scientific
Thermo Fisher
Scientific
Thermo Fisher
Scientific
Agilent Technologies
Agilent Technologies
Thermo Fisher
Scientific
Agilent Technologies
Agilent Technologies
10x Genomics
10x Genomics
10x Genomics
Illumina, Inc.
Axygen
Covaris
Ge Healthcare

NEBuffer 2 (10X)

B7002S

New England Biolabs

Primers
All primers should be resuspended in Low TE Buffer (10 mM Tris-HCl ph 8.0, 0.1 mM EDTA)
at a final concentration of 100 µM and stored at –20ºC.
The following primers should be purified by HPLC and stored as 5 µl aliquots:
>Bio_Illumina_Seq1_scCC_10X_3xPT
/5Phos/ACACTCTTTCCC/iBiodT/ACACGACGCTCTTCCGA*T*C*T
>Bio_Long_PB_LTR_3xPT
/5Phos/GCGTCAATTTTACGCAGAC/iBiodT/ATCTTTC*T*A*G
These primers should be purified by PAGE:
>scCC_PB_CustomRead2
CGTGTAGGGAAAGAGTGTGCGTCAATTTTACGCAGACTATCTTTCTAG
>scCC_CustomIndex1
GAGACTGGCAAGTACACGTCGCACTCACCATGA
These primers can be purified by standard desalting:
>scCC_P5_adapter
AATGATACGGCGACCACCGAGATCTTCACTCATTCCACACGACTCCTTGCCAGTC
TC*T
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>scCC_P7_adapter
/5Phos/GAGACTGGCAAGTACACGTCGCACTCACCATGA[index]ATCTCGTATGCCG
TCTTCTGCTTG
Note that you can replace [index] with an 8-10 bp sequence for multiplexing samples. For more
guidance, consult the Illumina Adapter Sequences Document.
>scCC_P5_primer
AATGATACGGCGACCACCGAGATC
>scCC_P7_primer
CAAGCAGAAGACGGCATACGAGAT
>10x_TSO
AAGCAGTGGTATCAACGCAGAGTACATrGrGrG
Equipment
•

10x Chromium Controller

•

Thermocycler for PCR

•

Heat blocks or programmable thermoshaker

•

Covaris AFA Ultrasonicator, model S2, S220, or E220.

Other reagents
•

Consult the 10x Chromium Single Cell 3' User Guide for scRNA-specific consumables
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•

Ethanol (96-100%)

•

ddH2O

A3.4Steps
A3.4.1

Single Cell Barcoding and Reverse Transcription

1. Prepare cells for isolation and encapsulation in gel bead emulsions (GEMs). If your
experiment involves a piggyBac transposase with PB-SRT-Puro transposons, cells that have
survived selection should be dissociated and resuspended in solution. If you are
using piggyBac with PB-SRT-tdTomato, we recommend using FACS to isolate tdTomatopositive cells, running cells transfected with PB-SRT-tdTomato alone as a gating control.
2. Follow 10x's instructions for GEM Generation & Barcoding, with this modification:
•

Step 1.1: Replace the RT Primer with an equivalent volume of Low TE Buffer. In v3
chemistry, The RT primer has been renamed Template Switch Oligo.

Proceed with Steps 1.2–1.5 as instructed: loading the Single Cell 3' chip, running the controller,
transferring GEMs, and reverse transcription.
Incubate the RT reaction under standard conditions.
•

Set lid temperature to 53 °C

•

00:45:00 53 °C

•

00:05:00 85 °C

•

Hold at 4 °C
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3. Step 2.1: clean the GEM-RT mixture using the Recovery Agent and DynaBeads MyOne
Silane per 10x's instructions. At the final elution stage, add 36.5 µl Elution Solution I to the tube,
mix by pipetting, and incubate at room temperature for 1 minute. Place the tube in a 10x
Magnetic Separator in the Low position until the solution turns clear. Transfer 36 µl of the eluted
sample to a new tube.
4. Divide the eluate into two 18-µl aliquots. These can be stored at –20ºC until needed. One
aliquot will be used for scRNA-seq library preparation, while the other will be used to generate
scCC libraries.

A3.4.2

Single Cell RNA-seq Library Preparation and Sequencing

5. To continue preparing scRNA-seq libraries, we need to add the template switch
oligonucleotide to first strand synthesis products from the RT reaction. Take one of the 18 µl
aliquots and thaw on ice.
6. Prepare the following 1X master mix:
•

20 µl Maxima 5X RT buffer

•

20 µl 20% w/v Ficoll PM-400

•

10 µl 10 mM dNTPs

•

2.5 µl RNaseOUT

•

2.5 µl 100 µM 10x_TSO

7. To the mix, add 18 µl of first strand RT product and 22 µl H2O. Add 5 µl Maxima H– RTase
to the reaction, flick to the mix, and centrifuge briefly.
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8. Incubate:
•

00:30:00 25 °C

•

01:30:00 50 °C

•

00:05:00 85 °C

9. Clean up following 10x's post GEM-RT Cleanup protocol, starting with the addition of
DynaBeads MyOne Silane (Step 2.1, part D). Clean samples per manufacturer's instructions.
10. Complete cDNA amplification and library construction according to the 10x's instructions
(Steps 2.2–3.7). For each sample, record which index sample index was used for the final PCR.
Quantiate each library by running a 1:10 dilution on an Agilent TapeStation High Sensitivity
D1000 ScreenTape.
11. Finished scRNA-seq libraries can be pooled and sequenced on Illumina MiSeq, NextSeq,
HiSeq, and NovaSeq platforms.

A3.4.3

Amplification of Self-Reporting Transcripts

12. To prepare single cell calling cards libraries, we start by amplifying self-reporting transcripts
from the other aliquot of first-strand synthesis product. As before, thaw the remaining 18 µl
aliquot on ice.
13. Prepare a PCR primer cocktail in a PCR tube:
•

5 µl of 100 µM Bio_Illumina_Seq1_scCC_10X_3xPT primer

•

5 µl of 100 µM Bio_Long_PB_LTR_3xPT primer

•

10 µl of Low TE Buffer
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Mix by vortexing and spin down briefly. This cocktail can be stored at –20ºC.
14. Prepare the following PCR mix in PCR tube:
•

25 µl of 2X Kapa HiFi Hotstart Readymix

•

18 µl of first-strand synthesis product

•

6 µl of ddH2O

•

1 µl of PCR primer cocktail

Keep on ice until ready for PCR.
15. Perform PCR using the following thermocycling parameters:
•

98ºC for 3 minutes

•

20 cycles of:

•

o

98ºC for 20 seconds

o

67ºC for 30 seconds

o

72ºC for 5 minutes

o

72ºC for 10 minutes

4ºC forever.

The number of cycles may need to be adjusted depending on the cell type and number of cells
represented in the library. If uncertain, you can use 9 µl of first-strand synthesis product as
template, reserving the other 9 µl for another round of PCR with more cycles as needed.
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A3.4.4

Purification of PCR Products

16. Vortex AMPure XP beads to resuspend them. Beads should be brought to room temperature
for at least 30 minutes prior to use.
17. Add 30 µl beads to the 50 µl PCR mixture (0.6x ratio). Mix by pipetting 10 times until
evenly dispersed.
18. Incubate at room temperature for 00:05:00
19. Place on a magnetic rack for 00:05:00
Aspirate supernatant and discard.
20. While the tube is still on the rack, add 200 µl of 70% ethanol and incubate ≥ 30 seconds.
Aspirate supernatant and discard.
21. Repeat Step #20
22. Air dry the pellet at room temperature for 00:02:00
23. Remove the tube from the magnetic rack. Add 40 µl QIAGEN Elution Buffer to elute PCR
products. Mix by pipetting until evenly dispersed. Incubate off the rack for 00:05:00
24. Place on magnetic rack for 00:05:00 or until supernatant is clear. Transfer supernatant to new
1.7 ml tube.
25. Take 1 µl of the eluate and dilute in 9 µl of ddH2O to make a 1:10 dilution. Quantitate on
TapeStation using a High Sensitivity D5000 ScreenTape. Measure the molar concentration of the
sample, taking everything from 250 bp to 7000 bp. Ideally, the diluted sample will be at least 750
pM, corresponding to 7.5 nM for the original eluate. If you kept half of the template aside, you
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can increase the number of PCR extension cycles until you get to a minimum of 7.5 nM of
product.
This is what a representative TapeStation trace looks like. The library should be smooth and
unimodal.

Figure A3.1: Representative TapeStation trace of SRT amplification from 10x 3' scRNA-seq library.

A3.4.5

Single Cell Calling Cards – Circularization

26. Thaw an aliquot of CB – Circularization Buffer 10X on ice.
27. Add the following components to a new 1.7 ml tube in this order:
1. 300 fmol self-reporting transcripts from Step 25
2. ddH2O up to a total of 268 µl
3. 30 µl CB
4. 2 µl Circularization Ligase
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To calculate what volume of eluate corresponds to 300 fmol, divide 300 by the molar
concentration (in nM) of the eluate. For example, if the concentration is 10 nM, 300 fmol/10 nM
= 30 µl, and consequently you would need 238 µl ddH2O. If you have less than 300 fmol total,
you may proceed but might need to make adjustments at the final PCR step. If you do not have a
way to quantitate the molarity of your solution, we have observed that 300 fmol of self-reporting
transcripts is (very) approximately 200 ng.
We strongly encourage you to calculate the volume of SRT solution based on molarity, not by
mass. The circularization reaction is sensitive to starting concentration. If overloaded, it can lead
to excess intermolecular ligations and, subsequently, increased noise with respect to the
assignment of insertions to cell types.
Mix by flicking the tube and spin down briefly. Incubate at 30 °C overnight (12-16 hours).

A3.4.6

Single Cell Calling Cards – Exonuclease and Setup

28. Add 9 µl of PS1 – Exonuclease directly to the overnight circularization mixture. Flick to mix,
spin down, and incubate as following:
•

00:30:00 37 °C

•

00:30:00 70 °C

29. While the exonuclease digestion proceeds, prepare for the rest of the library preparation. Fill
a large ice bucket with ice. Thaw, on ice, aliquots of:
•

STL – Stop Ligation Buffer

•

ERP3 – End Repair Mix
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•

ATL2 – A-tailing Mix

•

LIG2 – Ligation Mix

•

EPM – Enhanced PCR Mix

Also thaw the following oligonucleotides:
•

scCC_P5_adapter (100 µM)

•

scCC_P7_adapter (100 µM)

•

scCC_P5_primer (25 µM)

•

scCC_P7_primer (25 µM)

Finally, thaw NEBuffer 2
30. While the exonuclease incubates, anneal the scCC adapters. Prepare the following mixture in
a PCR tube, using a different indexed scCC_P7_adapter for each sample:
•

4.5 µl scCC_P5_adapter

•

4.5 µl scCC_P7_adapter

•

1 µl NEBuffer 2

31. Anneal scCC adapters in a thermocycler using the following settings:
•

95ºC for 5 minutes

•

70ºC for 15 minutes
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•

Ramp down to 25ºC as slowly as possible

•

25ºC for 5 minutes

•

4ºC forever

scCC adapters can be kept on ice until needed.
Adapters should be prepared fresh. NEBuffer 2 contains magnesium salts which can promote
DNase activity, leading to degradation of adapters.
32. Prepare the streptavidin-coated magnetic beads. These instructions are for 1 sample; up to 5
can be prepared in a single 1.7 ml tube. Resuspend Dynabeads M-280 by vortexing briefly.
33. Transfer 20 µl of beads to a clean 1.7 ml tube.
34. Place on a magnetic rack for 1 minute. Once clear, aspirate and discard supernatant.
35. Add 40 µl BBB – Bead Bind Buffer. Incubate for 1 minute, then aspirate and discard
supernatant.
36. Repeat Step #35.
37. Remove from rack and add 300 µl BBB. Beads can be stored at room temperature until
needed.
38. The exonuclease digestion should be complete by now. Add 12 µl STL – Stop Ligation
Buffer. Flick to mix and centrifuge gently.
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A3.4.7

Single Cell Calling Cards – Shearing and Capture

39. Transfer the entire sample (now approximately 320 µl) to a Covaris T6 tube. Add ddH2O as
necessary to fill to the top, then cap the tube. Check to make sure there are no air bubbles.
40. Shear DNA on a Covaris ultrasonicator. Here are recommended settings for various models
(we have tested this protocol on the E220):
Model
Peak Power Intensity
Intensity
Duty Cycle/Factor
Cycles Per Burst
Time
Temperature

S2
N/A
8
20%
200
40
6

S220
240
N/A
20%
200
40
6

E220
200
N/A
20%
200
40
6

Recommended shearing settings for preparing scCC libraries
41. Transfer the sample to a new 1.7 ml tube. Add 300 µl of bead solution to the sheared DNA.
42. Incubate 20 °C 00:15:00
If incubating on a thermoshaker, shake at 1000 RPM. Otherwise, flick to mix every 2 minutes.
43. Centrifuge briefly (5-10 seconds), then place on a magnetic rack for 1 minute. Discard the
supernatant.
44. Wash 4 times with BWB – Bead Wash Buffer:
•

Add 200 µl BWB

•

Remove from rack, flick to mix, and spin down briefly (1-2 seconds)

•

Place on rack for 30 seconds

•

Discard supernatant
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45. Wash 2 times with RSB – Resuspension Buffer:
•

Add 200 µl RSB

•

Remove from rack, flick to mix, and spin down briefly

•

Place on rack for 30 seconds

•

Discard supernatant

For the second wash, do not discard supernatant until ready to add the master mix in the next
step.
Repeat for a total for 4 washes

A3.4.8
Ligation

Single Cell Calling Cards – End Repair, A-Tailing, and Adapter

46. Prepare master mixes for End Repair and A-Tailing as follows.
1X End Repair Master Mix:
•

40 µl ERP3 – End Repair Mix

•

60 µl ddH2O

1X A-Tailing Master Mix:
•

12.5 µl ATL2 – A-Tailing Mix

•

17.5 µl ddH2O

47. Discard all supernatant from the DNA sample. Centrifuge briefly, then place on a magnetic
rack.
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48. Use a 10 µl pipette to aspirate any residual supernatant.
49. Add 100 µl End Repair reaction mix, remove from the rack, flick to mix, and centrifuge
briefly (do not allow beads to pellet).
50. Incubate 30 °C 00:30:00
If incubating on a thermoshaker, shake at 1000 RPM, to prevent beads from settling.
51. Centrifuge briefly (5-10 seconds), then place on a magnetic rack for 1 minute. Discard the
supernatant.
52. Wash 4 times with BWB – Bead Wash Buffer:
•

Add 200 µl BWB

•

Remove from rack, flick to mix, and spin down briefly (1-2 seconds)

•

Place on rack for 30 seconds

•

Discard supernatant

Repeat for a total for 4 washes
53. Wash 2 times with RSB – Resuspension Buffer:
•

Add 200 µl RSB

•

Remove from rack, flick to mix, and spin down briefly

•

Place on rack for 30 seconds

•

Discard supernatant
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For the second wash, do not discard supernatant until ready to add the master mix in the next
step.
54. Discard all supernatant from the DNA sample. Centrifuge briefly, then place on a magnetic
rack. Use a 10 µl pipette to aspirate any residual supernatant.
55. Add 30 µl A-Tailing reaction mix, remove from the rack, flick to mix, and centrifuge briefly
(do not allow beads to pellet).
56. Incubate 37 °C 00:30:00
If incubating on a thermoshaker, shake at 1000 RPM, to prevent beads from settling.
57. Add the following components in order to the A-tailing mix:
•

(30 µl A-tailing reaction)

•

2.5 µl LIG2 – Ligation Mix

•

4 µl ddH2O

•

1 µl annealed scCC adapter

Flick to mix and centrifuge briefly (do not allow beads to pellet).
58. Incubate 30 °C 00:10:00
59. Add 5 µl STL – Stop Ligation Buffer. Flick to mix.
60. Centrifuge briefly (5-10 seconds), then place on a magnetic rack for 1 minute. Discard the
supernatant.
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61. Wash 4 times with BWB – Bead Wash Buffer:
•

Add 200 µl BWB

•

Remove from rack, flick to mix, and spin down briefly (1-2 seconds)

•

Place on rack for 30 seconds

•

Discard supernatant

Repeat for a total for 4 washes
62. Wash 2 times with RSB – Resuspension Buffer:
•

Add 200 µl RSB

•

Remove from rack, flick to mix, and spin down briefly

•

Place on rack for 30 seconds

•

Discard supernatant

For the second wash, do not discard supernatant until ready to add the master mix in the next
step.

A3.4.9

Single Cell Calling Cards – Final PCR and Purification

63. Prepare a 1X PCR master mix in a new 1.7 ml tube:
•

20 µl EPM – Enhanced PCR Mix

•

28 µl ddH2O

•

1 µl scCC_P5_primer (25 µM)
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•

1 µl scCC_P7_primer (25 µM)

64. Discard all supernatant from the DNA sample. Centrifuge briefly, then place on a magnetic
rack. Use a 10 µl pipette to aspirate any residual supernatant.
65. Add 50 µl PCR reaction mix to the sample and pipette to mix. Transfer to PCR tubes.
66. Incubate in a thermocycler with the following settings:
•

98ºC for 30 seconds

•

15 cycles of:
o

98ºC for 10 seconds

o

60ºC for 30 seconds

o

72ºC for 2 minutes

•

72ºC for 5 minutes

•

4ºC forever.

If you started with less than 300 fmol of self-reporting transcripts, you can increase the number
of extension cycles here. More cycles will increase the risk of artifacts, however, so we
recommend increasing by the minimum necessary to obtain reasonable sequencing libraries. The
most we have pushed this PCR is to 17 extension cycles.
67. Vortex AMPure XP beads to resuspend them. Beads should be brought to room temperature
for at least 30 minutes prior to use.
68. Place PCR tubes on a magnetic rack for 1 minute. Transfer 50 µl of supernatant to new tubes.
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69. Add 35 µl beads to the 50 µl PCR mixture (0.7x ratio). Flick to mix and centrifuge briefly.
70. Incubate at room temperature for 00:05:00
71. Place on a magnetic rack for 00:05:00
Aspirate supernatant and discard.
72. Add 200 µl of 70% ethanol and incubate ≥ 30 seconds. Aspirate supernatant and discard.
73. Repeat Step #72
74. Air dry the pellet at room temperature for 00:02:00
75. Remove the tube from the magnetic rack. Add 25 µl RSB – Resuspension Buffer to elute
PCR products. Mix by pipetting until evenly dispersed. Incubate off the rack for 00:05:00
76. Place on magnetic rack for 00:05:00 or until supernatant is clear. Transfer supernatant to new
1.7 ml tube.
77. Make a 1:10 dilution of the eluate and quantitate on TapeStation using a High Sensitivity
D1000 ScreenTape. Measure the molar concentration of the sample, taking everything from 200
bp to 1300 bp.
This is what a representative TapeStation trace looks like. The library should be smooth and
unimodal, peaking between 500-700 bp. Occasionally, you may see a primer-dimer peak.
However, as scCC libraries are sequenced from the middle and not the ends, the primer-dimer
product will not sequence on the Illumina flow cell.
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Figure A3.2: Representative TapeStation trace of scCC libraries.

A3.4.10

Single Cell Calling Cards – Sequencing

78. Single cell calling cards libraries use a mix of standard and custom primers for sequencing
and rely on dual-indexing for proper demutiplexing. We have sequenced scCC libraries on
Illumina NextSeq 500 machines, using v2 Reagent Cartridges. These libraries use the standard
Illumina primers BP10 and BP14 for read 1 and index 2, respectively. Read 1 sequences the cell
barcode and unique molecular index (UMI), while index 2 reads into the terminal repeat of
the piggyBac transposon, confirming that molecules successfully circularized.
In addition, we use the custom sequencing primers scCC_PB_CustomRead2 and
scCC_CustomIndex1 for read 2 and index 1, respectively. Read 2 anneals at the end of the
transposon and sequences into the genome. The first six base pairs typically begin "GGTTAA",
which are the terminal two base pairs of the piggyBac repeat followed by the insertion site
tetramer. The remainder of the read is genomic DNA sequence. Index 1 sequences the samplespecific sequence on the scCC adapter and is used to demultiplex libraries.
280

Due to the low complexity nature of calling card libraries, we recommed adding PhiX at a final
concentration of 50%.
79. While index 1 should be sufficient to demultiplex libraries, we have observed a biphasic
response when sequencing scCC libraries at low and high concentrations. At low library
concentrations, (e.g., 1-2%) the index 1 read generates high-quality reads and can demultiplex
libraries; however at higher concentrations (i.e., 50%) the index 1 read can fail, yielding all N's.
If this happens, libraries can be demultiplexed by the index 2 read alone: scCC reads that have
successfully circularized will have "GCGTCAAT" as the index 2 sequence.
After this, scCC reads can be assigned to specific samples using the cell barcodes obtained from
the corresponding scRNA-seq libraries. Different libraries may, by chance, have cells that share
the same cell barcode. Typically, these represent a very small fraction of cells (< 1% per library)
and we discard these reads and cells from downstream calling cards and scRNA-seq analyses,
respectively.
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Appendix 4: Processing Bulk Calling Card
Sequencing Data
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.xwjfpcn)

A4.1Abstract
Here we present a computational pipeline for processing bulk RNA calling card data. These data
will have been generated from transfection/-duction of either undirected piggyBac transposase or
your favorite transcription factor (YFTF) fused to piggyBac. Multiple biological replicates
should have been generated, each with a unique combination of primer barcode and index
sequences. This workflow demonstrates how to analyze a single replicate; the workflow can be
parallelized on distributed computing architectures (e.g. slurm).

A4.2Guidelines
Please make sure you have installed the required software and packages (see Materials section).
This protocol describes how to analyze a SINGLE biological replicate from a bulk RNA calling
cards* experiment. Multiple replicates (e.g. 10-12) should be analyzed in each experiment to
distinguish independent transposition events into the same insertion site. This is essential for
adequate statistical power to detect transcription factor binding sites. Each replicate can be
processed following this protocol, making appropriate changes to the primer barcode sequence
and/or the index sequence(s). Data from multiple calling card replicates can be pooled at the end
into a single file.
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*If you are unfamiliar with calling card libraries, we recommend reading our quick start
guide (Appendix 1) and our library preparation protocol (Appendix 2).

A4.3Materials
The following external programs are required:
•

cutadapt (≥ 1.16)

•

samtools (≥ 1.9)

You will need a genomic aligner. Here we will use novoalign, but in theory any aligner should
be sufficient (e.g. bowtie2, GATK, STAR, etc.). Also, you will need a .2bit version of the
genome sequence you are aligning to; these are readily available from the UCSC Genome
Browser. (They can also be generated from a FASTA file using the faToTwoBit utility)
The following programs are optional, but highly recommended:
•

bedtools (≥ 2.27)

•

bedops (≥ 2.4)

In addition, this workflow calls some calling card-specific scripts, which use Python 3. It is
recommended that your Python installation be relatively up-to-date (i.e. ≥ 3.4). To check your
python version, type
python -V
You will need to install the following Python modules:
•

numpy
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•

pandas

•

pysam

•

twobitreader

All of these packages are available on PyPI and can be installed via pip:
pip install numpy pandas pysam twobitreader
(If Python3 is not the default on your system, replace pip with pip3)
Finally, these are the calling card-specific scripts you will need, all of which are available
on GitHub:
•

TagBam.py

•

AnnotateInsertionSites.py

•

BamToCallingCard.py

A4.4Steps
A4.4.1

Preamble

1. The objective of this protocol is to take sequencing reads from a calling cards library and
process them into a .ccf file. A CCF file is a modified BED file (BED3+3) that concisely
enumerates every transposition event in the sequenced library.
CCF files typically have six columns:
•

chrom: chromosome

•

start: beginning coordinate of the insertion site
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•

end: ending coordinate of the insertion site; since piggyBac inserts into TTAA's, this
typically spans the motif itself.

•

count: the number of reads supporting this insertion

•

strand: + or -, indicating which strand was targeted (optional but highly recommended)

•

barcode: a string identifying the library from which this insertion originated (optional but
highly recommended)

This workflow will walk through how to perform quality control, alignment, filtering, and
processing of calling card sequencing libraries to generate a CCF file. This file can then be used
in downstream applications, such as visualization on the (legacy) WashU Epigenome
Browser (instructions here), and as input for peak calling.
2. To illustrate the workflow, let's say that we have performed bulk RNA calling cards on our
favorite transcription factor (YFTF) in a human cell line. We have prepared libraries from 10
biological replicates of cells transfected with wild-type piggyBac transposase, and 10 replicates
of cells with YFTF-piggyBac. We have sequenced these libraries and now need to map these
insertions across the genome.
We will consider a single replicate; the workflow can then be repeated for all remaining
replicates. At the end we can combine the data from the 10 piggyBac replicates, and the 10
YFTF-piggyBac replicates, respectively, into a single CCF file each.
3. In this example, we will be analyzing a single replicate from the wild-type piggyBac libraries:
PBase_rep1. The read 1 sequencing file is PBase_rep1_L001_R1_001.fastq.gz
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For bulk RNA calling card libraries, only read 1 is analyzed, as it contains the junction between
the transposon and genome.
This biological replicate had GAT as its primer barcode and CTCACGGTGA as its index
sequence. It was prepared by PCR ligation with the following primers:
>OM-PB-GAT (barcode in bolded)
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC
TGATTTTACGCAGACTATCTTTCTAG
>Nextera_N7_CTCACGGTGA (index in bold; note the reverse complement orientation)
CAAGCAGAAGACGGCATACGAGATTCACCGTGAGGTCTCGTGGGCTCGG
Thus, each read 1 should begin with GATTTTACGCAGACTATCTTTCTAG.

A4.4.2

Adapter Trimming

4. The purpose of this step is to check that reads have (1) the appropriate primer barcode
sequence and (2) the transposon sequence is correct and ends in TTAA, piggyBac's insertion
motif. If these conditions are true, those bases are trimmed (hard clipped), to facilitate genomic
alignment. Only reads with perfect matches to the barcode and transposon sequence are carried
forward.
cutadapt \
-g ^GATTTTACGCAGACTATCTTTCTAGGGTTAA \
--minimum-length 1 \
--discard-untrimmed \
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-e 0 \
--no-indels \
-o PBase_rep1_trimBC.fastq.gz \
PBase_rep1_L001_R1_001.fastq.gz
Typically 70-90% of reads will pass this filter, although there may be sample-dependent
variation.
5. Next, we re-examine the passing reads and trim any reads that end in the Nextera adapter that
was added during tagmentation. This step reduces the amount of non-genomic bases, which
should accelerate alignment. Only a small fraction (5-10%) typically have any adapter sequence
at all, so virtually every read will pass this filter.
cutadapt \
-a
CTGTCTCTTATACACATCTCCGAGCCCACGAGACTCTCACGGTGATCTCGTATGCCGTCTTCTG
CTTG \
--minimum-length 1 \
-o PBase_rep1_trimmed.fastq.gz \
Base_rep1_trimBC.fastq.gz
The index sequence has been emphasized in bold, but if you are processing libraries with many
index different indexes, you can replace the bolded sequence with N's (keeping the length same).
cutadapt can handle degenerate bases in adapters.
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A4.4.3

Alignment

6. Now that our reads are trimmed, we are ready to align them to the genome. This step can be
done with any aligner; we typically use novoalign, so that is what we will demonstrate here.
novoalign \
-d hg38.nvx \
-f PBase_rep1_trimmed.fastq.gz \
-n 40 \
-o SAM \
-o SoftClip > PBase_rep1_trimmed.sam
The "-n 40" flag tells novoalign to align only the first 40 bases of the read. We have found that
this reduction can increase the speed of alignment with minimal impact on total number of
insertions recovered. Faster aligners (e.g. bowtie2, GATK, STAR) may not need this setting.
7. After alignment, we filter out reads that mapped to multiple locations in the genome (e.g. in a
repetitive element) and convert to the more space-efficient BAM format.
samtools view \
-bS -h -F 260 \
PBase_rep1_trimmed.sam | \
samtools sort - -o PBase_rep1_mapped.bam
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A4.4.4

Annotation

8. The BAM format provides a flexible way to annotate reads through the use of short tags.
These tags remain with the reads in the BAM file, which makes for a simple and portable archive
of a calling card experiment. We use the following custom tags:
•

XP: primer barcode

•

XJ: index 1 sequence

•

XK: index 2 sequence (optional; reserved for future use)

•

XI: insertion site annotation

•

XZ: adjacent sequence (to verify transposase motif)

9. First, we will annotate reads with the XP tag for the primer barcode GAT.
python TagBam.py \
--tag XP:Z:GAT \
PBase_rep1_mapped.bam \
PBase_rep1_tagged.bam
10. Next, we will annotate reads with the XJ tag for the index sequence CTCACGGTGA.
python TagBam.py \
--tag XJ:Z:CTCACGGTGA \
PBase_rep1_tagged.bam \
PBase_rep1_tagged2.bam
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11. Lastly, we will annotate reads with respect to the insertion site. This script checks each read
to make sure that it maps next to the piggyBac insertion site motif TTAA. Remember, this part of
read 1 was trimmed in step 4. By double checking that the read maps next to a genomic TTAA,
we add an extra layer of specificity to the alignment. The sequence of the adjacent bases will also
be annotated with the XZ tag. Reads that pass will be annotated with the insertion site
coordinates in the XI tag and written to the output file.
python AnnotateInsertionSites.py \
--transposase PB \
-f \
PBase_rep1_tagged2.bam \
hg38.2bit \
PBase_rep1_final.bam
You can provide a path to the .2bit file if your genome references are in another directory.

A4.4.5

Finishing Up

12. To finish, we first index the BAM file.
samtools index PBase_rep1_final.bam
13. Next, clean up intermediate files.
rm PBase_rep1_trimBC.fastq.gz
rm PBase_rep1_trimmed.fastq.gz
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rm PBase_rep1_trimmed.sam
rm PBase_rep1_mapped.bam
rm PBase_rep1_tagged.bam
rm PBase_rep1_tagged2.bam
14. Lastly, convert the BAM file to a CCF file.
python BamToCallingCard.py \
-b XP XJ \
-i PBase_rep1_final.bam \
-o PBase_rep1_final.ccf
This will use the combination of primer barcode and index sequence (XP and XJ, respectively) to
identify insertions derived from different biological replicates.
Here is an example of a CCF file:
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1

A4.4.6

28575
28575
28575
31191
31191
46620
54136
54818
57829
58414

28579
28579
28579
31195
31195
46624
54140
54822
57833
58418

2
10
1
1
49
5
42
16
6
40

+
+
+
+
+
+
+

GCA/TCGCCACCC
TAG/GAGGTACAG
GAT/GAGGTACAG
GCA/TCGCCACCC
TAG/TCGCCACCC
CTA/GAGGTACAG
GCA/TCGCCACCC
CTA/TCGCCACCC
CGT/GAGGTACAG
CTA/TCGCCACCC

Notes

15. This workflow described how to process a SINGLE biological replicate. After each replicate
has been processed, CCF files can be combined to consolidate all insertions from a given
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experiment. For example, to combine data from all replicates from our wildtype piggyBac libraries, we can use cat and bedops (preferred):
cat \
PBase_rep1_final.ccf \
PBase_rep2_final.ccf \
PBase_rep3_final.ccf \
PBase_rep4_final.ccf \
PBase_rep5_final.ccf \
PBase_rep6_final.ccf \
PBase_rep7_final.ccf \
PBase_rep8_final.ccf \
PBase_rep9_final.ccf \
PBase_rep10_final.ccf | sort-bed - > PBase.ccf
Similarly, CCFs from the YFTF replicates can be combined:
cat YFTF-PBase_rep*_final.ccf | sort-bed - > YFTF-PBase.ccf
The concatenated CCF files can also be sorted using bedtools:
cat PBase_rep*_final.ccf | bedtools sort -i - > PBase.ccf
Or, using the standard shell sort command:
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cat PBase_rep*_final.ccf | sort -k1V -k2n -k3n > PBase.ccf
16. Analogously, we can combine BAM files from biological replicates into a single archivalquality BAM file for an entire experiment:
samtools merge PBase.bam PBase_rep*_final.bam
17. Ideally, each biological replicate will have a unique primer barcode AND unique index
sequence. However, sometimes this is not possible. If so, each replicate should be identifiable
from a unique combination of primer barcode and index sequence. If multiple replicates share an
index, their reads will be found in the same FASTQ file. This is okay as step 3 can separate each
replicate based on an exact match to the primer barcode sequence. In that case, you will have to
provide the same input file to step 4 multiple times, each with a different primer barcode at the
start of the adapter.
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Appendix 5: Processing Single Cell Calling
Card Sequencing Data
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.4phgvj6)

A5.1Abstract
Here we present a computational pipeline for processing single cell calling card (scCC) data.
These data will have been generated from single cell RNA-seq libraries following transfection/duction of either undirected piggyBac transposase or your favorite transcription factor (YFTF)
fused to piggyBac. This workflow demonstrates how to process scCC sequencing data derived
from a 10x Chromium-based scCC library; the workflow can be parallelized on distributed
computing architectures (e.g. slurm).

A5.2Guidelines
Please make sure you have installed the required software and packages (see Materials section).
This protocol describes how to analyze a single cell calling cards* (scCC) experiment. These
libraries are derived from single cell RNA-seq libraries (scRNA-seq). Currently, we only support
10x Chromium 3'-based libaries. Unlike bulk calling card libraries, in which we require multiple
replicates (e.g. 10-12), each cell in a scCC library is considered a replicate. Sensitivity is driven
by the total number of insertions recovered, which is directly proportional to the number of
transformed cells in the scRNA-seq library. Therefore, we advise processing as many cells as
feasible to maximize discovery of transcription factor binding sites.
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*If you are unfamiliar with calling card libraries, we recommend reading our quick start
guide (Appendix 1) and our scCC library preparation protocol (Appendix 3).

A5.3Materials
The following external programs are required:
•

cutadapt (≥ 1.16)

•

samtools (≥ 1.9)

•

cellranger (≥ 2.1.0)

You will need a .2bit version of the genome sequence you are aligning to; these are readily
available from the UCSC Genome Browser. (They can also be generated from a FASTA file
using the faToTwoBit utility)
The following programs are optional, but highly recommended:
•

bedtools (≥ 2.27)

•

bedops (≥ 2.4)

In addition, this workflow calls some calling card-specific scripts, which use Python 3. It is
recommended that your Python installation be relatively up-to-date (i.e. ≥ 3.4). To check your
python version, type
python -V
You will need to install the following Python modules:
•

numpy
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•

pandas

•

pysam

•

twobitreader

All of these packages are available on PyPI and can be installed via pip:
pip install numpy pandas pysam twobitreader
(If Python3 is not the default on your system, replace pip with pip3)
Finally, these are the calling card-specific scripts you will need, all of which are available
on GitHub:
•

TagBam.py

•

AnnotateInsertionSites.py

•

BamToCallingCard.py

•

UMIFilter.py

•

FilterUniqueBarcodes.py

•

FilterBAMByBarcodes.py

•

FilterCCFByBarcodes.py

A5.4Steps
A5.4.1

Preamble

1. The objective of this protocol is to take sequencing reads from single cell calling cards (scCC)
library and process them into a CCF (calling card format; .ccf) file. A CCF file is a modified
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BED file (BED3+3) that concisely enumerates every transposition event in the sequenced
library.
CCF files typically have six columns:
•

chrom: chromosome

•

start: beginning coordinate of the insertion site

•

end: ending coordinate of the insertion site; since piggyBac inserts into TTAA's, this
typically spans the motif itself.

•

count: the number of reads supporting this insertion

•

strand: + or -, indicating which strand was targetted (optional but highly recommended)

•

barcode: a string identifying the library or cell from which this insertion originated. For
scCC, this is the sequence of the cell barcode.

Each line of the final .ccf file represents an independent calling card insertion, and the value in
the cell barcode column specifies in which cell this insertion was observed. If your sample is
heterogeneous, you may find that your cells can be grouped into biologically meaningful clusters
(e.g. different cell types) based on their scRNA-seq expression profiles. In this case, you will
have assigned cell barcodes to each cluster, and can use this information to split the .ccf file to
generate insertion profiles for each cluster (see Step 19). These split .ccf files can then be used to
identify differentially bound loci, or for visualization of TF binding in different clusters.
This workflow walks through how to perform quality control, alignment, filtering, and
processing of single cell calling card sequencing libraries to generate a .ccf file. This file can
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then be used in downstream applications, such as visualization on the (legacy) WashU
Epigenome Browser (instructions here), and as input for peak calling.
2. To illustrate the workflow, let's say that we have performed scCC on our favorite transcription
factor (YFTF) in a human cell line. We have prepared scRNA-seq and scCC libraries from
10,000 cells transfected with wild-type piggyBactransposase and 10,000 cells transfected with
YFTF-piggyBac. Both the wild-type and YFTF transfectants were loaded across two wells each
of a Chromium chip.

Figure A5.1: Example of a 10x Chromium chip loaded for a single cell calling cards experiment.
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This image illustrates our example experiment. Two wells have been loaded with piggyBactransfected cells in Row 1 (blue) and two wells with YFTF-piggyBac transfectants (pink). The
remaining wells, in grey, were empty (loaded with 50% glycerol). After emulsion generation, the
resulting libraries–in the row marked by the triangle–were kept separate and processed according
to the scCC molecular protocol.
3. scCC analysis requires two separate sequencing runs: one for the scRNA-seq library (which
will be used for dimensionality reduction and cell type identification) and one for the scCC
library (to assign insertions to specific cells). The scRNA-seq library can be sequenced using
10x's standard recommendations and processed using cellranger. We will assume this step has
already been completed. This step establishes a set of high-quality cell barcodes from each
library; we will cross-reference these with the scCC library to assign insertions to specific cells.
4. The scCC library should have been sequenced as recommended in our scCC molecular
workflow. Specifically, on a dual indexed-compatible Illumina sequencer; we prefer to sequence
these libraries on an Illumina NextSeq 500 with 50% phiX, allocating 26 bases to read 1, 50
bases to read 2, and 8 bases each to index 1 and index 2. Although scCC libraries should be
demultiplexable with unique index sequences, this does not always work and the index 1 read
can fail, reporting all N's. If this happens, reads from all libraries will be mixed together. We can
identify scCC reads from phiX and other artifacts by demultiplexing with the index 2 read
(should be GCGTCAAT). To further identify reads from the constituent libraries, we will
demultiplex using the cell barcode.
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5. In this example, we will be analyzing scCC sequencing run demultiplexed using index 2 only.
The read 1 file will contain the cell barcode and UMI, while read 2 will contain the junction
between the transposon and the genome. The read 1 and read 2 files are, respectively:
•

PB_YFTF-PB_combined_R1_001.fastq.gz

•

PB_YFTF-PB_combined_R2_001.fastq.gz

Read 1 is 26 bases long: the first 16 bases comprise the cell barcode, while the final 10 bases are
the UMI.
Read 2 is 50 bases long: the first 2 bp will contain transposon sequence (GG) followed by the
4bp TTAA insertion site; the rest of the read is genomic sequence (and maybe some P7 adapter).

A5.4.2

Adapter Trimming

6. We first ensure that read 2 begins with GGTTAA. If it does, those bases are trimmed (hard
clipped) to facilitate genomic alignment. Only reads with perfect matches are carried forward.
cutadapt \
-g ^GGTTAA \
-o PB_YFTF-PB_combined-trim1_R2_001.fastq.gz \
-p PB_YFTF-PB_combined-trim1_R1_001.fastq.gz \
--minimum-length 1 \
--discard-untrimmed \
-e 0 \
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--no-indels \
PB_YFTF-PB_combined_R2_001.fastq.gz \
PB_YFTF-PB_combined_R1_001.fastq.gz
Typically 70-90% of reads will pass this filter, although there may be sample-dependent
variation.
7. Next, we re-examine the passing reads and trim any reads that end in the P7 adapter that was
added during scCC library preparation. This step reduces the amount of non-genomic bases,
which should accelerate alignment. Only a small fraction (5-10%) typically have any adapter
sequence at all, so the majority of reads pass this filter.
cutadapt \
-a
AGAGACTGGCAAGTACACGTCGCACTCACCATGANNNNNNNNNATCTCGTATGCCGTCTTCTGC
TTG \
-o PB_YFTF-PB_S1_L001_R2_001.fastq.gz \
-p PB_YFTF-PB_S1_L001_R1_001.fastq.gz \
--minimum-length 1 \
PB_YFTF-PB_combined-trim1_R2_001.fastq.gz \
PB_YFTF-PB_combined-trim1_R1_001.fastq.gz

301

Here, NNNNNNNNN indicates where the index 1 sequence would be. The N's do not have to be
replaced as cutadapt can tolerate ambiguous bases.
For running cellranger in next step, the input FASTQ filenames MUST conform to the following
pattern:
[Sample Name]_S1_L00[Lane Number]_[Read Type]_001.fastq.gz
[Read Type] is R1 or R2. [Lane Number] can be varied; for simplicity, we use L001 here.

A5.4.3

Alignment

8. Now that our reads are trimmed, we are ready to align them to the genome. At the same time,
we need to perform error-correction on our cell barcode and UMI sequences. We will use
cellranger, as it can perform both whole-genome alignment and barcode curation at once. We
need to specify the directory where the trimmed FASTQ files can be found. Note that this
directory should be "flat", i.e have no subdirectories.
cellranger count \
--id=PB_YFTF-PB_map_scCC \
--fastqs=fastq_dir/ \
--transcriptome=/opt/refdata-cellranger-GRCh38-3.0.0 \
--sample=PB_YFTF-PB \
--expect-cells=5000 \
--nosecondary \
--chemistry=SC3Pv2 \
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--localcores=16 \
--localmem=30
A few notes on this command:
•

--id= will specify the output directory that will be created. This will be familiar to
anyone who was worked with cellranger before.

•

--expect-cells= is an estimate for how many cells are present in the libray. This is
much more important for scRNA-seq libraries than scCC libraries, and so can probably
be safely excluded.

•

--nosecondary skips the dimensionality reduction step of the cellranger pipeline. We
are only concerned with mapping insertions to the genome.

•

--chemistry= specifies the chemistry of the 10x kit. We prefer to explicitly specify
this. Here, we used version 2 of the single cell 3' kit. The scCC workflow should also be
immediately compatible with v3 chemistry.

•

--localcores= and --localmem=30 specify machine settings. Here, we used 16
cores and 30 GB of memory. These can be adjusted to fit your setup.

cellranger automatically performs barcode whitelisting and error-correction of UMIs, which are
encoded in the program's output .bam file. The CB tag contains the read's verified cell barcode,
and the UB tag denotes the corrected UMI. A full description of cellranger BAM tags can be
found here.
9. We then filter mapped reads for primary alignments, to eliminate multi-mapped reads:
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samtools view \
-b -h -F 260 \
-o PB_YFTF-PB_map_scCC_uniq.bam \
PB_YFTF-PB_map_scCC/outs/possorted_genome_bam.bam

A5.4.4

Annotation

10. We then filter mapped reads for primary alignments, to eliminate multi-mapped reads:
samtools view \
-b -h -F 260 \
-o PB_YFTF-PB_map_scCC_uniq.bam \
PB_YFTF-PB_map_scCC/outs/possorted_genome_bam.bam
11. Now we will annotate reads with respect to the insertion site. This script checks each read to
make sure that it maps next to the piggyBac insertion site motif TTAA. Remember, this part of
read 1 was trimmed in step 5. By double checking that the read maps next to a genomic TTAA,
we add an extra layer of specificity to the alignment. The sequence of the adjacent bases will also
be annotated with the XZ tag. Reads that pass will be annotated with the insertion site
coordinates in the XI tag and written to the output file.
python AnnotateInsertionSites.py \
--transposase PB \
-f \
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PB_YFTF-PB_map_scCC_uniq.bam \
hg38.2bit \
PB_YFTF-PB_map_scCC_tagged.bam
You can provide a path to the .2bit file if your genome references are in another directory.
12. We perform one last quality control check on the processed scCC reads. Since scCC libraries
involve intramolecular circularization, there is a small chance that concatamerization can occur.
These would appear as singleton events where a cell barcode and UMI are linked to an insertion
in a different cell. To guard against this, we require all insertions in a given cell (i.e. sharing the
same cell barcode) to have at least two different UMIs each. This yields libraries with excellent
specificity (see e.g. Figure 2.13B)
python UMIFilter.py \
-p 10x \
-i PB_YFTF-PB_map_scCC_tagged.bam \
--verbose \
-o PB_YFTF-PB_map_scCC_final.bam
13. Finally, we convert this BAM file to a (sorted) CCF file. The sorting step relies on bedops;
see here for alternatives.
python BamToCallingCard.py \
-b CB \
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-i PB_YFTF-PB_map_scCC_final.bam \
-o PB_YFTF-PB_map_scCC_unsorted.ccf
sort-bed PB_YFTF-PB_map_scCC_unsorted.ccf > PB_YFTFPB_map_scCC_final.ccf

A5.4.5

Demultiplexing

14. At this point, PB_YFTF-PB_map_scCC_final.bam contains all insertions from all cells in
our single cell library, both from the wild-type piggyBac transfectants and the YFTFpiggyBac transfectants. How can we determine which insertions came from which library? We
will use the cell barcodes to further demultiplex the CCF file.
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Figure A5.2: Demultiplexing scCC libraries.
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This figure summarizes Steps 15-18, wherein we use the cell barcodes (obtained from the
respective scRNA-seq libraries) to demultiplex the combined scCC .bam file, generate .ccf files
from each library, and finally create master .ccf files for each condition (i.e. piggyBac and
YFTF-piggyBac treatments).
15. In step 2, we prepared our 10x libraries by loading four wells of the Chromium chip: two for
wild-type PB, and two for YFTF-PB. Let us call these libraries PB-1, PB-2, YFTF-1, and YFTF2; further, assume that we have completed the scRNA-seq portions of the scCC workflow,
including analysis with cellranger. For each of these four libraries, we can get a list of highquality barcodes.
After cellranger has finished, each library's cell barcodes can be found in the following locations,
respectively:
PB-1/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv
PB-2/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv
YFTF-1/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv
YFTF-2/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv
Starting with cellranger v3, the barcodes.tsv file may be gzipped (barcodes.tsv.gz). If that is the
case, you will need to unzip before proceeding (gunzip barcodes.tsv.gz)
16. Since GEM generation was performed independently for each sample, there is a small chance
(see note below) that the same cell barcode was captured more than once across libraries. This
could, in theory, confound interpretation of TF binding, as a shared cell barcode may belong to
cells of different types or states. While the effect of these is likely small, we recommend
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discarding shared barcodes between libraries. The following command takes in a set of barcode
files; for each, an output file is created containing the subset of unique barcodes found only in
the respective input file.
python UMIFilter.py \
-i PB-1/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv \
PB-2/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv \
YFTF-1/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv \
YFTF-2/outs/filtered_gene_bc_matrices/hg38/barcodes.tsv \
-o PB-1_unique_barcodes.txt \
PB-2_unique_barcodes.txt \
YFTF-1_unique_barcodes.txt \
YFTF-2_unique_barcodes.txt
Note that this can command can take in any number of input files (2, 3, 4, 5, etc.). The only
requirements are: (1) a matched list of output files is provided; and (2) the input barcode files
contain one barcode per line.
For the curious: the probability of a shared barcode (i.e. barcode collision) between two 10x
scRNA-seq libraries is quite small, but is dependent on library size. For two libraries of 5,000
cells each, the probability is < 1%. As the number of libraries increases, the probability of
collision increases approximately. We have filtered unique cell barcodes across as many as six
libraries and have discarded no more than 5% of total cell barcodes.
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17. Now that we have a list of cell barcodes unique to each library, we can demultiplex our
calling card BAM file. The example show is for PB_1 but can be generalized to all samples.
python FilterBAMByBarcodes.py \
-i PB_YFTF-PB_map_scCC_final.bam
-b PB-1_unique_barcodes.txt \
-o PB-1_scCC_final.bam
We can now convert this BAM file to CCF output.
python BamToCallingCard.py \
-b CB \
-i PB-1_scCC_final.bam \
-o PB-1_scCC_unsorted.ccf
We can also combine the two wild-type piggyBac libraries into a single, sorted CCF file. (The
second step requires bedops; see here for alternative sorting commands).
cat PB-1_scCC_unsorted.ccf PB-2_scCC_unsorted.ccf | sort-bed - >
PB_scCC_final.ccf
cat YFTF-PB-1_scCC_unsorted.ccf YFTF-PB-2_scCC_unsorted.ccf |
sort-bed > YFTF-PB_scCC_final.ccf
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18. At last, we have a CCF file containing all insertions across all (unique) cells in a scCC
experiment. This file can be further visualized on the WashU Epigenome Browser and used as
input for peak calling. Here is an example of scCC CCF output.
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1
chr1

A5.4.6

29884
30355
32116
32303
33031
33031
33031
33031
33169
34572

29888
30359
32120
32307
33035
33035
33035
33035
33173
34576

3
4
11
674
2
21
25
98
26
4

+
+
+
+
+
-

GCATGATCAGACGTAG-1
CAGCTGGTCGCAAACT-1
GTGTGCGAGCTTCGCG-1
GTCGTAAAGGTAGCTG-1
TTAGTTCTCAACACTG-1
GCAATCAGTGGTTTCA-1
GCACTCTAGTAGCCGA-1
GTTTCTACAGACGCAA-1
CAAGAAAGTACAGCAG-1
CGTTCTGCAAATTGCC-1

Notes

19. In the course of analzying your scRNA-seq data, you may find biologically meaningful
clusters and may wish to identify differentially bound loci. Let us suppose that in the your
analysis of the YFTF-PB transfectants, you find two clusters of cells (Alfa and Bravo) and wish
to stratify insertions specific to each cluster. If the cell barcodes in each cluster are in
Barcodes_Alfa.txt and Barcodes_Bravo.txt, we can directly filter insertions from the YFTF-PB
CCF file, instead of going back to the BAM file.
python FilterCCFByBarcodes.py \
-i YFTF-PB_scCC_final.ccf \
-b Barcode_Alfa.txt \
-o YFTF-PB_scCC_Alfa.ccf
python FilterCCFByBarcodes.py \
-i YFTF-PB_scCC_final.ccf \
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-b Barcode_Bravo.txt \
-o YFTF-PB_scCC_Bravo.ccf
Note that if the input CCF file is sorted, the output file should automatically be sorted as well.
20. Currently, the scCC pipeline does not support 10x scRNA-seq libraries merged
using cellranger aggr. Guidance on this will be provided in the future.
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Appendix 6: Calling Peaks on piggyBac
Calling Card Data
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.bb9xir7n)

A6.1Abstract
This protocol describes how to all peaks on mammalian calling card data using either undirected,
or transcription factor fusions, to the piggyBac transposase. It is applicable for both bulk as well
as single cell calling card data.

A6.2Guidelines
Please make sure you have installed the required software and packages (see Materials section).
This protocol describes how to go from a CCF file, the processed output of a calling cards
experiment, to a set of peaks enriched for transcription factor (TF) binding. If you are unfamiliar
CCF files, we recommend reading our bulk or single cell calling card data processing protocols
first. We assume that you have performed either bulk calling cards (with sufficient replicates) or
single cell calling cards with undirected piggyBac (to map BRD4 binding) and, optionally, with a
TF-piggyBac fusion for your favorite TF (YFTF). To identify peaks in BRD4 binding, you
should prepare a single CCF containing insertions from all replicates of
undirected piggyBac calling cards. To call peaks on YFTF peaks, you will need two CCF files:
one from all replicates of undirected piggyBac experiments, and one from all replicates of YFTFpiggyBac experiments.
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A6.3Materials
This protocol requires a FASTA file for your genome of interest (e.g. hg38.fa) and the following
script:
•

kmer.cc

In addition, this workflow relies on some calling card-specific scripts, which use Python 3. It is
recommended that your Python installation be relatively up-to-date (i.e. ≥ 3.4). To check your
python version, type:
python -V
You will need the following Python modules:
•

numpy

•

pandas

•

scipy

•

statsmodels

•

pybedtools

•

astropy

All of these packages are available on PyPI and can be installed via pip:
pip install numpy pandas scipy statsmodels pybedtools astropy
(If Python3 is not the default on your system, replace pip with pip3)
These are the calling card-specific scripts you will need, all of which are available on GitHub:
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•

SegmentCCF.py

•

CCFIdeogram.py

•

BBPeakCaller_TF.py

•

BBPeakCaller_BRD4.py

The following programs are optional, but highly recommended:
•

bedtools (≥ 2.27)

•

bedops (≥ 2.4)

A6.4Steps
A6.4.1

Preprocessing

1. Before calling peaks on calling card data, it is useful to create a file listing the location of
every TTAA tetramer in the genome. The piggyBac transposase inserts almost exclusively into
this motif. Morever, we use the presence of a TTAA adjacent to a mapped read as an internal
quality check when creating CCF files. This section will walk you through how to quickly find
all TTAAs in a genome.
2. Compile the kmer.cc program as follows:
g++ kmer.cc -o kmer
The result should be a C++ executable in your directory called kmer.
3. This program takes as input a FASTA file and k-mer and outputs a BED file of all exact
matches to that k-mer. Here we use it to find all exact matches to the 4-mer TTAA.
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Download or copy to your working directory a FASTA file of your genome of interest. Using the
latest human genome build as an example:
./kmer hg38.fa TTAA > hg38_TTAA.bed
The file hg38_TTAA.bed now lists all TTAA's in hg38.fa.
It is important that the FASTA file that you use in this step is the same FASTA sequence used
for aligning calling card reads. For example, if you mapped to a repeat-masked genome earlier,
you should supply a repeat-masked FASTA file here.
4. (Optional) More recent builds of the human and mouse genomes contain unplaced contigs and
alternate haplotypes. You maybe interested in restricting your analysis to the "canonical"
chromosomes (e.g. 1-22, X & Y for humans). Here is a simple way to filter only "canonical"
TTAAs:
grep -v '_' hg38_TTAA.bed > hg38_TTAA_canon.bed
(If you are being nitpicky, this file will include TTAAs on the mitochondrial chromosome, but
we have not found this to be a problem for peak calling).
If you filter only "canonical" TTAAs, it is important that you also filter your CCF file so it
contains only insertions mapping to "canonical" chromosomes. The above command can be used
to do so. If you do not do this, you may get "divide by zero" errors in subsequent steps.
5. The TTAA file only needs to be generated once per genome. Afterwards, all experiments
using the same reference genome can use the same TTAA file.
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A6.4.2

Bayesian Blocks

6. The core of calling peaks in calling card data is Bayesian blocks. This algorithm, originally
developed in astrophysics, segments one-dimensional datasets into regions of piecewise-constant
density. We use it to initially partition the genome into intervals, where each interval contains a
constant rate of piggyBac insertions. These intervals are referred to as blocks; two adjacent
blocks are characterized by different insertion rates and, accordingly, different insertion
densities. One attractive reason for using Bayesian blocks is that it can find a mathematically
optimal partition of the data into blocks. Peak calling then proceeds by testing each block to see
if it contains more insertions than expected by some background model.
This much overview of Bayesian blocks is sufficient to understand peak calling. For more
details, we recommend reading the original paper (Scargle et al. 2013) or this blog post by Jake
VanderPlas.
7. We generate a list of blocks from CCF files, but these files must first be sorted. Here are three
ways to sort CCF files, in order of preference:
Using bedops:
sort-bed sample.ccf > sample_sorted.ccf
Using bedtools:
bedtools sort -i sample.ccf > sample_sorted.ccf
Using the standard shell sort command:
sort -k1V -k2n -k3n sample.ccf > sample_sorted.ccf
For the remainder of this protocol, we assume your CCF files are already sorted.
317

A6.4.3

Calling BRD4 Peaks

8. Here we will describe how to call BRD4 peaks from undirected piggyBac insertions. Our
sample file is HCT-116_PBase.ccf, which contains insertions from 10 replicates of bulk RNA
calling cards in the HCT-116 cell line. This file contains 1.5 million insertions:
wc -l HCT-116_PBase.ccf
1521048 HCT-116_PBase.ccf
9. We start by creating creating blocks from the CCF file. To do this, we use the SegmentCCF.py
script:
python SegmentCCF.py HCT-116_PBase.ccf | sed -e '/^\s*$/d' >
HCT-116_PBase.blocks
The output file is a BED-formatted list of blocks inferred by Bayesian blocks. The piped sed
command simply removes blank lines.
You may see a warning about false positive rates for event data, as well as possibly a dividing by
zero warning. These are automatically generated by astropy, the library which contains the
Bayesian blocks algorithm and can be safely ignored. We have successfully called peaks with the
blocks generated despite these warnings.
Segmenting the CCF file is often the most time-consuming step. The Bayesian blocks algorithm
has quadratic runtime complexity. If one CCF file has twice as many insertions as another, the
former is expected to take roughly four times longer to segment as the latter.
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10. We then provide the CCF and blocks files, as well as the TTAA file, to
BBPeakCaller_BRD4.py, which tests each block for statistical significance. This script performs
the following steps:
1. Divide the number of insertions by the number of TTAAs in the TTAA file. This defines
a global rate parameter (r) under a null model assuming a uniform distribution of
insertions.
2. For each block b, count the number of TTAAs in b and multiply it by r. This value
specifies the expected number of insertions in b if insertions were uniformly distribution
(denoted λb).
3. For each block b, let xb be the number of observed insertions in the block. The script then
performs a one-tailed Poisson significance test on the block. This is calculated as the
probability of observing xb insertions or more in the block parametrized by a Poisson
distribution with expected value λb.
4. Multiple hypothesis correction is performed (based on user preferences).
5. Finally, blocks that pass multiple hypothesis correction are polished and written to file.
The output file is in BED format.
11. BBPeakCaller_BRD4.py takes four required positional arguments: CCF file, blocks file,
TTAA file, and output filename. An example command would look like this:
python BBPeakCaller_BRD4.py HCT-116_PBase.ccf HCT116_PBase.blocks hg38_TTAA_canon.bed HCT-116_PBase_peaks.bed
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This command WILL NOT RUN as written because it does not specify how peaks should be
thresholded. See Step 12 for details.
12. Required flag:
BBPeakCaller_BRD4.py has one required flag which specifies the statistical threshold for
filtering blocks. There are two options for this: a straight p-value cutoff or with a multiple
hypothesis correction method. The former is specified by the –p flag; the value supplied to it
must be the –log10 transformation of the desired p-value.
Example: select only those blocks with p < 10-9
-p 9
Alternatively, you can control for multiple hypotheses at a desired alpha level. This is specified
by the –a flag and the value supplied is not transformed. If this option is used, you must supply a
method (–m) of multiple hypothesis correction. Valid methods are listed here.
Example: Bonferroni correction at an alpha of 0.05
-a 0.05 -m bonferroni
Example: Benjamini-Hochberg correction at false discovery rate of 10%
-a 0.1 -m fdr_bh
Remember: You must use EITHER –p OR –a –m for the program to run.
BRD4 peaks may require choosing a p-value cutoff that is more stringent than, for example,
Bonferroni correction. This appears to scale with size of the dataset: with more insertions, a more
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stringent cutoff is needed. To guide settling on an optimal p-value, we recommend calling peaks
at a variety of cutoffs, visualizing CCF data and peak files (eg. on the WashU Epigenome
Browser), and choosing a value whose peak boundaries reasonably accord with insertion
densities.
Optional flags:
Mutliple significant blocks may occur in close proximity to one another. If you want to merge
these into larger peaks, you can specify a distance (–d). Significant blocks within this distance
will be merged together.
Example: merge blocks within 12.5 kb
-d 12500
Finally, while the primary output of BBPeakCaller_BRD4.py is a list of peaks in BED format,
an intermediate filename (-i) can be supplied to write information about each block and it's pvalue. This file will be written in CSV format.
Example: write an intermediate file for the HCT-116 PBase dataset
-i HCT-116_PBase_intermediate.csv
13. The blocks file, in addition to being used to call peaks, can also be used to calculate
normalized insertion densities across the genome. This is done using the CCFIdeogram.py script,
which takes as input a CCF file and a blocks file and outputs a bedgraph file. Each entry in the
bedgraph file is a block and the numerical value for each block is the number of insertions in that
block per million mapped insertions per kilobase (IPKM).
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python CCFIdeogram.py HCT-116_PBase.ccf HCT-116_PBase.blocks
HCT-116_PBase.bedgraph
This script is named after ideograms because the resulting bedgraph files, when visualized as
densities, create banding patterns that resemble karyotyped chromosomes.
14. Let's put this all together. Here is the command to recreate our analysis from our recent
preprint:
python BBPeakCaller_BRD4.py -p 30 -d 12500 HCT-116_PBase.ccf
HCT-116_PBase.blocks hg38_TTAA_canon.bed HCT-116_PBase_peaks.bed
This generates a BED file containing nearly 2000 peaks.
wc -l HCT-116_PBase_peaks.bed
1939 HCT-116_PBase_peaks.bed
15. Here is the output of our sample analysis as visualized on the WashU Epigenome Browser.
The top track is the raw CCF data. The next track is the per-block insertion densities as
calculated by CCFIdeogram.py. The third track is the same as the second but with in-browser
smoothing (15 px). We then show peak boundaries at a variety of p-value thresholds, in order of
increasing stringency. Notice how peaks grow, merge, shrink, and vanish at different cutoffs.
The dark blue peaks track corresponds to the threshold used in the previous step. BRD4 and
H3K27ac data, marks of enhancers and super-enhancers, are shown for reference.
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Figure A6.1: Example of a BRD4-directed calling cards peak.

A6.4.4

Calling TF Peaks

16. Peak calling on TF-directed piggyBac insertions is similar to calling BRD4 peaks. The major
distinction is in the choice of background model. With undirected piggyBac, the background is
modeled as a uniform distribution of the observed number of insertions. For TFdirected piggyBac, however, the background is the undirected piggyBac dataset from the same
cell line or system.
For this example, we will use HCT-116_SP1-PBase.ccf. This file was generated from 10
replicates of bulk RNA calling cards with SP1-piggyBac in HCT-116 cells. The control file is the
undirected piggyBac data from the same system, i.e. HCT-116_PBase.ccf.
wc -l HCT-116_SP1-PBase.ccf
410588 HCT-116_SP1-PBase.ccf
17. As before, we start by creating creating blocks from the CCF file:
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python SegmentCCF.py HCT-116_SP1-PBase.ccf | sed -e '/^\s*$/d' >
HCT-116_SP1-PBase.blocks
The same notes from Step 9 apply here as well.
18. We then provide the CCF and blocks files, as well as the background CCF file, to
BBPeakCaller_TF.py, which tests each block for statistical significance. This script performs the
following steps:
1. Divide the number of insertions in the TF CCF file by the number of insertions in the
background CCF file. This defines a global scaling parameter (s). This enables us to
account for library size differences between the TF-directed and undirected control
libraries.
2. For each block b, count the number of insertions from the background CCF file in b and
multiply it by s, then add a pseudocount c. This value specifies the normalized expected
number of insertions in b from the undirected control experiment (denoted λb).
3. For each block b, let xb be the number of insertions from the TF-directed CCF file. The
script then performs a one-tailed Poisson significance test on the block. This is calculated
as the probability of observing xb insertions or more in the block parametrized by a
Poisson distribution with expected value λb.
4. Multiple hypothesis correction is performed (based on user preferences).
5. Finally, blocks that pass multiple hypothesis correction are polished and written to file.
The output file is in BED format.
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19. BBPeakCaller_TF.py takes four required positional arguments: TF-directed CCF file, TFdirected blocks file, undirected CCF file, and output filename. An example command would look
like this:
python BBPeakCaller_TF.py HCT-116_SP1-PBase.ccf HCT-116_SP1PBase.blocks HCT-116_PBase.ccf HCT-116_SP1-PBase_peaks.bed
This command WILL NOT RUN as written because it does not specify how peaks should be
thresholded. See Step 20 for details.
20. Required flag:
BBPeakCaller_TF.py has one required flag which specifies the statistical threshold for filtering
blocks. There are two options for this: a straight p-value cutoff or with a multiple hypothesis
correction method. The former is specified by the –p flag; the value supplied to it must be the –
log10 transformation of the desired p-value.
Example: select only those blocks with p < 10-9
-p 9
Alternatively, you can control for multiple hypotheses at a desired alpha level. This is specified
by the –a flag and the value supplied is not transformed. If this option is used, you must supply a
method (–m) of multiple hypothesis correction. Valid methods are listed here.
Example: Bonferroni correction at an alpha of 0.05
-a 0.05 -m bonferroni
Example: Benjamini-Hochberg correction at false discovery rate of 10%
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-a 0.1 -m fdr_bh
Remember: You must use EITHER –p OR –a –m for the program to run.
Optional flags:
Multiple significant blocks may occur in close proximity to one another. If you want to merge
these into larger peaks, you can specify a distance (–d). Significant blocks within this distance
will be merged together.
Example: merge blocks within 250 bp
-d 250
Peaks are composed of one or more blocks. Bayesian blocks draws block boundaries halfway
between adjacent insertions. This can, in some cases, lead to unnecessarily wide peaks.
The refine (–r) flag constrains the block edges so that they start and end at insertions. This, in
turn, helps increase the resolution of peak calls.
Peaks can be further filtered based on a size threshold. You can specify a minimum (–
n) and maximum (–x) size bound on reported peaks.
Example: report all peaks less than 5 kb in length
-x 5000
Example: report only peaks between 100 and 500 bp in length
-n 100 -x 500
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TF-piggyBac fusions redirect, but do not abolish, piggyBac's natural affinity for BRD4. This is
why TF-directed experiments must use an undirected calling card experiment as a control. This
can also pose a challenge for peak calling: whereas most TF's have narrow, sharp peaks, BRD4
can bind much broader stretches of the genome. Peak calling may not completely eliminate this
signal, which is typically reflected in large, but statisically significant, peaks. Broad peaks can
also occur in the shoulder regions flanking a TF binding site, likely from "spillover" of insertions
by the increased local concentration of transposase.
A simple way to increase peak specificity is to threshold on peak size. In our experience, in a
number of cell lines with a variety of TFs, 5 kb is a reasonable upper bound for filtering peaks.
This threshold is greater than the median peak sizes we have observed, which lets us preserve the
majority of called peaks.
By default, the pseudocount added to all peaks is 1. This value (–c) can be changed if desired.
Example: use a pseudocount of 0.1
-c 0.1
Finally, while the primary output of BBPeakCaller_TF.py is a list of peaks in BED format,
an intermediate filename (-i) can be supplied to write information about each block and it's pvalue. This file will be written in CSV format.
Example: write an intermediate file for the HCT-116 SP1-PBase dataset
-i HCT-116_SP1-PBase_intermediate.csv
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21. As before, TF-directed CCF files can also be used to create insertion density tracks,
following the instructions in Step 13.
22. Let's put this all together. This command calls peaks from SP1-PBase at a false discovery
rate of 5%, merging significant blocks within 250 bp, refining block edges, and outputing all
peaks less than 5 kb in length:
python BBPeakCaller_TF.py -a 0.05 -m fdr_bh -d 250 -r -x 5000
HCT-116_SP1-PBase.ccf HCT-116_SP1-PBase.blocks HCT-116_PBase.ccf
HCT-116_SP1-PBase_peaks.bed
This generates a BED file containing around 5600 peaks.
wc -l HCT-116_SP1-PBase_peaks.bed
5615 HCT-116_SP1-PBase_peaks.bed
23. Here is the output of our sample analysis as visualized on the WashU Epigenome Browser.
The top track are the undirected insertions, followed by the SP1-directed insertions. The next
track is the per-block insertion densities for the SP1-PBase data with in-browser smoothing (3
px). Finally, we plot peak boundaries at a variety of p-value thresholds, in order of decreasing
stringency. Notice how peaks grow, merge, shrink, and vanish at different cutoffs. The dark blue
peaks track corresponds to the threshold used in the previous step. The dark blue track shows all
significant peaks at 5% FDR less then 5 kb in length. The light blue track shows all peaks
without size restriction. Notice how imposing a maximum peak size filters out potentially
artifactual peaks.
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Figure A6.2: Example of an SP1-directed calling cards peak.

A6.4.5

Final Thoughts

24. BBPeakCaller_TF.py can also be used to call differential peaks between two different
undirected or TF-directed calling card datasets, such as between cell types or treatments. In this
use case, one sample serves as the "background" for the other. For example, let's imagine that we
have done one undirected (a.k.a. BRD4) calling cards experiment on cells treated with DMSO
and another treated with dexamethasone. To identify peaks that are enriched in the
dexamethasone condition, we could call:
python BBPeakCaller_TF.py -p 9 -d 12500 DEX.ccf DEX.blocks
DMSO.ccf DEX_peaks.bed
Since these tests are one-tailed, to find peaks that are enriched in the other direction, i.e. in the
DMSO condition, we simply swap the datasets:
python BBPeakCaller_TF.py -p 9 -d 12500 DMSO.ccf DMSO.blocks
DEX.ccf DMSO_peaks.bed
25. The output of these peak calling scripts are BED files listing peak coordinates only. They do
not annotate the peaks themselves. There are a number of programs for secondary analyses:
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•

Peaks can be annotated with overlapping and nearest genes using HOMER.

•

Peaks can be connected to putative genetic targets using GREAT.

•

De novo motif analysis on peaks can be done with either HOMER or MEME.

26. For guidance on how to visualize calling card data, see our Appendix 7. Documentation is
also available from the WashU Epigenome Browser.
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Appendix 7: Visualizing Calling Card Data
on the WashU Epigenome Browser
(A version of this appendix has been published on protocols.io:
https://doi.org/10.17504/protocols.io.bca8ishw)

A7.1Abstract
This document explains how to visualize calling card insertions as wells as density and peak
tracks on the WashU Epigenome Browser.

A7.2Guidelines
Please make sure you have installed the required software and packages (see Materials section).
This protocol describes how to visualize calling card data, such as raw insertions (in a CCF file),
insertion densities (bedgraph file), and peaks (BED file). Ideally, you will be able to store files
on a publicly-accessible webserver. This requires enabling Cross-Origin Resource Sharing
(CORS). If this is not possible, data files can also be directly uploaded from your computer to the
browser. This approach is described in the second half of the protocol.

A7.3Materials
If you are hosting files on a server, you will require the following software package:
•

htslib

A7.4Steps
A7.4.1

Introduction

1. During the course of a calling card experiment, or after all the analysis has been said and done,
you may want to visually inspect the data. These can be the raw insertions (stored as a CCF file),
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insertion densities (as a bedgraph file), or the peak boundaries (as a BED file). Instructions for
generating these kinds of files can be found in the following protocols:
•

Processing Bulk RNA Calling Card Sequencing Data (Appendix 4)

•

Processing Single Cell Calling Card Sequencing Data (Appendix 5)

•

Calling Peaks on piggyBac Calling Card Data (Appendix 6)

2. The WashU Epigenome Browser natively supports visualizing CCF files as a calling card
track. In addition, it supports standard genomic file formats such as BED, bedgraph, bigWig, and
HiC. This allows us to compare and contrast calling card data to popular genomic assays like
ChIP-seq, DNase-seq, ATAC-seq, and Hi-C.
There are two ways load data onto the browser:
1. Hosting your data on a publicly-accessible server and letting the browser fetch the data.
2. Directly uploading text files to the browser.
The first method is preferred: track information and preferences can be stored in a simple text
file, which can then be shared with collaborators. This saves the effort and cost of moving
around potentially large datasets. Instead, the data remains in one place and can be accessed by
anyone from anywhere.
The second option can be used if a public server is not available to you, or if you want to rapidly
look at files that are already on your computer.
3. For this protocol, we will use the following files:
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•

HCT-116_PBase.ccf, a file of raw calling card insertions

•

HCT-116_PBase.bedgraph, a file of calling card insertion densities across the genome

•

HCT-116_PBase_peaks.bed, a file of peaks inferred from calling card data

A7.4.2

Uploading Data from an External Server

4. BED, bedgraph, and CCF files are all text-based formats. Before being hosted on an external
server, these files must be compressed and indexed. This allows for fast, random-access to the
data. For this step, make sure you have installed htslib (see Materials).
To compress the file:
bgzip HCT-116_PBase.ccf
This will compress the original file, creating HCT-116_PBase.ccf.gz
To index the compressed file:
tabix -p bed HCT-116_PBase.ccf.gz
This will create an index file, HCT-116_PBase.ccf.gz.tbi
Both HCT-116_PBase.ccf.gz and HCT-116_PBase.ccf.gz.tbi should be copied to a publiclyaccessible webserver. These steps also apply to bedgraph and BED files.
5. Next, we create a JSON file. JSON is a generic standard describing objects and their
properties. Here, we use it to describe each track, its data, and any options we may want to
customize. The JSON file is plain text; it is recommended that you use a text editor (e.g.
Sublime, Atom, Visual Studio Code, vim/emacs, etc.) instead of a word processor (e.g. Microsoft
Word) to create this file.
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We will create HCT-116_PBase.json for our data. Here is the structure of a JSON file for a
single track depicting calling card data:
[ { "type":"callingcard",
"url":"https://htcf.wustl.edu/files/xXl8ZAXy/HCT116_PBase.ccf.gz", "name":"piggyBac insertions",
"showOnHubLoad":"true", "options":{ "color":"#3182bd",
"height":100, "logScale":"log10",
"markerSize":3,
"opacity":[100],
"show":"all", "sampleSize":1000,
},
},
]
All tracks in the JSON file must be between the square brackets [...]. Curly braces {...} and
commas separate invidual tracks, and within a track, another set of curly braces may be used to
specify grouped options. Let's consider each of these entries in turn:
"type":"callingcard",
This specifies the track type, which in this case is a calling card track.
"url":"https://htcf.wustl.edu/files/xXl8ZAXy/HCT116_PBase.ccf.gz",
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This points to the web address where your data are stored. Note that this must point to the
compressed file. The browser will automatically located the index file. (If the index file is not
present, it will throw an error).
"name":"piggyBac insertions",
This is the track label.
"showOnHubLoad":"true",
This specifies whether the track should be display immediately after the JSON file has been
uploaded. The default value is "false."
There are also a number of options that can be specified to customize the track appearance.
While all of them can be changed after the tracks have been loaded, specifying them in the JSON
file helps to record and reproduce settings. Note that these only need to be set if you wish to
override defaults.
"color":"#f4916c",
This sets the color of the individual calling card markers. The default is blue.
"height":100,
This sets the height of the track in pixels. The default is 40.
"logScale":"log10",
This transforms the y-axis from a linear scale to a logarithmic scale. By default, the track uses a
linear scale, but for calling card experiments we recommed using a logarithmic scale.
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"markerSize":3,
This is the radius of the marker in pixels. The default value is 3.
"opacity":[100],
This specifies the opacity of the markers, which can help emphasize data-dense regions. This
takes an integer value between 0 and 100. The value supplied must be in square brackets. The
default value is 100.
"show":"all", "sampleSize":1000,
This pair of options specify whether the browser should display all data points, or simply a
random subsample. If there are many (e.g. thousands) of data points in view, it can slow down
your web browser. Subsampling can help preserve a global representation of your data while still
remaining responsive and memory-friendly. The "show" option can take two values: "all"
(default) or "sample." The former draws all data points. If the latter is specified, then the
"sampleSize" option is applied. This number determines how many points to subsample and is
set to 1000 by default.
6. We can also add the bedgraph and BED files to the JSON:
[ { "type":"callingcard",
"url":"https://htcf.wustl.edu/files/xXl8ZAXy/HCT116_PBase.ccf.gz", "name":"piggyBac insertions",
"showOnHubLoad":"true", "options":{ "color":"#3182bd",
"height":100, "logScale":"log10",
"markerSize":3,
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"opacity":[100],
"show":"all", "sampleSize":1000,
},
},
{ "type":"bedgraph",
"url":"https://htcf.wustl.edu/files/xXl8ZAXy/HCT116_PBase.bedgraph", "name":"HCT-116 PBase density",
"showOnHubLoad":"true", "options":{ "color":"#3182bd",
"height":50,
},
},
{ "type":"bed",
"url":"https://htcf.wustl.edu/files/xXl8ZAXy/HCT-116_PBase.bed",
"name":"HCT-116 PBase peaks", "showOnHubLoad":"true", "options":
{ "color":"#3182bd",
"height":20, "displayMode":"density",
}
},
]
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Many options have the same names and settings as the calling card track. A complete list of
options for bedgraph and BED tracks can be found here.
7. Now we can upload this file to the browser and visualize it. Go to the homepage and select the
appropriate genome:
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Figure A7.1: WashU Epigenome Browser splash page.

8. Once the genome has loaded, click on the blue "Tracks" button and select "Custom tracks."
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Figure A7.2: Custom tracks pane.

9. Select the second tab, "Add Custom Data Hub."

Figure A7.3: Load custom data hub.

Clicking on the second dialog box ("Choose datahub file") will open a filesystem navigator
window. Find the JSON file on your system and upload it.
Upon successful upload, you should see a table listing the uploaded tracks:
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Figure A7.4: Successfully uploaded data hub.

10. After closing the custom track pane (with the red X in the upper right corner), all three tracks
should be visible:

Figure A7.5: Default view after uploading data hub.

Note that the gencodeV29 track has been removed for this screenshot.
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A7.4.3

Uploading Local Data Files

11. As an alternative to hosting your data externally, you can directly upload text-based data
files, including CCF, bedgraph, and BED. If you choose this option, your files should not be
compressed. Also, for very large files, this approach may slow down your browser.
12. Click on the blue "Tracks" button and select "Text track."

Figure A7.6: Text track pane.

13. Select "callingcard" from the dropdown menu, then click on the "Choose Files" button.
Select one or more CCF files to upload. The browser will then load the tracks; this may take a
few moments, depending on the size of the file(s).
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Figure A7.7: Uploading a calling cards text file.

14. After the tracks have been loaded, close the pane by clicking on the red X in the top right
corner. When directly uploading text files, tracks will be rendered with default options.

Figure A7.8: Default view after uploading text file.

343

These steps can be repeated for BED and bedgraph files.

A7.4.4

Interacting with the Calling Card Track

15. The calling card track was designed for interactive exploration. This is chiefly accomplished
by a rollover box that appears as the mouse cursor nears a data point. An approximate location is
at the top of the pane, while the bottom lists the read count, strand, and barcode for each
insertion:

Figure A7.9: Hovering over a calling cards insertion.

16. Right clicking on the calling card track will bring up a preference pane, where tracks can be
dynamically customized:
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Figure A7.10: Calling cards customization pane.

Similar preference panes exist for the BED and bedgraph tracks.
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17. This example showcases all the different options available for calling card tracks, such as
color, marker size, opacity, and subsampling:

Figure 11: Various customizations applied to calling card tracks.
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Appendix 8: Online Resources
A8.1Links to Online Resources
Computational analyses are a necessary aspect of modern biology and this thesis would not have
been possible without custom, task-specific software. While a number of software repositories
and other online resources are mentioned throughout the text, we have collected them here for
easy reference:
•

Main calling cards repository: https://github.com/arnavm/calling_cards
o This houses scripts referenced in Chapter 2 and Appendices 4-6. Additional
scripts are provided specifically for use on the High-Throughput Computing
Facility (HTCF) cluster at Washington University in St. Louis. Finally, this
repository also has several notebooks that detail the single cell analyses in
Chapter 2.

•

WashU Epigenome Browser with Calling Card support: https://github.com/arnavm/egreact
o This fork of the new WashU Epigenome Browser incorporates code for
visualizing the calling card track (Appendix 7). These edits have since been
merged back into the main branch of the WashU Epigenome Browser.

•

Legacy WashU Epigenome Browser with Calling Card support:
https://github.com/arnavm/eg
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o This was the original fork of the WashU Epigenome Browser that originated the
calling card track. While it has been superseded by the previous repository,
references to this version can be found in Chapter 2.
•

Blockify: https://github.com/arnavm/blockify
o This repository contains the source code for blockify, a genomic segmentation
algorithm based on Bayesian blocks (Chapter 4).
o A packaged version of this code is available from the Python Package Index:
https://pypi.org/project/blockify/.
o Accompanying documentation can be found at https://blockify.readthedocs.io/

•

Mirror of the calling cards repository: https://gitlab.com/arnavm/calling_cards
o This is a fork of the main calling cards codebase on GitHub. One key difference is
that this repository has a Ref folder containing data files that are fetched in
blockify’s unit tests.

•

Transposon calling cards protocols: https://www.protocols.io/workspaces/calling-cards/
o This folder contains online versions of transposon calling cards protocols
(Appendices 1-7).

•

kmer.cc: https://gist.github.com/arnavm/039e76a34a386a4f29b82682bc8e6c72
o This is a fast program for finding exact sequence matches in a genome and is
referenced in Appendix 6.
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•

Multi-modal scRNA-seq figure: https://github.com/arnavm/multimodal-scRNA-seq
o This repository contains the multi-modal scRNA-seq figure graphic referenced in
Chapter 1 as well as links to relevant references.
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